BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 50665227 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(CC=C)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.76,4.32,;-9.99,2.98,;-10.76,1.65,;-9.99,.32,;-10.76,-1.02,;-8.45,.32,;-7.68,-1.03,;-6.15,-1.03,;-5.37,.3,;-6.14,1.64,;-7.69,1.64,;-3.83,.3,;-2.74,-.8,;-1.65,.28,;-2.74,1.37,;-.11,.28,;.65,-1.06,;-.12,-2.39,;2.19,-1.06,;2.96,-2.4,;4.5,-2.4,;5.4,-3.65,;6.87,-3.18,;8.11,-4.08,;9.52,-3.46,;10.76,-4.36,;6.86,-1.63,;8,-.61,;7.69,.89,;6.22,1.36,;5.09,.34,;5.41,-1.16,;5.9,2.87,;7.04,3.9,;4.44,3.34,;5.49,4.36,)| InChI=1S/C25H32F3N5O3/c1-3-11-33-21-10-7-17(25(26,27)28)12-20(21)23(31-33)29-13-22(34)30-18-14-32(15-18)19-8-5-16(6-9-19)24(35)36-4-2/h3,7,10,12,16,18-19H,1,4-6,8-9,11,13-15H2,2H3,(H,29,31)(H,30,34) BDWRIURLGQMQKO-UHFFFAOYSA-N 50355247 CHEMBL1834779 C-C chemokine receptor type 2 Homo sapiens 53 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355247&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54756156 136361933 CHEMBL1834779 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665228 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(CC)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.14,4.18,;-9.37,2.84,;-10.14,1.51,;-9.37,.18,;-10.14,-1.16,;-7.83,.18,;-7.06,-1.17,;-5.53,-1.17,;-4.75,.16,;-5.52,1.5,;-7.06,1.5,;-3.21,.16,;-2.12,-.94,;-1.03,.14,;-2.11,1.23,;.51,.14,;1.28,-1.2,;.5,-2.53,;2.82,-1.2,;3.58,-2.54,;5.12,-2.55,;6.02,-3.79,;7.49,-3.32,;8.73,-4.22,;10.14,-3.6,;7.49,-1.78,;8.63,-.75,;8.31,.75,;6.85,1.22,;5.71,.2,;6.03,-1.3,;6.52,2.73,;7.67,3.76,;5.06,3.2,;6.11,4.22,)| InChI=1S/C24H32F3N5O3/c1-3-32-20-10-7-16(24(25,26)27)11-19(20)22(30-32)28-12-21(33)29-17-13-31(14-17)18-8-5-15(6-9-18)23(34)35-4-2/h7,10-11,15,17-18H,3-6,8-9,12-14H2,1-2H3,(H,28,30)(H,29,33) HLMHWYIWIILJEU-UHFFFAOYSA-N 50355248 CHEMBL1834721 C-C chemokine receptor type 2 Homo sapiens 15 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355248&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755560 136361934 CHEMBL1834721 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665229 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-9.38,3.96,;-8.61,2.63,;-9.38,1.29,;-8.61,-.04,;-9.38,-1.38,;-7.07,-.04,;-6.3,-1.39,;-4.77,-1.39,;-3.99,-.06,;-4.76,1.28,;-6.31,1.29,;-2.45,-.06,;-1.36,-1.16,;-.27,-.08,;-1.36,1.02,;1.27,-.08,;2.03,-1.42,;1.26,-2.75,;3.57,-1.42,;4.34,-2.76,;5.88,-2.76,;6.78,-4.01,;8.25,-3.53,;8.24,-1.99,;9.38,-.97,;9.07,.53,;7.6,1,;6.47,-.02,;6.79,-1.51,;7.28,2.51,;8.42,3.54,;5.82,2.98,;6.87,4.01,)| InChI=1S/C22H28F3N5O3/c1-2-33-21(32)13-3-6-16(7-4-13)30-11-15(12-30)27-19(31)10-26-20-17-9-14(22(23,24)25)5-8-18(17)28-29-20/h5,8-9,13,15-16H,2-4,6-7,10-12H2,1H3,(H,27,31)(H2,26,28,29) BFNOLBZMRSIRMC-UHFFFAOYSA-N 50355249 CHEMBL1834719 C-C chemokine receptor type 2 Homo sapiens 27 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355249&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755081 136361935 CHEMBL1834719 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665230 NC(=O)n1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(10.56,-4.99,;10.72,-3.46,;12.13,-2.83,;9.48,-2.55,;8.01,-3.02,;7.11,-1.78,;5.57,-1.78,;4.8,-.44,;3.26,-.43,;2.49,-1.77,;2.5,.9,;.96,.91,;-.13,-.18,;-1.22,.92,;-.13,2,;-2.76,.93,;-3.54,-.4,;-5.07,-.4,;-5.84,.94,;-5.08,2.27,;-3.53,2.26,;-7.38,.94,;-8.14,-.39,;-9.67,-.39,;-10.45,.94,;-11.96,1.26,;-12.13,2.79,;-10.72,3.43,;-9.68,2.28,;-8.14,2.28,;8.02,-.53,;7.7,.96,;8.83,1.99,;10.3,1.51,;10.61,.01,;9.47,-1.01,;8.51,3.49,;9.65,4.52,;7.05,3.96,;8.1,4.99,)| InChI=1S/C27H29F3N6O4/c28-27(29,30)17-4-7-21-20(10-17)25(34-36(21)26(31)38)32-11-24(37)33-18-12-35(13-18)19-5-1-15(2-6-19)16-3-8-22-23(9-16)40-14-39-22/h3-4,7-10,15,18-19H,1-2,5-6,11-14H2,(H2,31,38)(H,32,34)(H,33,37) DFOPMFXQYWVKQK-UHFFFAOYSA-N 50355250 CHEMBL1834718 C-C chemokine receptor type 2 Homo sapiens 82 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355250&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56668309 136361936 CHEMBL1834718 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665231 CC(C)(C)NC(=O)n1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:22.26,19.19,(11.1,-6.21,;11.26,-4.68,;12.67,-4.05,;12.35,-5.76,;10.02,-3.77,;10.18,-2.24,;11.59,-1.61,;8.93,-1.33,;7.47,-1.8,;6.57,-.56,;5.03,-.56,;4.26,.78,;2.72,.78,;1.95,-.55,;1.96,2.12,;.42,2.13,;-.67,1.04,;-1.76,2.14,;-.67,3.22,;-3.3,2.14,;-4.08,.81,;-5.61,.82,;-6.38,2.16,;-5.62,3.49,;-4.07,3.48,;-7.92,2.16,;-8.68,.83,;-10.21,.82,;-10.99,2.16,;-12.5,2.48,;-12.67,4.01,;-11.26,4.65,;-10.23,3.5,;-8.68,3.5,;7.48,.69,;7.16,2.18,;8.29,3.2,;9.76,2.73,;10.07,1.23,;8.93,.21,;7.97,4.71,;9.11,5.74,;6.51,5.18,;7.56,6.21,)| InChI=1S/C31H37F3N6O4/c1-30(2,3)37-29(42)40-24-10-7-20(31(32,33)34)13-23(24)28(38-40)35-14-27(41)36-21-15-39(16-21)22-8-4-18(5-9-22)19-6-11-25-26(12-19)44-17-43-25/h6-7,10-13,18,21-22H,4-5,8-9,14-17H2,1-3H3,(H,35,38)(H,36,41)(H,37,42) HYZGGNZNVAYPFO-UHFFFAOYSA-N 50355251 CHEMBL1834717 C-C chemokine receptor type 2 Homo sapiens 55 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355251&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56661444 136361937 CHEMBL1834717 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665232 OCCn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(11.97,-5.44,;10.72,-4.54,;10.88,-3,;9.64,-2.1,;8.17,-2.57,;7.27,-1.33,;5.73,-1.32,;4.97,.01,;3.43,.02,;2.65,-1.31,;2.66,1.36,;1.12,1.36,;.03,.27,;-1.06,1.37,;.04,2.45,;-2.6,1.38,;-3.38,.05,;-4.91,.05,;-5.68,1.4,;-4.91,2.72,;-3.37,2.72,;-7.22,1.39,;-7.97,.07,;-9.51,.06,;-10.29,1.4,;-11.8,1.71,;-11.97,3.25,;-10.56,3.88,;-9.52,2.74,;-7.98,2.73,;8.18,-.08,;7.86,1.41,;9,2.44,;10.46,1.96,;10.78,.46,;9.64,-.56,;8.67,3.94,;9.82,4.98,;7.21,4.42,;8.26,5.44,)| InChI=1S/C28H32F3N5O4/c29-28(30,31)19-4-7-23-22(12-19)27(34-36(23)9-10-37)32-13-26(38)33-20-14-35(15-20)21-5-1-17(2-6-21)18-3-8-24-25(11-18)40-16-39-24/h3-4,7-8,11-12,17,20-21,37H,1-2,5-6,9-10,13-16H2,(H,32,34)(H,33,38) NAWKYIASORHDMZ-UHFFFAOYSA-N 50355252 CHEMBL1834652 C-C chemokine receptor type 2 Homo sapiens 21 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355252&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755801 136361938 CHEMBL1834652 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665233 FC(F)(F)c1ccc2onc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccc4OCOc4c3)c2c1 |r,wU:23.27,20.20,(10.41,3.54,;9.27,2.51,;7.8,2.98,;8.86,4.01,;9.59,1,;11.06,.53,;11.37,-.97,;10.23,-1.99,;10.23,-3.53,;8.77,-4.01,;7.87,-2.76,;6.33,-2.76,;5.56,-1.42,;4.02,-1.42,;3.25,-2.75,;3.26,-.08,;1.72,-.08,;.62,-1.16,;-.47,-.06,;.63,1.02,;-2.01,-.06,;-2.78,-1.39,;-4.32,-1.39,;-5.08,-.04,;-4.32,1.29,;-2.77,1.28,;-6.62,-.04,;-7.38,-1.37,;-8.92,-1.38,;-9.69,-.04,;-11.21,.28,;-11.37,1.81,;-9.96,2.44,;-8.93,1.3,;-7.39,1.3,;8.77,-1.51,;8.46,-.02,)| InChI=1S/C26H27F3N4O4/c27-26(28,29)17-4-8-21-20(10-17)25(32-37-21)30-11-24(34)31-18-12-33(13-18)19-5-1-15(2-6-19)16-3-7-22-23(9-16)36-14-35-22/h3-4,7-10,15,18-19H,1-2,5-6,11-14H2,(H,30,32)(H,31,34) HQGJCOXCZNLUFA-UHFFFAOYSA-N 50355253 CHEMBL1834651 C-C chemokine receptor type 2 Homo sapiens 36 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355253&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755919 136361939 CHEMBL1834651 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665234 CS(=O)(=O)N[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-7.87,2.63,;-8.63,1.29,;-10.13,1.7,;-9.73,.21,;-7.86,-.04,;-6.32,-.04,;-5.56,1.29,;-4.01,1.28,;-3.25,-.06,;-4.02,-1.39,;-5.56,-1.39,;-1.71,-.06,;-.62,-1.16,;.48,-.08,;-.61,1.02,;2.02,-.08,;2.78,-1.42,;2.01,-2.75,;4.32,-1.42,;5.09,-2.76,;6.63,-2.76,;7.53,-4.01,;8.99,-3.53,;8.99,-1.99,;10.13,-.97,;9.82,.53,;8.35,1,;7.22,-.02,;7.54,-1.51,;8.03,2.51,;9.17,3.54,;6.56,2.98,;7.62,4.01,)| InChI=1S/C20H27F3N6O3S/c1-33(31,32)28-13-3-5-15(6-4-13)29-10-14(11-29)25-18(30)9-24-19-16-8-12(20(21,22)23)2-7-17(16)26-27-19/h2,7-8,13-15,28H,3-6,9-11H2,1H3,(H,25,30)(H2,24,26,27) ULYVIQRDWMYXRX-UHFFFAOYSA-N 50355254 CHEMBL1834650 C-C chemokine receptor type 2 Homo sapiens 2080 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355254&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56678640 136361940 CHEMBL1834650 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665235 N[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:1.0,4.7,(-9,-.04,;-7.46,-.04,;-6.69,1.29,;-5.15,1.28,;-4.38,-.06,;-5.16,-1.39,;-6.69,-1.39,;-2.84,-.06,;-1.75,-1.16,;-.66,-.08,;-1.74,1.02,;.88,-.08,;1.65,-1.42,;.87,-2.75,;3.19,-1.42,;3.95,-2.76,;5.49,-2.76,;6.39,-4.01,;7.86,-3.53,;7.86,-1.99,;9,-.97,;8.68,.53,;7.22,1,;6.08,-.02,;6.4,-1.51,;6.9,2.51,;8.04,3.54,;5.43,2.98,;6.48,4.01,)| InChI=1S/C19H25F3N6O/c20-19(21,22)11-1-6-16-15(7-11)18(27-26-16)24-8-17(29)25-13-9-28(10-13)14-4-2-12(23)3-5-14/h1,6-7,12-14H,2-5,8-10,23H2,(H,25,29)(H2,24,26,27) KHGASTLPNIZCGV-UHFFFAOYSA-N 50355255 CHEMBL1834649 C-C chemokine receptor type 2 Homo sapiens >25000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355255&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56668413 136361941 CHEMBL1834649 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665236 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@@H]3CC[C@@H](CC3)OCC=C)c2c1 |r,wU:23.27,20.20,(8.42,3.54,;7.28,2.51,;5.82,2.98,;6.87,4.01,;7.6,1,;9.07,.53,;9.38,-.97,;8.24,-1.99,;8.25,-3.53,;6.78,-4.01,;5.88,-2.76,;4.34,-2.76,;3.57,-1.42,;2.03,-1.42,;1.26,-2.75,;1.27,-.08,;-.27,-.08,;-1.36,-1.16,;-2.45,-.06,;-1.36,1.02,;-3.99,-.06,;-4.76,1.28,;-6.31,1.29,;-7.07,-.04,;-6.3,-1.39,;-4.77,-1.39,;-8.61,-.04,;-9.38,1.29,;-8.61,2.63,;-9.38,3.96,;6.79,-1.51,;6.47,-.02,)| InChI=1S/C22H28F3N5O2/c1-2-9-32-17-6-4-16(5-7-17)30-12-15(13-30)27-20(31)11-26-21-18-10-14(22(23,24)25)3-8-19(18)28-29-21/h2-3,8,10,15-17H,1,4-7,9,11-13H2,(H,27,31)(H2,26,28,29) USSMAYHMTCOLDZ-UHFFFAOYSA-N 50355256 CHEMBL1834648 C-C chemokine receptor type 2 Homo sapiens 200 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355256&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56675302 136361942 CHEMBL1834648 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665237 CCO[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:3.2,6.9,(-8.61,2.63,;-9.38,1.29,;-8.61,-.04,;-7.07,-.04,;-6.31,1.29,;-4.76,1.28,;-3.99,-.06,;-4.77,-1.39,;-6.3,-1.39,;-2.45,-.06,;-1.36,-1.16,;-.27,-.08,;-1.36,1.02,;1.27,-.08,;2.03,-1.42,;1.26,-2.75,;3.57,-1.42,;4.34,-2.76,;5.88,-2.76,;6.78,-4.01,;8.24,-3.53,;8.24,-1.99,;9.38,-.97,;9.07,.53,;7.6,1,;6.47,-.02,;6.79,-1.51,;7.28,2.51,;8.42,3.54,;5.82,2.98,;6.87,4.01,)| InChI=1S/C21H28F3N5O2/c1-2-31-16-6-4-15(5-7-16)29-11-14(12-29)26-19(30)10-25-20-17-9-13(21(22,23)24)3-8-18(17)27-28-20/h3,8-9,14-16H,2,4-7,10-12H2,1H3,(H,26,30)(H2,25,27,28) CVZMFXLZFUQQCZ-UHFFFAOYSA-N 50355257 CHEMBL1834647 C-C chemokine receptor type 2 Homo sapiens 140 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355257&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56675301 136361943 CHEMBL1834647 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665238 O[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:1.0,4.7,(-9,-.04,;-7.46,-.04,;-6.69,1.29,;-5.15,1.28,;-4.38,-.06,;-5.16,-1.39,;-6.69,-1.39,;-2.84,-.06,;-1.75,-1.16,;-.66,-.08,;-1.74,1.02,;.88,-.08,;1.65,-1.42,;.87,-2.75,;3.19,-1.42,;3.95,-2.76,;5.49,-2.76,;6.39,-4.01,;7.86,-3.53,;7.86,-1.99,;9,-.97,;8.68,.53,;7.22,1,;6.08,-.02,;6.4,-1.51,;6.9,2.51,;8.04,3.54,;5.43,2.98,;6.48,4.01,)| InChI=1S/C19H24F3N5O2/c20-19(21,22)11-1-6-16-15(7-11)18(26-25-16)23-8-17(29)24-12-9-27(10-12)13-2-4-14(28)5-3-13/h1,6-7,12-14,28H,2-5,8-10H2,(H,24,29)(H2,23,25,26) JHOIOEADFLDOHZ-UHFFFAOYSA-N 50355258 CHEMBL1834646 C-C chemokine receptor type 2 Homo sapiens 530 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355258&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56675300 136361944 CHEMBL1834646 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665239 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@H](COCC=C)CC2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.17,(10.23,-42.67,;8.98,-41.76,;7.52,-42.23,;6.62,-40.99,;5.08,-40.99,;4.31,-39.65,;2.77,-39.65,;2,-40.98,;2.01,-38.31,;.47,-38.3,;-.63,-39.39,;-1.72,-38.29,;-.62,-37.21,;-3.26,-38.29,;-4.03,-36.95,;-5.57,-36.94,;-6.33,-38.27,;-7.87,-38.27,;-8.65,-36.94,;-7.88,-35.6,;-8.65,-34.27,;-7.88,-32.93,;-5.57,-39.61,;-4.03,-39.62,;7.52,-39.74,;7.21,-38.25,;8.34,-37.23,;9.81,-37.7,;10.12,-39.2,;8.98,-40.22,;8.02,-35.72,;9.16,-34.69,;6.55,-35.25,;7.61,-34.22,)| InChI=1S/C24H32F3N5O2/c1-3-10-34-15-16-4-7-19(8-5-16)32-13-18(14-32)29-22(33)12-28-23-20-11-17(24(25,26)27)6-9-21(20)31(2)30-23/h3,6,9,11,16,18-19H,1,4-5,7-8,10,12-15H2,2H3,(H,28,30)(H,29,33) XSTSZTTUPFLRLY-UHFFFAOYSA-N 50355259 CHEMBL1834645 C-C chemokine receptor type 2 Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355259&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754724 136361945 CHEMBL1834645 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665240 CCOC[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:7.10,4.3,(12.26,-25.29,;13.03,-26.62,;12.26,-27.95,;13.03,-29.29,;14.57,-29.29,;15.34,-27.96,;16.88,-27.97,;17.65,-29.3,;16.87,-30.63,;15.34,-30.63,;19.19,-29.31,;20.28,-30.41,;21.37,-29.32,;20.29,-28.23,;22.91,-29.33,;23.68,-30.66,;22.9,-31.99,;25.22,-30.67,;25.98,-32,;27.52,-32.01,;28.42,-33.25,;29.89,-32.78,;31.13,-33.69,;29.89,-31.24,;31.03,-30.22,;30.71,-28.72,;29.25,-28.24,;28.11,-29.27,;28.43,-30.76,;28.92,-26.74,;30.07,-25.7,;27.46,-26.26,;28.51,-25.24,)| InChI=1S/C23H32F3N5O2/c1-3-33-14-15-4-7-18(8-5-15)31-12-17(13-31)28-21(32)11-27-22-19-10-16(23(24,25)26)6-9-20(19)30(2)29-22/h6,9-10,15,17-18H,3-5,7-8,11-14H2,1-2H3,(H,27,29)(H,28,32) NLACPXOSKRJIGO-UHFFFAOYSA-N 50355260 CHEMBL1834644 C-C chemokine receptor type 2 Homo sapiens 27 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355260&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754723 136361946 CHEMBL1834644 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665241 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@H](CO)CC2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.17,(8.93,-30.5,;7.68,-29.59,;6.22,-30.06,;5.32,-28.82,;3.78,-28.81,;3.01,-27.48,;1.47,-27.47,;.7,-28.8,;.71,-26.14,;-.83,-26.13,;-1.93,-27.22,;-3.02,-26.12,;-1.92,-25.04,;-4.56,-26.11,;-5.32,-24.78,;-6.87,-24.77,;-7.63,-26.1,;-9.17,-26.1,;-9.94,-24.76,;-6.87,-27.44,;-5.33,-27.44,;6.23,-27.57,;5.91,-26.08,;7.04,-25.05,;8.51,-25.53,;8.82,-27.03,;7.68,-28.05,;6.72,-23.55,;7.86,-22.52,;5.25,-23.07,;6.31,-22.05,)| InChI=1S/C21H28F3N5O2/c1-28-18-7-4-14(21(22,23)24)8-17(18)20(27-28)25-9-19(31)26-15-10-29(11-15)16-5-2-13(12-30)3-6-16/h4,7-8,13,15-16,30H,2-3,5-6,9-12H2,1H3,(H,25,27)(H,26,31) LDEUNNVWDAAUOC-UHFFFAOYSA-N 50355261 CHEMBL1834643 C-C chemokine receptor type 2 Homo sapiens 44 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355261&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754722 136361947 CHEMBL1834643 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665242 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)C(N)=O)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(31.19,-22.92,;29.94,-22.01,;28.48,-22.49,;27.58,-21.24,;26.04,-21.24,;25.27,-19.9,;23.73,-19.9,;22.96,-21.23,;22.97,-18.56,;21.43,-18.56,;20.33,-19.64,;19.24,-18.54,;20.34,-17.46,;17.7,-18.54,;16.93,-19.87,;15.39,-19.87,;14.63,-18.52,;15.39,-17.19,;16.94,-17.2,;13.09,-18.52,;12.32,-17.19,;12.32,-19.86,;28.49,-19.99,;28.17,-18.5,;29.3,-17.48,;30.77,-17.95,;31.08,-19.45,;29.94,-20.47,;28.98,-15.97,;30.12,-14.94,;27.51,-15.5,;28.57,-14.47,)| InChI=1S/C21H27F3N6O2/c1-29-17-7-4-13(21(22,23)24)8-16(17)20(28-29)26-9-18(31)27-14-10-30(11-14)15-5-2-12(3-6-15)19(25)32/h4,7-8,12,14-15H,2-3,5-6,9-11H2,1H3,(H2,25,32)(H,26,28)(H,27,31) AFBZMWCSHPIYMB-UHFFFAOYSA-N 50355262 CHEMBL1834642 C-C chemokine receptor type 2 Homo sapiens 510 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355262&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754845 136361948 CHEMBL1834642 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665243 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)C(O)=O)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(9.81,-20.88,;8.56,-19.98,;7.1,-20.45,;6.2,-19.21,;4.66,-19.2,;3.89,-17.86,;2.35,-17.86,;1.58,-19.19,;1.59,-16.52,;.05,-16.52,;-1.05,-17.6,;-2.14,-16.5,;-1.04,-15.43,;-3.68,-16.5,;-4.45,-17.83,;-5.99,-17.83,;-6.75,-16.48,;-5.99,-15.16,;-4.45,-15.16,;-8.29,-16.48,;-9.07,-15.15,;-9.06,-17.82,;7.1,-17.96,;6.79,-16.46,;7.92,-15.44,;9.39,-15.91,;9.7,-17.41,;8.56,-18.44,;7.6,-13.93,;8.74,-12.9,;6.13,-13.46,;7.19,-12.44,)| InChI=1S/C21H26F3N5O3/c1-28-17-7-4-13(21(22,23)24)8-16(17)19(27-28)25-9-18(30)26-14-10-29(11-14)15-5-2-12(3-6-15)20(31)32/h4,7-8,12,14-15H,2-3,5-6,9-11H2,1H3,(H,25,27)(H,26,30)(H,31,32) XZAJJVGHCXUBKX-UHFFFAOYSA-N 50355263 CHEMBL1834641 C-C chemokine receptor type 2 Homo sapiens 2600 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355263&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56661559 136361949 CHEMBL1834641 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665244 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:8.11,5.4,(13.3,-4.72,;14.07,-6.05,;13.3,-7.39,;14.07,-8.72,;13.31,-10.06,;15.61,-8.72,;16.38,-10.07,;17.92,-10.07,;18.69,-8.74,;17.92,-7.4,;16.38,-7.39,;20.23,-8.74,;21.32,-9.84,;22.41,-8.76,;21.33,-7.66,;23.95,-8.76,;24.72,-10.1,;23.95,-11.43,;26.26,-10.1,;27.03,-11.44,;28.57,-11.44,;29.47,-12.69,;30.93,-12.21,;32.18,-13.12,;30.93,-10.67,;32.07,-9.65,;31.75,-8.15,;30.29,-7.68,;29.16,-8.7,;29.47,-10.19,;29.97,-6.17,;31.11,-5.14,;28.5,-5.7,;29.56,-4.67,)| InChI=1S/C23H30F3N5O3/c1-3-34-22(33)14-4-7-17(8-5-14)31-12-16(13-31)28-20(32)11-27-21-18-10-15(23(24,25)26)6-9-19(18)30(2)29-21/h6,9-10,14,16-17H,3-5,7-8,11-13H2,1-2H3,(H,27,29)(H,28,32) QTKVWRRRHCBCAH-UHFFFAOYSA-N 50355264 CHEMBL1834640 C-C chemokine receptor type 2 Homo sapiens 13 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355264&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671925 136361950 CHEMBL1834640 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665245 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@@H](CC2)C2CCCCC2)c2cc(ccc12)C(F)(F)F |r,wU:16.20,13.13,(10.9,-11.84,;9.66,-10.93,;8.19,-11.4,;7.29,-10.16,;5.75,-10.16,;4.99,-8.82,;3.45,-8.81,;2.67,-10.15,;2.68,-7.48,;1.14,-7.47,;.05,-8.56,;-1.04,-7.46,;.06,-6.38,;-2.58,-7.45,;-3.35,-6.12,;-4.89,-6.11,;-5.66,-7.44,;-4.89,-8.78,;-3.36,-8.78,;-7.2,-7.44,;-7.97,-6.11,;-9.5,-6.1,;-10.28,-7.43,;-9.51,-8.77,;-7.96,-8.78,;8.2,-8.91,;7.88,-7.42,;9.02,-6.39,;10.48,-6.87,;10.8,-8.37,;9.66,-9.39,;8.69,-4.89,;9.84,-3.86,;7.23,-4.42,;8.28,-3.39,)| InChI=1S/C26H36F3N5O/c1-33-23-12-9-19(26(27,28)29)13-22(23)25(32-33)30-14-24(35)31-20-15-34(16-20)21-10-7-18(8-11-21)17-5-3-2-4-6-17/h9,12-13,17-18,20-21H,2-8,10-11,14-16H2,1H3,(H,30,32)(H,31,35) BPTIGDWWEZBMFT-UHFFFAOYSA-N 50355265 CHEMBL1834639 C-C chemokine receptor type 2 Homo sapiens 120 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355265&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671924 136361951 CHEMBL1834639 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665246 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@@H](CC2)C#N)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(30.89,-2.35,;29.64,-1.44,;28.17,-1.91,;27.27,-.67,;25.73,-.67,;24.97,.67,;23.43,.67,;22.65,-.66,;22.66,2.01,;21.12,2.02,;20.03,.93,;18.94,2.03,;20.04,3.11,;17.4,2.03,;16.63,3.37,;15.09,3.38,;14.32,2.05,;15.09,.71,;16.62,.7,;12.78,2.05,;11.25,2.05,;28.18,.58,;27.87,2.07,;29,3.09,;30.46,2.62,;30.78,1.12,;29.64,.1,;28.68,4.6,;29.82,5.63,;27.21,5.07,;28.26,6.1,)| InChI=1S/C21H25F3N6O/c1-29-18-7-4-14(21(22,23)24)8-17(18)20(28-29)26-10-19(31)27-15-11-30(12-15)16-5-2-13(9-25)3-6-16/h4,7-8,13,15-16H,2-3,5-6,10-12H2,1H3,(H,26,28)(H,27,31) YMWLGNDIOUYMFZ-UHFFFAOYSA-N 50355266 CHEMBL1834638 C-C chemokine receptor type 2 Homo sapiens 330 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355266&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754844 136361952 CHEMBL1834638 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665247 CC(C)[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:6.9,3.2,(-9.77,4.13,;-9,2.8,;-9.77,1.46,;-7.46,2.8,;-6.7,4.12,;-5.15,4.12,;-4.38,2.78,;-5.16,1.45,;-6.69,1.45,;-2.85,2.78,;-1.76,1.68,;-.66,2.76,;-1.75,3.85,;.88,2.76,;1.64,1.42,;.87,.09,;3.18,1.42,;3.95,.08,;5.49,.08,;6.39,-1.17,;7.85,-.7,;7.85,.85,;8.99,1.87,;8.68,3.37,;7.21,3.84,;6.08,2.82,;6.4,1.32,;6.89,5.35,;8.03,6.38,;5.43,5.82,;6.48,6.84,)| InChI=1S/C22H30F3N5O/c1-13(2)14-3-6-17(7-4-14)30-11-16(12-30)27-20(31)10-26-21-18-9-15(22(23,24)25)5-8-19(18)28-29-21/h5,8-9,13-14,16-17H,3-4,6-7,10-12H2,1-2H3,(H,27,31)(H2,26,28,29) ALAVGBJMBKWLAD-UHFFFAOYSA-N 50355267 CHEMBL1834637 C-C chemokine receptor type 2 Homo sapiens 370 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355267 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355267&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755193 136361953 CHEMBL1834637 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665248 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)n3ccccc3=O)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.44,2.51,;6.97,2.98,;8.03,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.94,-4.01,;7.04,-2.76,;5.5,-2.76,;4.73,-1.42,;3.19,-1.42,;2.42,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.2,1.02,;-2.84,-.06,;-3.61,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.15,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,1.3,;-9.77,1.29,;-10.54,-.04,;-9.77,-1.38,;-8.23,-1.38,;-7.46,-2.71,;7.94,-1.51,;7.63,-.02,)| InChI=1S/C24H27F3N6O2/c25-24(26,27)15-4-9-20-19(11-15)23(31-30-20)28-12-21(34)29-16-13-32(14-16)17-5-7-18(8-6-17)33-10-2-1-3-22(33)35/h1-4,9-11,16-18H,5-8,12-14H2,(H,29,34)(H2,28,30,31) OWPZOIUERRHILB-UHFFFAOYSA-N 50355268 CHEMBL1834636 C-C chemokine receptor type 2 Homo sapiens 63 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355268 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355268&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755083 136361954 CHEMBL1834636 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665249 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(12.85,-40.75,;11.6,-39.84,;10.14,-40.31,;9.24,-39.07,;7.7,-39.07,;6.93,-37.73,;5.39,-37.72,;4.62,-39.06,;4.63,-36.39,;3.09,-36.38,;1.99,-37.47,;.9,-36.37,;2,-35.29,;-.64,-36.36,;-1.41,-37.69,;-2.95,-37.69,;-3.71,-36.35,;-2.95,-35.02,;-1.4,-35.03,;-5.25,-36.35,;-6.03,-37.68,;-7.57,-37.68,;-8.34,-36.34,;-9.83,-36.03,;-10,-34.51,;-8.61,-33.88,;-7.58,-35.02,;-6.03,-35.01,;10.15,-37.82,;9.83,-36.33,;10.96,-35.3,;12.43,-35.78,;12.74,-37.28,;11.6,-38.3,;10.64,-33.8,;11.78,-32.77,;9.17,-33.33,;10.23,-32.3,)| InChI=1S/C27H30F3N5O3/c1-34-22-8-5-18(27(28,29)30)11-21(22)26(33-34)31-12-25(36)32-19-13-35(14-19)20-6-2-16(3-7-20)17-4-9-23-24(10-17)38-15-37-23/h4-5,8-11,16,19-20H,2-3,6-7,12-15H2,1H3,(H,31,33)(H,32,36) QPEQRQQPWVTPFP-UHFFFAOYSA-N 50355269 CHEMBL1834635 C-C chemokine receptor type 2 Homo sapiens 13 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355269&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56664979 136361955 CHEMBL1834635 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665250 COc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(-11.69,1.29,;-10.92,-.05,;-9.38,-.04,;-8.61,1.29,;-7.07,1.29,;-6.3,-.04,;-7.07,-1.37,;-8.6,-1.38,;-4.76,-.04,;-4,-1.39,;-2.46,-1.39,;-1.69,-.06,;-2.45,1.28,;-4,1.29,;-.15,-.06,;.94,-1.16,;2.04,-.08,;.95,1.02,;3.58,-.08,;4.34,-1.42,;3.57,-2.75,;5.88,-1.42,;6.65,-2.76,;8.19,-2.76,;9.09,-4.01,;10.55,-3.53,;10.55,-1.99,;11.69,-.97,;11.38,.53,;9.91,1,;8.78,-.02,;9.1,-1.51,;9.59,2.51,;10.73,3.54,;8.12,2.98,;9.18,4.01,)| InChI=1S/C25H29F3N6O2/c1-36-23-9-4-16(11-29-23)15-2-6-19(7-3-15)34-13-18(14-34)31-22(35)12-30-24-20-10-17(25(26,27)28)5-8-21(20)32-33-24/h4-5,8-11,15,18-19H,2-3,6-7,12-14H2,1H3,(H,31,35)(H2,30,32,33) WANRYTYAXACNHP-UHFFFAOYSA-N 50355270 CHEMBL1834634 C-C chemokine receptor type 2 Homo sapiens 12 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355270 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355270&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754968 136361956 CHEMBL1834634 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665251 NC(=O)Cc1ccc(cc1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:13.17,10.10,(-8.25,-29.41,;-9.01,-28.08,;-10.55,-28.08,;-8.24,-26.74,;-6.7,-26.75,;-5.93,-28.09,;-4.39,-28.09,;-3.62,-26.75,;-4.4,-25.41,;-5.94,-25.41,;-2.08,-26.75,;-1.31,-28.09,;.22,-28.1,;1,-26.77,;.23,-25.43,;-1.32,-25.42,;2.54,-26.77,;3.63,-27.87,;4.72,-26.79,;3.63,-25.69,;6.26,-26.79,;7.03,-28.13,;6.25,-29.46,;8.57,-28.13,;9.33,-29.47,;10.87,-29.47,;11.77,-30.71,;13.24,-30.24,;13.24,-28.7,;14.37,-27.68,;14.06,-26.18,;12.6,-25.71,;11.46,-26.73,;11.78,-28.22,;12.27,-24.2,;13.42,-23.17,;10.81,-23.73,;11.86,-22.7,)| InChI=1S/C27H31F3N6O2/c28-27(29,30)19-7-10-23-22(12-19)26(35-34-23)32-13-25(38)33-20-14-36(15-20)21-8-5-18(6-9-21)17-3-1-16(2-4-17)11-24(31)37/h1-4,7,10,12,18,20-21H,5-6,8-9,11,13-15H2,(H2,31,37)(H,33,38)(H2,32,34,35) LJAWGNFSXAWFQQ-UHFFFAOYSA-N 50355271 CHEMBL1834633 C-C chemokine receptor type 2 Homo sapiens 12 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355271 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355271&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755079 136361957 CHEMBL1834633 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665252 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccc4OCOc4c3)c2c1 |r,wU:20.20,23.27,(33.39,-15.27,;32.25,-16.3,;30.78,-15.83,;31.83,-14.8,;32.57,-17.8,;34.03,-18.28,;34.35,-19.78,;33.21,-20.8,;33.21,-22.34,;31.74,-22.81,;30.84,-21.57,;29.3,-21.57,;28.54,-20.23,;27,-20.22,;26.22,-21.56,;26.23,-18.89,;24.69,-18.88,;23.6,-19.97,;22.51,-18.87,;23.61,-17.79,;20.97,-18.86,;20.19,-20.19,;18.66,-20.19,;17.89,-18.85,;18.66,-17.52,;20.2,-17.53,;16.35,-18.85,;15.58,-20.18,;14.04,-20.18,;13.27,-18.84,;11.77,-18.53,;11.61,-17.01,;13,-16.38,;14.03,-17.52,;15.57,-17.51,;31.75,-20.32,;31.44,-18.83,)| InChI=1S/C26H28F3N5O3/c27-26(28,29)17-4-7-21-20(10-17)25(33-32-21)30-11-24(35)31-18-12-34(13-18)19-5-1-15(2-6-19)16-3-8-22-23(9-16)37-14-36-22/h3-4,7-10,15,18-19H,1-2,5-6,11-14H2,(H,31,35)(H2,30,32,33) CHXGVUFRAUAFHM-UHFFFAOYSA-N 50355272 CHEMBL1834632 C-C chemokine receptor type 2 Homo sapiens 6 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355272&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754969 136361958 CHEMBL1834632 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665253 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccccc3)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.44,2.51,;6.97,2.98,;8.03,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.94,-4.01,;7.04,-2.76,;5.5,-2.76,;4.73,-1.42,;3.19,-1.42,;2.42,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.2,1.02,;-2.84,-.06,;-3.61,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.15,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,-1.38,;-9.77,-1.38,;-10.54,-.04,;-9.77,1.29,;-8.23,1.3,;7.94,-1.51,;7.63,-.02,)| InChI=1S/C25H28F3N5O/c26-25(27,28)18-8-11-22-21(12-18)24(32-31-22)29-13-23(34)30-19-14-33(15-19)20-9-6-17(7-10-20)16-4-2-1-3-5-16/h1-5,8,11-12,17,19-20H,6-7,9-10,13-15H2,(H,30,34)(H2,29,31,32) MBQDUNUKUGTDDX-UHFFFAOYSA-N 50355273 CHEMBL1834631 C-C chemokine receptor type 2 Homo sapiens 12 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355273&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671923 136361959 CHEMBL1834631 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665254 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccccc3)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.44,2.51,;6.97,2.98,;8.03,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.94,-4.01,;7.04,-2.76,;5.5,-2.76,;4.73,-1.42,;3.19,-1.42,;2.42,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.2,1.02,;-2.84,-.06,;-3.61,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.15,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,-1.38,;-9.77,-1.38,;-10.54,-.04,;-9.77,1.29,;-8.23,1.3,;7.94,-1.51,;7.63,-.02,)| InChI=1S/C25H28F3N5O/c26-25(27,28)18-8-11-22-21(12-18)24(32-31-22)29-13-23(34)30-19-14-33(15-19)20-9-6-17(7-10-20)16-4-2-1-3-5-16/h1-5,8,11-12,17,19-20H,6-7,9-10,13-15H2,(H,30,34)(H2,29,31,32) MBQDUNUKUGTDDX-UHFFFAOYSA-N 50355273 CHEMBL1834631 C-C chemokine receptor type 2 Homo sapiens 12 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355273&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671923 136361959 CHEMBL1834631 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665255 FC(F)(F)c1ccc2[nH]nc(OCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccccc3)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.44,2.51,;6.97,2.98,;8.03,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.94,-4.01,;7.04,-2.76,;5.5,-2.76,;4.73,-1.42,;3.19,-1.42,;2.42,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.2,1.02,;-2.84,-.06,;-3.61,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.15,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,-1.38,;-9.77,-1.38,;-10.54,-.04,;-9.77,1.29,;-8.23,1.3,;7.94,-1.51,;7.63,-.02,)| InChI=1S/C25H27F3N4O2/c26-25(27,28)18-8-11-22-21(12-18)24(31-30-22)34-15-23(33)29-19-13-32(14-19)20-9-6-17(7-10-20)16-4-2-1-3-5-16/h1-5,8,11-12,17,19-20H,6-7,9-10,13-15H2,(H,29,33)(H,30,31) YYGBWXQXZHZCCD-UHFFFAOYSA-N 50355274 CHEMBL1834581 C-C chemokine receptor type 2 Homo sapiens 510 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355274 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355274&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56678497 136361960 CHEMBL1834581 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665256 FC(F)(F)c1ccc2[nH]nc(SCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccccc3)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.44,2.51,;6.97,2.98,;8.03,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.94,-4.01,;7.04,-2.76,;5.5,-2.76,;4.73,-1.42,;3.19,-1.42,;2.42,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.2,1.02,;-2.84,-.06,;-3.61,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.15,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,-1.38,;-9.77,-1.38,;-10.54,-.04,;-9.77,1.29,;-8.23,1.3,;7.94,-1.51,;7.63,-.02,)| InChI=1S/C25H27F3N4OS/c26-25(27,28)18-8-11-22-21(12-18)24(31-30-22)34-15-23(33)29-19-13-32(14-19)20-9-6-17(7-10-20)16-4-2-1-3-5-16/h1-5,8,11-12,17,19-20H,6-7,9-10,13-15H2,(H,29,33)(H,30,31) ZTINSVIFUPXRGW-UHFFFAOYSA-N 50355275 CHEMBL1834580 C-C chemokine receptor type 2 Homo sapiens 290 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355275&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56668306 136361961 CHEMBL1834580 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665257 FC(F)(F)c1ccc2[nH]n(CC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccccc3)c(=O)c2c1 |r,wU:21.25,18.18,(9.59,-5.17,;9.6,-3.63,;10.93,-2.86,;10.92,-4.39,;8.26,-2.85,;6.93,-3.62,;5.61,-2.84,;5.62,-1.31,;4.47,-.29,;5.1,1.11,;4.34,2.45,;2.8,2.45,;2.02,1.12,;2.03,3.79,;.49,3.79,;-.6,2.71,;-1.69,3.81,;-.59,4.88,;-3.23,3.81,;-4.01,2.48,;-5.54,2.48,;-6.31,3.83,;-5.54,5.15,;-4,5.15,;-7.85,3.83,;-8.62,2.49,;-10.16,2.49,;-10.93,3.83,;-10.16,5.16,;-8.63,5.17,;6.63,.95,;7.67,2.09,;6.95,-.56,;8.27,-1.33,)| InChI=1S/C25H27F3N4O2/c26-25(27,28)18-8-11-22-21(12-18)24(34)32(30-22)15-23(33)29-19-13-31(14-19)20-9-6-17(7-10-20)16-4-2-1-3-5-16/h1-5,8,11-12,17,19-20,30H,6-7,9-10,13-15H2,(H,29,33) PSCBTTNPZFBOIJ-UHFFFAOYSA-N 50355276 CHEMBL1834579 C-C chemokine receptor type 2 Homo sapiens 5400 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355276 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355276&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56681842 136361962 CHEMBL1834579 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665258 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cncs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(32.69,-2.28,;31.44,-1.37,;29.98,-1.84,;29.08,-.6,;27.54,-.6,;26.77,.74,;25.23,.74,;24.46,-.59,;24.47,2.08,;22.93,2.09,;21.83,1,;20.74,2.1,;21.84,3.18,;19.21,2.1,;18.43,.77,;16.9,.78,;16.13,2.12,;16.89,3.45,;18.44,3.44,;14.59,2.12,;13.68,3.37,;12.22,2.9,;12.22,1.36,;13.69,.88,;29.99,.65,;29.67,2.14,;30.8,3.16,;32.27,2.69,;32.58,1.19,;31.44,.17,;30.48,4.67,;31.62,5.7,;29.02,5.14,;30.07,6.17,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)8-18(19)22(30-31)28-10-21(33)29-16-11-32(12-16)17-5-2-14(3-6-17)20-9-27-13-34-20/h4,7-9,13-14,16-17H,2-3,5-6,10-12H2,1H3,(H,28,30)(H,29,33) XBPRBIMQCWCMJS-UHFFFAOYSA-N 50355277 CHEMBL1834793 Cytochrome P450 3A4 Homo sapiens 6800 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2127&target=Cytochrome+P450+3A4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355277&enzyme=Cytochrome+P450+3A4&column=ki&startPg=0&Increment=50&submit=Search 56678507 136361963 CHEMBL1834793 1 MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGA 7LXL,3NXU,2V0M,2J0D,1W0G,1W0F,1W0E,9GK1,4NY4 Cytochrome P450 3A4 CP3A4_HUMAN P08684 P05184 Q16757 Q9UK50 Cytochrome P450 3A Q6GRK0_HUMAN Q6GRK0 50665259 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cncs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(32.69,-2.28,;31.44,-1.37,;29.98,-1.84,;29.08,-.6,;27.54,-.6,;26.77,.74,;25.23,.74,;24.46,-.59,;24.47,2.08,;22.93,2.09,;21.83,1,;20.74,2.1,;21.84,3.18,;19.21,2.1,;18.43,.77,;16.9,.78,;16.13,2.12,;16.89,3.45,;18.44,3.44,;14.59,2.12,;13.68,3.37,;12.22,2.9,;12.22,1.36,;13.69,.88,;29.99,.65,;29.67,2.14,;30.8,3.16,;32.27,2.69,;32.58,1.19,;31.44,.17,;30.48,4.67,;31.62,5.7,;29.02,5.14,;30.07,6.17,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)8-18(19)22(30-31)28-10-21(33)29-16-11-32(12-16)17-5-2-14(3-6-17)20-9-27-13-34-20/h4,7-9,13-14,16-17H,2-3,5-6,10-12H2,1H3,(H,28,30)(H,29,33) XBPRBIMQCWCMJS-UHFFFAOYSA-N 50355277 CHEMBL1834793 Cytochrome P450 2C9 Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2128&target=Cytochrome+P450+2C9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355277&enzyme=Cytochrome+P450+2C9&column=ki&startPg=0&Increment=50&submit=Search 56678507 136361963 CHEMBL1834793 1 MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYIDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVPPFYQLCFIPV Cytochrome P450 2C9 CP2C9_HUMAN P11712 P11713 Q16756 Q16872 Q5VX92 Q6IRV8 Q8WW80 50665260 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cncs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(32.69,-2.28,;31.44,-1.37,;29.98,-1.84,;29.08,-.6,;27.54,-.6,;26.77,.74,;25.23,.74,;24.46,-.59,;24.47,2.08,;22.93,2.09,;21.83,1,;20.74,2.1,;21.84,3.18,;19.21,2.1,;18.43,.77,;16.9,.78,;16.13,2.12,;16.89,3.45,;18.44,3.44,;14.59,2.12,;13.68,3.37,;12.22,2.9,;12.22,1.36,;13.69,.88,;29.99,.65,;29.67,2.14,;30.8,3.16,;32.27,2.69,;32.58,1.19,;31.44,.17,;30.48,4.67,;31.62,5.7,;29.02,5.14,;30.07,6.17,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)8-18(19)22(30-31)28-10-21(33)29-16-11-32(12-16)17-5-2-14(3-6-17)20-9-27-13-34-20/h4,7-9,13-14,16-17H,2-3,5-6,10-12H2,1H3,(H,28,30)(H,29,33) XBPRBIMQCWCMJS-UHFFFAOYSA-N 50355277 CHEMBL1834793 Cytochrome P450 2C19 Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2148&target=Cytochrome+P450+2C19&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355277&enzyme=Cytochrome+P450+2C19&column=ki&startPg=0&Increment=50&submit=Search 56678507 136361963 CHEMBL1834793 1 MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKIYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFMESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRGHMPYTDAVVHEVQRYIDLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFKKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVPPFYQLCFIPV Cytochrome P450 2C19 CP2CJ_HUMAN P33261 P33259 Q8WZB1 Q8WZB2 Q9UCD4 50665261 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cncs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(32.69,-2.28,;31.44,-1.37,;29.98,-1.84,;29.08,-.6,;27.54,-.6,;26.77,.74,;25.23,.74,;24.46,-.59,;24.47,2.08,;22.93,2.09,;21.83,1,;20.74,2.1,;21.84,3.18,;19.21,2.1,;18.43,.77,;16.9,.78,;16.13,2.12,;16.89,3.45,;18.44,3.44,;14.59,2.12,;13.68,3.37,;12.22,2.9,;12.22,1.36,;13.69,.88,;29.99,.65,;29.67,2.14,;30.8,3.16,;32.27,2.69,;32.58,1.19,;31.44,.17,;30.48,4.67,;31.62,5.7,;29.02,5.14,;30.07,6.17,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)8-18(19)22(30-31)28-10-21(33)29-16-11-32(12-16)17-5-2-14(3-6-17)20-9-27-13-34-20/h4,7-9,13-14,16-17H,2-3,5-6,10-12H2,1H3,(H,28,30)(H,29,33) XBPRBIMQCWCMJS-UHFFFAOYSA-N 50355277 CHEMBL1834793 Cytochrome P450 2D6 Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=356&target=Cytochrome+P450+2D6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355277&enzyme=Cytochrome+P450+2D6&column=ki&startPg=0&Increment=50&submit=Search 56678507 136361963 CHEMBL1834793 1 MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPR 6CSD,6CSB Cytochrome P450 2D6 CP2D6_HUMAN P10635 Q16752 Q2XND6 Q2XND7 Q2XNE0 Q6B012 Q6NXU8 Cytochrome P450 C1ID52_HUMAN C1ID52 50665262 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cncs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(32.69,-2.28,;31.44,-1.37,;29.98,-1.84,;29.08,-.6,;27.54,-.6,;26.77,.74,;25.23,.74,;24.46,-.59,;24.47,2.08,;22.93,2.09,;21.83,1,;20.74,2.1,;21.84,3.18,;19.21,2.1,;18.43,.77,;16.9,.78,;16.13,2.12,;16.89,3.45,;18.44,3.44,;14.59,2.12,;13.68,3.37,;12.22,2.9,;12.22,1.36,;13.69,.88,;29.99,.65,;29.67,2.14,;30.8,3.16,;32.27,2.69,;32.58,1.19,;31.44,.17,;30.48,4.67,;31.62,5.7,;29.02,5.14,;30.07,6.17,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)8-18(19)22(30-31)28-10-21(33)29-16-11-32(12-16)17-5-2-14(3-6-17)20-9-27-13-34-20/h4,7-9,13-14,16-17H,2-3,5-6,10-12H2,1H3,(H,28,30)(H,29,33) XBPRBIMQCWCMJS-UHFFFAOYSA-N 50355277 CHEMBL1834793 Cytochrome P450 1A2 Homo sapiens >10000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2146&target=Cytochrome+P450+1A2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355277&enzyme=Cytochrome+P450+1A2&column=ki&startPg=0&Increment=50&submit=Search 56678507 136361963 CHEMBL1834793 1 MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPLLGHVLTLGKNPHLALSRMSQRYGDVLQIRIGSTPVLVLSRLDTIRQALVRQGDDFKGRPDLYTSTLITDGQSLTFSTDSGPVWAARRRLAQNALNTFSIASDPASSSSCYLEEHVSKEAKALISRLQELMAGPGHFDPYNQVVVSVANVIGAMCFGQHFPESSDEMLSLVKNTHEFVETASSGNPLDFFPILRYLPNPALQRFKAFNQRFLWFLQKTVQEHYQDFDKNSVRDITGALFKHSKKGPRASGNLIPQEKIVNLVNDIFGAGFDTVTTAISWSLMYLVTKPEIQRKIQKELDTVIGRERRPRLSDRPQLPYLEAFILETFRHSSFLPFTIPHSTTRDTTLNGFYIPKKCCVFVNQWQVNHDPELWEDPSEFRPERFLTADGTAINKPLSEKMMLFGMGKRRCIGEVLAKWEIFLFLAILLQQLEFSVPPGVKVDLTPIYGLTMKHARCEHVQARLRFSIN 2HI4 Cytochrome P450 1A2 CP1A2_HUMAN P05177 Q16754 Q6NWU3 Q6NWU5 Q9BXX7 Q9UK49 50665263 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3cncs3)c2c1 |r,wU:20.20,23.27,(9.53,6.18,;8.39,5.15,;6.93,5.63,;7.98,6.65,;8.71,3.65,;10.18,3.17,;10.49,1.67,;9.35,.65,;9.36,-.89,;7.89,-1.36,;6.99,-.12,;5.45,-.11,;4.68,1.22,;3.14,1.23,;2.37,-.1,;2.38,2.56,;.84,2.57,;-.25,1.48,;-1.34,2.58,;-.25,3.66,;-2.88,2.59,;-3.66,1.26,;-5.19,1.26,;-5.96,2.6,;-5.2,3.93,;-3.65,3.92,;-7.5,2.6,;-8.4,3.85,;-9.87,3.38,;-9.87,1.84,;-8.4,1.36,;7.9,1.13,;7.58,2.62,)| InChI=1S/C22H25F3N6OS/c23-22(24,25)14-3-6-18-17(7-14)21(30-29-18)27-9-20(32)28-15-10-31(11-15)16-4-1-13(2-5-16)19-8-26-12-33-19/h3,6-8,12-13,15-16H,1-2,4-5,9-11H2,(H,28,32)(H2,27,29,30) VIVZXPJCCFWJDH-UHFFFAOYSA-N 50355278 CHEMBL1834792 C-C chemokine receptor type 2 Homo sapiens 16 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355278 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355278&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671795 136361964 CHEMBL1834792 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665264 Cc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:7.7,10.14,(-11.36,.17,;-9.82,.17,;-9.05,1.51,;-7.51,1.51,;-6.74,.18,;-7.51,-1.16,;-9.04,-1.16,;-5.2,.18,;-4.44,-1.17,;-2.9,-1.17,;-2.13,.16,;-2.89,1.5,;-4.44,1.5,;-.59,.16,;.5,-.94,;1.6,.14,;.51,1.23,;3.14,.14,;3.9,-1.2,;3.13,-2.53,;5.44,-1.2,;6.21,-2.54,;7.75,-2.55,;8.65,-3.79,;10.11,-3.32,;11.36,-4.22,;10.11,-1.78,;11.25,-.75,;10.94,.75,;9.47,1.22,;8.34,.2,;8.66,-1.3,;9.15,2.73,;10.29,3.76,;7.68,3.2,;8.74,4.22,)| InChI=1S/C26H31F3N6O/c1-16-3-4-18(12-30-16)17-5-8-21(9-6-17)35-14-20(15-35)32-24(36)13-31-25-22-11-19(26(27,28)29)7-10-23(22)34(2)33-25/h3-4,7,10-12,17,20-21H,5-6,8-9,13-15H2,1-2H3,(H,31,33)(H,32,36) BJIIFQCSJMKUPV-UHFFFAOYSA-N 50355279 CHEMBL1834791 C-C chemokine receptor type 2 Homo sapiens 7 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355279 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355279&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56661451 136361965 CHEMBL1834791 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665265 COc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(-11.74,1.5,;-10.97,.17,;-9.43,.17,;-8.66,1.51,;-7.13,1.51,;-6.36,.18,;-7.12,-1.16,;-8.66,-1.16,;-4.82,.18,;-4.05,-1.17,;-2.52,-1.17,;-1.74,.16,;-2.51,1.5,;-4.05,1.5,;-.2,.16,;.89,-.94,;1.98,.14,;.9,1.23,;3.52,.14,;4.29,-1.2,;3.51,-2.53,;5.83,-1.2,;6.59,-2.54,;8.13,-2.55,;9.03,-3.79,;10.5,-3.32,;11.74,-4.22,;10.5,-1.78,;11.64,-.75,;11.32,.75,;9.86,1.22,;8.73,.2,;9.04,-1.3,;9.54,2.73,;10.68,3.76,;8.07,3.2,;9.12,4.22,)| InChI=1S/C26H31F3N6O2/c1-34-22-9-6-18(26(27,28)29)11-21(22)25(33-34)31-13-23(36)32-19-14-35(15-19)20-7-3-16(4-8-20)17-5-10-24(37-2)30-12-17/h5-6,9-12,16,19-20H,3-4,7-8,13-15H2,1-2H3,(H,31,33)(H,32,36) SYJSQOHBESPDKE-UHFFFAOYSA-N 50355280 CHEMBL1834790 C-C chemokine receptor type 2 Homo sapiens 9 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355280&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671794 136361966 CHEMBL1834790 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665266 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cccnc2)c2cc(ccc12)C(F)(F)F |r,wU:16.20,13.13,(10.59,-4.22,;9.34,-3.32,;7.88,-3.79,;6.98,-2.55,;5.44,-2.54,;4.67,-1.2,;3.13,-1.2,;2.36,-2.53,;2.37,.14,;.83,.14,;-.27,-.94,;-1.36,.16,;-.26,1.23,;-2.9,.16,;-3.67,-1.17,;-5.21,-1.17,;-5.97,.18,;-5.21,1.5,;-3.66,1.5,;-7.51,.18,;-8.28,1.51,;-9.82,1.51,;-10.59,.17,;-9.81,-1.16,;-8.28,-1.16,;7.89,-1.3,;7.57,.2,;8.7,1.22,;10.17,.75,;10.48,-.75,;9.34,-1.78,;8.38,2.73,;9.52,3.76,;6.91,3.2,;7.97,4.22,)| InChI=1S/C25H29F3N6O/c1-33-22-9-6-18(25(26,27)28)11-21(22)24(32-33)30-13-23(35)31-19-14-34(15-19)20-7-4-16(5-8-20)17-3-2-10-29-12-17/h2-3,6,9-12,16,19-20H,4-5,7-8,13-15H2,1H3,(H,30,32)(H,31,35) DPMNRWVBWPCZHV-UHFFFAOYSA-N 50355281 CHEMBL1834789 C-C chemokine receptor type 2 Homo sapiens 56 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355281 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355281&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671793 136361967 CHEMBL1834789 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665267 Cc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:7.7,10.14,(-11.31,-.05,;-9.77,-.04,;-9,1.29,;-7.46,1.29,;-6.69,-.04,;-7.45,-1.37,;-8.99,-1.38,;-5.15,-.04,;-4.38,-1.39,;-2.85,-1.39,;-2.07,-.06,;-2.84,1.28,;-4.39,1.29,;-.53,-.06,;.56,-1.16,;1.65,-.08,;.56,1.02,;3.19,-.08,;3.96,-1.42,;3.18,-2.75,;5.5,-1.42,;6.26,-2.76,;7.8,-2.76,;8.7,-4.01,;10.17,-3.53,;10.17,-1.99,;11.31,-.97,;10.99,.53,;9.53,1,;8.39,-.02,;8.71,-1.51,;9.2,2.51,;10.35,3.54,;7.74,2.98,;8.79,4.01,)| InChI=1S/C25H29F3N6O/c1-15-2-3-17(11-29-15)16-4-7-20(8-5-16)34-13-19(14-34)31-23(35)12-30-24-21-10-18(25(26,27)28)6-9-22(21)32-33-24/h2-3,6,9-11,16,19-20H,4-5,7-8,12-14H2,1H3,(H,31,35)(H2,30,32,33) STKWJCBTZQGCNO-UHFFFAOYSA-N 50355282 CHEMBL1834788 C-C chemokine receptor type 2 Homo sapiens 6 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355282&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56675205 136361968 CHEMBL1834788 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665269 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3cccnc3)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.43,2.51,;6.97,2.98,;8.02,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.93,-4.01,;7.03,-2.76,;5.49,-2.76,;4.73,-1.42,;3.19,-1.42,;2.41,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.21,1.02,;-2.84,-.06,;-3.62,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.16,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,1.29,;-9.77,1.29,;-10.54,-.04,;-9.76,-1.38,;-8.22,-1.37,;7.94,-1.51,;7.62,-.02,)| InChI=1S/C24H27F3N6O/c25-24(26,27)17-5-8-21-20(10-17)23(32-31-21)29-12-22(34)30-18-13-33(14-18)19-6-3-15(4-7-19)16-2-1-9-28-11-16/h1-2,5,8-11,15,18-19H,3-4,6-7,12-14H2,(H,30,34)(H2,29,31,32) YXXGTVBNVRVOKC-UHFFFAOYSA-N 50355283 CHEMBL1834787 C-C chemokine receptor type 2 Homo sapiens 30 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355283 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355283&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671792 136361969 CHEMBL1834787 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665270 CN(C)c1cccc(c1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:9.9,12.16,(-11.35,-2.51,;-9.81,-2.5,;-9.04,-3.83,;-9.05,-1.16,;-9.82,.17,;-9.06,1.51,;-7.52,1.51,;-6.75,.18,;-7.51,-1.16,;-5.21,.18,;-4.44,-1.17,;-2.91,-1.17,;-2.13,.16,;-2.9,1.5,;-4.44,1.5,;-.59,.16,;.5,-.94,;1.59,.14,;.51,1.23,;3.13,.14,;3.9,-1.2,;3.12,-2.53,;5.44,-1.2,;6.2,-2.54,;7.74,-2.55,;8.64,-3.79,;10.11,-3.32,;11.35,-4.22,;10.11,-1.78,;11.25,-.75,;10.93,.75,;9.47,1.22,;8.33,.2,;8.65,-1.3,;9.14,2.73,;10.29,3.76,;7.68,3.2,;8.73,4.22,)| InChI=1S/C28H35F3N6O/c1-35(2)23-6-4-5-19(13-23)18-7-10-22(11-8-18)37-16-21(17-37)33-26(38)15-32-27-24-14-20(28(29,30)31)9-12-25(24)36(3)34-27/h4-6,9,12-14,18,21-22H,7-8,10-11,15-17H2,1-3H3,(H,32,34)(H,33,38) NNTVFWNDCFPONC-UHFFFAOYSA-N 50355284 CHEMBL1834786 C-C chemokine receptor type 2 Homo sapiens 5 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355284 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355284&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56657930 136361970 CHEMBL1834786 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665271 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccccc2)c2cc(ccc12)C(F)(F)F |r,wU:16.20,13.13,(10.59,-4.22,;9.34,-3.32,;7.88,-3.79,;6.98,-2.55,;5.44,-2.54,;4.67,-1.2,;3.13,-1.2,;2.36,-2.53,;2.37,.14,;.83,.14,;-.27,-.94,;-1.36,.16,;-.26,1.23,;-2.9,.16,;-3.67,-1.17,;-5.21,-1.17,;-5.97,.18,;-5.21,1.5,;-3.66,1.5,;-7.51,.18,;-8.28,1.51,;-9.82,1.51,;-10.59,.17,;-9.81,-1.16,;-8.28,-1.16,;7.89,-1.3,;7.57,.2,;8.7,1.22,;10.17,.75,;10.48,-.75,;9.34,-1.78,;8.38,2.73,;9.52,3.76,;6.91,3.2,;7.97,4.22,)| InChI=1S/C26H30F3N5O/c1-33-23-12-9-19(26(27,28)29)13-22(23)25(32-33)30-14-24(35)31-20-15-34(16-20)21-10-7-18(8-11-21)17-5-3-2-4-6-17/h2-6,9,12-13,18,20-21H,7-8,10-11,14-16H2,1H3,(H,30,32)(H,31,35) GWGRACKHWJVFCC-UHFFFAOYSA-N 50355285 CHEMBL1834785 C-C chemokine receptor type 2 Homo sapiens 19 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355285 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355285&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56657929 136361971 CHEMBL1834785 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665272 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C2CCCC2)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.63,5.18,;-9.85,3.85,;-10.62,2.51,;-9.85,1.18,;-10.62,-.15,;-8.31,1.18,;-7.55,-.16,;-6.01,-.17,;-5.24,1.16,;-6,2.5,;-7.55,2.51,;-3.7,1.16,;-2.61,.06,;-1.51,1.15,;-2.6,2.24,;.03,1.14,;.79,-.2,;.02,-1.53,;2.33,-.2,;3.1,-1.54,;4.64,-1.54,;5.54,-2.78,;7,-2.31,;8.25,-3.22,;8.25,-4.75,;9.72,-5.23,;10.63,-3.98,;9.72,-2.74,;7,-.77,;8.14,.25,;7.83,1.75,;6.36,2.22,;5.23,1.2,;5.55,-.29,;6.04,3.73,;7.18,4.76,;4.57,4.2,;5.63,5.23,)| InChI=1S/C27H36F3N5O3/c1-2-38-26(37)17-7-10-20(11-8-17)34-15-19(16-34)32-24(36)14-31-25-22-13-18(27(28,29)30)9-12-23(22)35(33-25)21-5-3-4-6-21/h9,12-13,17,19-21H,2-8,10-11,14-16H2,1H3,(H,31,33)(H,32,36) FYZNJPJSHPKWIX-UHFFFAOYSA-N 50355286 CHEMBL1834784 C-C chemokine receptor type 2 Homo sapiens 650 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355286 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355286&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56668313 136361972 CHEMBL1834784 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665273 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CN=C1NC(Cc2ccccc2)c2ccc(cc12)C(F)(F)F |r,w:19.20,wU:5.4,8.11,(-11.55,4.32,;-10.78,2.98,;-11.54,1.65,;-10.77,.32,;-11.54,-1.02,;-9.23,.32,;-8.47,-1.03,;-6.93,-1.03,;-6.16,.3,;-6.92,1.64,;-8.47,1.64,;-4.62,.3,;-3.53,-.8,;-2.43,.28,;-3.52,1.38,;-.89,.28,;-.13,-1.06,;-.9,-2.39,;1.41,-1.06,;2.18,-2.4,;3.72,-2.4,;4.62,-3.65,;6.08,-3.17,;7.33,-4.08,;8.74,-3.46,;9.98,-4.37,;11.38,-3.74,;11.55,-2.21,;10.29,-1.3,;8.89,-1.93,;6.08,-1.63,;7.22,-.61,;6.91,.89,;5.44,1.36,;4.31,.34,;4.63,-1.15,;5.12,2.87,;6.26,3.9,;3.65,3.34,;4.71,4.37,)| InChI=1S/C30H35F3N4O3/c1-2-40-29(39)20-8-11-23(12-9-20)37-17-22(18-37)35-27(38)16-34-28-25-15-21(30(31,32)33)10-13-24(25)26(36-28)14-19-6-4-3-5-7-19/h3-7,10,13,15,20,22-23,26H,2,8-9,11-12,14,16-18H2,1H3,(H,34,36)(H,35,38) MYRGKAVLHHTTPL-UHFFFAOYSA-N 50355287 CHEMBL1834783 C-C chemokine receptor type 2 Homo sapiens 170 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355287&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56657928 136361973 CHEMBL1834783 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665274 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(c2ccc(cc12)C(F)(F)F)S(C)(=O)=O |r,wU:5.4,8.11,(-10.14,4.84,;-9.37,3.5,;-10.14,2.17,;-9.37,.84,;-10.14,-.5,;-7.83,.84,;-7.06,-.51,;-5.53,-.51,;-4.75,.82,;-5.52,2.16,;-7.06,2.16,;-3.21,.82,;-2.12,-.28,;-1.03,.8,;-2.11,1.89,;.51,.8,;1.28,-.54,;.5,-1.87,;2.82,-.54,;3.58,-1.88,;5.12,-1.88,;6.02,-3.13,;7.49,-2.66,;7.49,-1.11,;8.63,-.09,;8.31,1.41,;6.85,1.88,;5.71,.86,;6.03,-.64,;6.52,3.39,;7.67,4.42,;5.06,3.86,;6.11,4.88,;8.73,-3.56,;10.14,-2.94,;7.95,-4.88,;9.49,-4.88,)| InChI=1S/C23H30F3N5O5S/c1-3-36-22(33)14-4-7-17(8-5-14)30-12-16(13-30)28-20(32)11-27-21-18-10-15(23(24,25)26)6-9-19(18)31(29-21)37(2,34)35/h6,9-10,14,16-17H,3-5,7-8,11-13H2,1-2H3,(H,27,29)(H,28,32) OKJTXDQDWLLOMB-UHFFFAOYSA-N 50355288 CHEMBL1834782 C-C chemokine receptor type 2 Homo sapiens 920 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355288 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355288&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56678506 136361974 CHEMBL1834782 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665275 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C(N)=O)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.14,4.94,;-9.37,3.61,;-10.14,2.27,;-9.37,.94,;-10.14,-.39,;-7.83,.94,;-7.06,-.4,;-5.53,-.4,;-4.75,.93,;-5.52,2.26,;-7.06,2.27,;-3.21,.92,;-2.12,-.18,;-1.03,.91,;-2.11,2,;.51,.9,;1.28,-.43,;.5,-1.77,;2.82,-.44,;3.58,-1.78,;5.12,-1.78,;6.02,-3.02,;7.49,-2.55,;8.73,-3.46,;10.14,-2.83,;8.57,-4.99,;7.49,-1.01,;8.63,.01,;8.31,1.51,;6.85,1.99,;5.71,.96,;6.03,-.53,;6.52,3.49,;7.67,4.52,;5.06,3.96,;6.11,4.99,)| InChI=1S/C23H29F3N6O4/c1-2-36-21(34)13-3-6-16(7-4-13)31-11-15(12-31)29-19(33)10-28-20-17-9-14(23(24,25)26)5-8-18(17)32(30-20)22(27)35/h5,8-9,13,15-16H,2-4,6-7,10-12H2,1H3,(H2,27,35)(H,28,30)(H,29,33) BSPCGOZVENCINN-UHFFFAOYSA-N 50355289 CHEMBL1834781 C-C chemokine receptor type 2 Homo sapiens 56 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355289&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54756045 136361975 CHEMBL1834781 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665276 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(CC(F)(F)F)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.8,4.32,;-10.03,2.98,;-10.8,1.65,;-10.03,.32,;-10.8,-1.02,;-8.49,.32,;-7.72,-1.03,;-6.19,-1.03,;-5.41,.3,;-6.18,1.64,;-7.73,1.64,;-3.87,.3,;-2.78,-.8,;-1.69,.28,;-2.78,1.37,;-.15,.28,;.62,-1.06,;-.16,-2.39,;2.16,-1.06,;2.92,-2.4,;4.46,-2.4,;5.36,-3.65,;6.83,-3.18,;8.07,-4.08,;9.48,-3.46,;9.64,-1.93,;10.72,-4.36,;10.8,-2.67,;6.83,-1.63,;7.96,-.61,;7.65,.89,;6.19,1.36,;5.05,.34,;5.37,-1.16,;5.86,2.87,;7.01,3.9,;4.4,3.34,;5.45,4.36,)| InChI=1S/C24H29F6N5O3/c1-2-38-22(37)14-3-6-17(7-4-14)34-11-16(12-34)32-20(36)10-31-21-18-9-15(24(28,29)30)5-8-19(18)35(33-21)13-23(25,26)27/h5,8-9,14,16-17H,2-4,6-7,10-13H2,1H3,(H,31,33)(H,32,36) JDJZCKOOSFAVKN-UHFFFAOYSA-N 50355290 CHEMBL1834780 C-C chemokine receptor type 2 Homo sapiens 230 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355290&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755562 136361976 CHEMBL1834780 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665277 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2nccs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(11.37,-11.31,;10.13,-10.4,;8.66,-10.87,;7.76,-9.63,;6.22,-9.63,;5.45,-8.29,;3.91,-8.29,;3.14,-9.62,;3.15,-6.95,;1.61,-6.94,;.52,-8.03,;-.57,-6.93,;.52,-5.85,;-2.11,-6.93,;-2.89,-8.26,;-4.42,-8.25,;-5.19,-6.91,;-4.43,-5.58,;-2.88,-5.59,;-6.73,-6.91,;-7.63,-5.66,;-9.1,-6.13,;-9.1,-7.67,;-7.63,-8.15,;8.67,-8.38,;8.35,-6.89,;9.48,-5.87,;10.95,-6.34,;11.26,-7.84,;10.12,-8.86,;9.16,-4.36,;10.3,-3.33,;7.7,-3.89,;8.75,-2.86,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)10-18(19)21(30-31)28-11-20(33)29-16-12-32(13-16)17-5-2-14(3-6-17)22-27-8-9-34-22/h4,7-10,14,16-17H,2-3,5-6,11-13H2,1H3,(H,28,30)(H,29,33) KODYZMOGJJLGIT-UHFFFAOYSA-N 50355291 CHEMBL1834794 C-C chemokine receptor type 2 Homo sapiens 17 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355291&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56678508 136361977 CHEMBL1834794 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665278 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cncs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(32.69,-2.28,;31.44,-1.37,;29.98,-1.84,;29.08,-.6,;27.54,-.6,;26.77,.74,;25.23,.74,;24.46,-.59,;24.47,2.08,;22.93,2.09,;21.83,1,;20.74,2.1,;21.84,3.18,;19.21,2.1,;18.43,.77,;16.9,.78,;16.13,2.12,;16.89,3.45,;18.44,3.44,;14.59,2.12,;13.68,3.37,;12.22,2.9,;12.22,1.36,;13.69,.88,;29.99,.65,;29.67,2.14,;30.8,3.16,;32.27,2.69,;32.58,1.19,;31.44,.17,;30.48,4.67,;31.62,5.7,;29.02,5.14,;30.07,6.17,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)8-18(19)22(30-31)28-10-21(33)29-16-11-32(12-16)17-5-2-14(3-6-17)20-9-27-13-34-20/h4,7-9,13-14,16-17H,2-3,5-6,10-12H2,1H3,(H,28,30)(H,29,33) XBPRBIMQCWCMJS-UHFFFAOYSA-N 50355277 CHEMBL1834793 C-C chemokine receptor type 2 Homo sapiens 14 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355277&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56678507 136361963 CHEMBL1834793 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665279 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3cncs3)c2c1 |r,wU:20.20,23.27,(9.53,6.18,;8.39,5.15,;6.93,5.63,;7.98,6.65,;8.71,3.65,;10.18,3.17,;10.49,1.67,;9.35,.65,;9.36,-.89,;7.89,-1.36,;6.99,-.12,;5.45,-.11,;4.68,1.22,;3.14,1.23,;2.37,-.1,;2.38,2.56,;.84,2.57,;-.25,1.48,;-1.34,2.58,;-.25,3.66,;-2.88,2.59,;-3.66,1.26,;-5.19,1.26,;-5.96,2.6,;-5.2,3.93,;-3.65,3.92,;-7.5,2.6,;-8.4,3.85,;-9.87,3.38,;-9.87,1.84,;-8.4,1.36,;7.9,1.13,;7.58,2.62,)| InChI=1S/C22H25F3N6OS/c23-22(24,25)14-3-6-18-17(7-14)21(30-29-18)27-9-20(32)28-15-10-31(11-15)16-4-1-13(2-5-16)19-8-26-12-33-19/h3,6-8,12-13,15-16H,1-2,4-5,9-11H2,(H,28,32)(H2,27,29,30) VIVZXPJCCFWJDH-UHFFFAOYSA-N 50355278 CHEMBL1834792 C-C chemokine receptor type 2 Homo sapiens 11 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355278 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355278&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671795 136361964 CHEMBL1834792 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665280 Cc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:7.7,10.14,(-11.36,.17,;-9.82,.17,;-9.05,1.51,;-7.51,1.51,;-6.74,.18,;-7.51,-1.16,;-9.04,-1.16,;-5.2,.18,;-4.44,-1.17,;-2.9,-1.17,;-2.13,.16,;-2.89,1.5,;-4.44,1.5,;-.59,.16,;.5,-.94,;1.6,.14,;.51,1.23,;3.14,.14,;3.9,-1.2,;3.13,-2.53,;5.44,-1.2,;6.21,-2.54,;7.75,-2.55,;8.65,-3.79,;10.11,-3.32,;11.36,-4.22,;10.11,-1.78,;11.25,-.75,;10.94,.75,;9.47,1.22,;8.34,.2,;8.66,-1.3,;9.15,2.73,;10.29,3.76,;7.68,3.2,;8.74,4.22,)| InChI=1S/C26H31F3N6O/c1-16-3-4-18(12-30-16)17-5-8-21(9-6-17)35-14-20(15-35)32-24(36)13-31-25-22-11-19(26(27,28)29)7-10-23(22)34(2)33-25/h3-4,7,10-12,17,20-21H,5-6,8-9,13-15H2,1-2H3,(H,31,33)(H,32,36) BJIIFQCSJMKUPV-UHFFFAOYSA-N 50355279 CHEMBL1834791 C-C chemokine receptor type 2 Homo sapiens 7 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355279 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355279&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56661451 136361965 CHEMBL1834791 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665281 COc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(-11.74,1.5,;-10.97,.17,;-9.43,.17,;-8.66,1.51,;-7.13,1.51,;-6.36,.18,;-7.12,-1.16,;-8.66,-1.16,;-4.82,.18,;-4.05,-1.17,;-2.52,-1.17,;-1.74,.16,;-2.51,1.5,;-4.05,1.5,;-.2,.16,;.89,-.94,;1.98,.14,;.9,1.23,;3.52,.14,;4.29,-1.2,;3.51,-2.53,;5.83,-1.2,;6.59,-2.54,;8.13,-2.55,;9.03,-3.79,;10.5,-3.32,;11.74,-4.22,;10.5,-1.78,;11.64,-.75,;11.32,.75,;9.86,1.22,;8.73,.2,;9.04,-1.3,;9.54,2.73,;10.68,3.76,;8.07,3.2,;9.12,4.22,)| InChI=1S/C26H31F3N6O2/c1-34-22-9-6-18(26(27,28)29)11-21(22)25(33-34)31-13-23(36)32-19-14-35(15-19)20-7-3-16(4-8-20)17-5-10-24(37-2)30-12-17/h5-6,9-12,16,19-20H,3-4,7-8,13-15H2,1-2H3,(H,31,33)(H,32,36) SYJSQOHBESPDKE-UHFFFAOYSA-N 50355280 CHEMBL1834790 C-C chemokine receptor type 2 Homo sapiens 15 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355280&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671794 136361966 CHEMBL1834790 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665282 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cccnc2)c2cc(ccc12)C(F)(F)F |r,wU:16.20,13.13,(10.59,-4.22,;9.34,-3.32,;7.88,-3.79,;6.98,-2.55,;5.44,-2.54,;4.67,-1.2,;3.13,-1.2,;2.36,-2.53,;2.37,.14,;.83,.14,;-.27,-.94,;-1.36,.16,;-.26,1.23,;-2.9,.16,;-3.67,-1.17,;-5.21,-1.17,;-5.97,.18,;-5.21,1.5,;-3.66,1.5,;-7.51,.18,;-8.28,1.51,;-9.82,1.51,;-10.59,.17,;-9.81,-1.16,;-8.28,-1.16,;7.89,-1.3,;7.57,.2,;8.7,1.22,;10.17,.75,;10.48,-.75,;9.34,-1.78,;8.38,2.73,;9.52,3.76,;6.91,3.2,;7.97,4.22,)| InChI=1S/C25H29F3N6O/c1-33-22-9-6-18(25(26,27)28)11-21(22)24(32-33)30-13-23(35)31-19-14-34(15-19)20-7-4-16(5-8-20)17-3-2-10-29-12-17/h2-3,6,9-12,16,19-20H,4-5,7-8,13-15H2,1H3,(H,30,32)(H,31,35) DPMNRWVBWPCZHV-UHFFFAOYSA-N 50355281 CHEMBL1834789 C-C chemokine receptor type 2 Homo sapiens 11 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355281 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355281&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671793 136361967 CHEMBL1834789 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665283 Cc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:7.7,10.14,(-11.31,-.05,;-9.77,-.04,;-9,1.29,;-7.46,1.29,;-6.69,-.04,;-7.45,-1.37,;-8.99,-1.38,;-5.15,-.04,;-4.38,-1.39,;-2.85,-1.39,;-2.07,-.06,;-2.84,1.28,;-4.39,1.29,;-.53,-.06,;.56,-1.16,;1.65,-.08,;.56,1.02,;3.19,-.08,;3.96,-1.42,;3.18,-2.75,;5.5,-1.42,;6.26,-2.76,;7.8,-2.76,;8.7,-4.01,;10.17,-3.53,;10.17,-1.99,;11.31,-.97,;10.99,.53,;9.53,1,;8.39,-.02,;8.71,-1.51,;9.2,2.51,;10.35,3.54,;7.74,2.98,;8.79,4.01,)| InChI=1S/C25H29F3N6O/c1-15-2-3-17(11-29-15)16-4-7-20(8-5-16)34-13-19(14-34)31-23(35)12-30-24-21-10-18(25(26,27)28)6-9-22(21)32-33-24/h2-3,6,9-11,16,19-20H,4-5,7-8,12-14H2,1H3,(H,31,35)(H2,30,32,33) STKWJCBTZQGCNO-UHFFFAOYSA-N 50355282 CHEMBL1834788 C-C chemokine receptor type 2 Homo sapiens 11 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355282&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56675205 136361968 CHEMBL1834788 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665285 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3cccnc3)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.43,2.51,;6.97,2.98,;8.02,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.93,-4.01,;7.03,-2.76,;5.49,-2.76,;4.73,-1.42,;3.19,-1.42,;2.41,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.21,1.02,;-2.84,-.06,;-3.62,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.16,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,1.29,;-9.77,1.29,;-10.54,-.04,;-9.76,-1.38,;-8.22,-1.37,;7.94,-1.51,;7.62,-.02,)| InChI=1S/C24H27F3N6O/c25-24(26,27)17-5-8-21-20(10-17)23(32-31-21)29-12-22(34)30-18-13-33(14-18)19-6-3-15(4-7-19)16-2-1-9-28-11-16/h1-2,5,8-11,15,18-19H,3-4,6-7,12-14H2,(H,30,34)(H2,29,31,32) YXXGTVBNVRVOKC-UHFFFAOYSA-N 50355283 CHEMBL1834787 C-C chemokine receptor type 2 Homo sapiens 31 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355283 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355283&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671792 136361969 CHEMBL1834787 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665286 CN(C)c1cccc(c1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:9.9,12.16,(-11.35,-2.51,;-9.81,-2.5,;-9.04,-3.83,;-9.05,-1.16,;-9.82,.17,;-9.06,1.51,;-7.52,1.51,;-6.75,.18,;-7.51,-1.16,;-5.21,.18,;-4.44,-1.17,;-2.91,-1.17,;-2.13,.16,;-2.9,1.5,;-4.44,1.5,;-.59,.16,;.5,-.94,;1.59,.14,;.51,1.23,;3.13,.14,;3.9,-1.2,;3.12,-2.53,;5.44,-1.2,;6.2,-2.54,;7.74,-2.55,;8.64,-3.79,;10.11,-3.32,;11.35,-4.22,;10.11,-1.78,;11.25,-.75,;10.93,.75,;9.47,1.22,;8.33,.2,;8.65,-1.3,;9.14,2.73,;10.29,3.76,;7.68,3.2,;8.73,4.22,)| InChI=1S/C28H35F3N6O/c1-35(2)23-6-4-5-19(13-23)18-7-10-22(11-8-18)37-16-21(17-37)33-26(38)15-32-27-24-14-20(28(29,30)31)9-12-25(24)36(3)34-27/h4-6,9,12-14,18,21-22H,7-8,10-11,15-17H2,1-3H3,(H,32,34)(H,33,38) NNTVFWNDCFPONC-UHFFFAOYSA-N 50355284 CHEMBL1834786 C-C chemokine receptor type 2 Homo sapiens 4 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355284 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355284&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56657930 136361970 CHEMBL1834786 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665287 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccccc2)c2cc(ccc12)C(F)(F)F |r,wU:16.20,13.13,(10.59,-4.22,;9.34,-3.32,;7.88,-3.79,;6.98,-2.55,;5.44,-2.54,;4.67,-1.2,;3.13,-1.2,;2.36,-2.53,;2.37,.14,;.83,.14,;-.27,-.94,;-1.36,.16,;-.26,1.23,;-2.9,.16,;-3.67,-1.17,;-5.21,-1.17,;-5.97,.18,;-5.21,1.5,;-3.66,1.5,;-7.51,.18,;-8.28,1.51,;-9.82,1.51,;-10.59,.17,;-9.81,-1.16,;-8.28,-1.16,;7.89,-1.3,;7.57,.2,;8.7,1.22,;10.17,.75,;10.48,-.75,;9.34,-1.78,;8.38,2.73,;9.52,3.76,;6.91,3.2,;7.97,4.22,)| InChI=1S/C26H30F3N5O/c1-33-23-12-9-19(26(27,28)29)13-22(23)25(32-33)30-14-24(35)31-20-15-34(16-20)21-10-7-18(8-11-21)17-5-3-2-4-6-17/h2-6,9,12-13,18,20-21H,7-8,10-11,14-16H2,1H3,(H,30,32)(H,31,35) GWGRACKHWJVFCC-UHFFFAOYSA-N 50355285 CHEMBL1834785 C-C chemokine receptor type 2 Homo sapiens 30 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355285 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355285&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56657929 136361971 CHEMBL1834785 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665288 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CN=C1NC(Cc2ccccc2)c2ccc(cc12)C(F)(F)F |r,w:19.20,wU:5.4,8.11,(-11.55,4.32,;-10.78,2.98,;-11.54,1.65,;-10.77,.32,;-11.54,-1.02,;-9.23,.32,;-8.47,-1.03,;-6.93,-1.03,;-6.16,.3,;-6.92,1.64,;-8.47,1.64,;-4.62,.3,;-3.53,-.8,;-2.43,.28,;-3.52,1.38,;-.89,.28,;-.13,-1.06,;-.9,-2.39,;1.41,-1.06,;2.18,-2.4,;3.72,-2.4,;4.62,-3.65,;6.08,-3.17,;7.33,-4.08,;8.74,-3.46,;9.98,-4.37,;11.38,-3.74,;11.55,-2.21,;10.29,-1.3,;8.89,-1.93,;6.08,-1.63,;7.22,-.61,;6.91,.89,;5.44,1.36,;4.31,.34,;4.63,-1.15,;5.12,2.87,;6.26,3.9,;3.65,3.34,;4.71,4.37,)| InChI=1S/C30H35F3N4O3/c1-2-40-29(39)20-8-11-23(12-9-20)37-17-22(18-37)35-27(38)16-34-28-25-15-21(30(31,32)33)10-13-24(25)26(36-28)14-19-6-4-3-5-7-19/h3-7,10,13,15,20,22-23,26H,2,8-9,11-12,14,16-18H2,1H3,(H,34,36)(H,35,38) MYRGKAVLHHTTPL-UHFFFAOYSA-N 50355287 CHEMBL1834783 C-C chemokine receptor type 2 Homo sapiens 67 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355287&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56657928 136361973 CHEMBL1834783 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665289 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C(N)=O)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.14,4.94,;-9.37,3.61,;-10.14,2.27,;-9.37,.94,;-10.14,-.39,;-7.83,.94,;-7.06,-.4,;-5.53,-.4,;-4.75,.93,;-5.52,2.26,;-7.06,2.27,;-3.21,.92,;-2.12,-.18,;-1.03,.91,;-2.11,2,;.51,.9,;1.28,-.43,;.5,-1.77,;2.82,-.44,;3.58,-1.78,;5.12,-1.78,;6.02,-3.02,;7.49,-2.55,;8.73,-3.46,;10.14,-2.83,;8.57,-4.99,;7.49,-1.01,;8.63,.01,;8.31,1.51,;6.85,1.99,;5.71,.96,;6.03,-.53,;6.52,3.49,;7.67,4.52,;5.06,3.96,;6.11,4.99,)| InChI=1S/C23H29F3N6O4/c1-2-36-21(34)13-3-6-16(7-4-13)31-11-15(12-31)29-19(33)10-28-20-17-9-14(23(24,25)26)5-8-18(17)32(30-20)22(27)35/h5,8-9,13,15-16H,2-4,6-7,10-12H2,1H3,(H2,27,35)(H,28,30)(H,29,33) BSPCGOZVENCINN-UHFFFAOYSA-N 50355289 CHEMBL1834781 C-C chemokine receptor type 2 Homo sapiens 14 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355289&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54756045 136361975 CHEMBL1834781 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665290 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(CC=C)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.76,4.32,;-9.99,2.98,;-10.76,1.65,;-9.99,.32,;-10.76,-1.02,;-8.45,.32,;-7.68,-1.03,;-6.15,-1.03,;-5.37,.3,;-6.14,1.64,;-7.69,1.64,;-3.83,.3,;-2.74,-.8,;-1.65,.28,;-2.74,1.37,;-.11,.28,;.65,-1.06,;-.12,-2.39,;2.19,-1.06,;2.96,-2.4,;4.5,-2.4,;5.4,-3.65,;6.87,-3.18,;8.11,-4.08,;9.52,-3.46,;10.76,-4.36,;6.86,-1.63,;8,-.61,;7.69,.89,;6.22,1.36,;5.09,.34,;5.41,-1.16,;5.9,2.87,;7.04,3.9,;4.44,3.34,;5.49,4.36,)| InChI=1S/C25H32F3N5O3/c1-3-11-33-21-10-7-17(25(26,27)28)12-20(21)23(31-33)29-13-22(34)30-18-14-32(15-18)19-8-5-16(6-9-19)24(35)36-4-2/h3,7,10,12,16,18-19H,1,4-6,8-9,11,13-15H2,2H3,(H,29,31)(H,30,34) BDWRIURLGQMQKO-UHFFFAOYSA-N 50355247 CHEMBL1834779 C-C chemokine receptor type 2 Homo sapiens 28 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355247&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54756156 136361933 CHEMBL1834779 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665291 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(CC)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.14,4.18,;-9.37,2.84,;-10.14,1.51,;-9.37,.18,;-10.14,-1.16,;-7.83,.18,;-7.06,-1.17,;-5.53,-1.17,;-4.75,.16,;-5.52,1.5,;-7.06,1.5,;-3.21,.16,;-2.12,-.94,;-1.03,.14,;-2.11,1.23,;.51,.14,;1.28,-1.2,;.5,-2.53,;2.82,-1.2,;3.58,-2.54,;5.12,-2.55,;6.02,-3.79,;7.49,-3.32,;8.73,-4.22,;10.14,-3.6,;7.49,-1.78,;8.63,-.75,;8.31,.75,;6.85,1.22,;5.71,.2,;6.03,-1.3,;6.52,2.73,;7.67,3.76,;5.06,3.2,;6.11,4.22,)| InChI=1S/C24H32F3N5O3/c1-3-32-20-10-7-16(24(25,26)27)11-19(20)22(30-32)28-12-21(33)29-17-13-31(14-17)18-8-5-15(6-9-18)23(34)35-4-2/h7,10-11,15,17-18H,3-6,8-9,12-14H2,1-2H3,(H,28,30)(H,29,33) HLMHWYIWIILJEU-UHFFFAOYSA-N 50355248 CHEMBL1834721 C-C chemokine receptor type 2 Homo sapiens 7 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355248&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755560 136361934 CHEMBL1834721 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665292 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1noc2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-9.38,3.96,;-8.61,2.63,;-9.38,1.29,;-8.61,-.04,;-9.38,-1.38,;-7.07,-.04,;-6.3,-1.39,;-4.77,-1.39,;-3.99,-.06,;-4.76,1.28,;-6.31,1.29,;-2.45,-.06,;-1.36,-1.16,;-.27,-.08,;-1.36,1.02,;1.27,-.08,;2.03,-1.42,;1.26,-2.75,;3.57,-1.42,;4.34,-2.76,;5.88,-2.76,;6.78,-4.01,;8.25,-3.53,;8.24,-1.99,;9.38,-.97,;9.07,.53,;7.6,1,;6.47,-.02,;6.79,-1.51,;7.28,2.51,;8.42,3.54,;5.82,2.98,;6.87,4.01,)| InChI=1S/C22H27F3N4O4/c1-2-32-21(31)13-3-6-16(7-4-13)29-11-15(12-29)27-19(30)10-26-20-17-9-14(22(23,24)25)5-8-18(17)33-28-20/h5,8-9,13,15-16H,2-4,6-7,10-12H2,1H3,(H,26,28)(H,27,30) XODCWPJDJRYTNL-UHFFFAOYSA-N 50355292 CHEMBL1834720 C-C chemokine receptor type 2 Homo sapiens 34 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355292&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54756038 136361978 CHEMBL1834720 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665293 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-9.38,3.96,;-8.61,2.63,;-9.38,1.29,;-8.61,-.04,;-9.38,-1.38,;-7.07,-.04,;-6.3,-1.39,;-4.77,-1.39,;-3.99,-.06,;-4.76,1.28,;-6.31,1.29,;-2.45,-.06,;-1.36,-1.16,;-.27,-.08,;-1.36,1.02,;1.27,-.08,;2.03,-1.42,;1.26,-2.75,;3.57,-1.42,;4.34,-2.76,;5.88,-2.76,;6.78,-4.01,;8.25,-3.53,;8.24,-1.99,;9.38,-.97,;9.07,.53,;7.6,1,;6.47,-.02,;6.79,-1.51,;7.28,2.51,;8.42,3.54,;5.82,2.98,;6.87,4.01,)| InChI=1S/C22H28F3N5O3/c1-2-33-21(32)13-3-6-16(7-4-13)30-11-15(12-30)27-19(31)10-26-20-17-9-14(22(23,24)25)5-8-18(17)28-29-20/h5,8-9,13,15-16H,2-4,6-7,10-12H2,1H3,(H,27,31)(H2,26,28,29) BFNOLBZMRSIRMC-UHFFFAOYSA-N 50355249 CHEMBL1834719 C-C chemokine receptor type 2 Homo sapiens 15 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355249&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755081 136361935 CHEMBL1834719 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665294 NC(=O)n1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(10.56,-4.99,;10.72,-3.46,;12.13,-2.83,;9.48,-2.55,;8.01,-3.02,;7.11,-1.78,;5.57,-1.78,;4.8,-.44,;3.26,-.43,;2.49,-1.77,;2.5,.9,;.96,.91,;-.13,-.18,;-1.22,.92,;-.13,2,;-2.76,.93,;-3.54,-.4,;-5.07,-.4,;-5.84,.94,;-5.08,2.27,;-3.53,2.26,;-7.38,.94,;-8.14,-.39,;-9.67,-.39,;-10.45,.94,;-11.96,1.26,;-12.13,2.79,;-10.72,3.43,;-9.68,2.28,;-8.14,2.28,;8.02,-.53,;7.7,.96,;8.83,1.99,;10.3,1.51,;10.61,.01,;9.47,-1.01,;8.51,3.49,;9.65,4.52,;7.05,3.96,;8.1,4.99,)| InChI=1S/C27H29F3N6O4/c28-27(29,30)17-4-7-21-20(10-17)25(34-36(21)26(31)38)32-11-24(37)33-18-12-35(13-18)19-5-1-15(2-6-19)16-3-8-22-23(9-16)40-14-39-22/h3-4,7-10,15,18-19H,1-2,5-6,11-14H2,(H2,31,38)(H,32,34)(H,33,37) DFOPMFXQYWVKQK-UHFFFAOYSA-N 50355250 CHEMBL1834718 C-C chemokine receptor type 2 Homo sapiens 34 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355250&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56668309 136361936 CHEMBL1834718 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665295 CC(C)(C)NC(=O)n1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:22.26,19.19,(11.1,-6.21,;11.26,-4.68,;12.67,-4.05,;12.35,-5.76,;10.02,-3.77,;10.18,-2.24,;11.59,-1.61,;8.93,-1.33,;7.47,-1.8,;6.57,-.56,;5.03,-.56,;4.26,.78,;2.72,.78,;1.95,-.55,;1.96,2.12,;.42,2.13,;-.67,1.04,;-1.76,2.14,;-.67,3.22,;-3.3,2.14,;-4.08,.81,;-5.61,.82,;-6.38,2.16,;-5.62,3.49,;-4.07,3.48,;-7.92,2.16,;-8.68,.83,;-10.21,.82,;-10.99,2.16,;-12.5,2.48,;-12.67,4.01,;-11.26,4.65,;-10.23,3.5,;-8.68,3.5,;7.48,.69,;7.16,2.18,;8.29,3.2,;9.76,2.73,;10.07,1.23,;8.93,.21,;7.97,4.71,;9.11,5.74,;6.51,5.18,;7.56,6.21,)| InChI=1S/C31H37F3N6O4/c1-30(2,3)37-29(42)40-24-10-7-20(31(32,33)34)13-23(24)28(38-40)35-14-27(41)36-21-15-39(16-21)22-8-4-18(5-9-22)19-6-11-25-26(12-19)44-17-43-25/h6-7,10-13,18,21-22H,4-5,8-9,14-17H2,1-3H3,(H,35,38)(H,36,41)(H,37,42) HYZGGNZNVAYPFO-UHFFFAOYSA-N 50355251 CHEMBL1834717 C-C chemokine receptor type 2 Homo sapiens 19 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355251&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56661444 136361937 CHEMBL1834717 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665296 OCCn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(11.97,-5.44,;10.72,-4.54,;10.88,-3,;9.64,-2.1,;8.17,-2.57,;7.27,-1.33,;5.73,-1.32,;4.97,.01,;3.43,.02,;2.65,-1.31,;2.66,1.36,;1.12,1.36,;.03,.27,;-1.06,1.37,;.04,2.45,;-2.6,1.38,;-3.38,.05,;-4.91,.05,;-5.68,1.4,;-4.91,2.72,;-3.37,2.72,;-7.22,1.39,;-7.97,.07,;-9.51,.06,;-10.29,1.4,;-11.8,1.71,;-11.97,3.25,;-10.56,3.88,;-9.52,2.74,;-7.98,2.73,;8.18,-.08,;7.86,1.41,;9,2.44,;10.46,1.96,;10.78,.46,;9.64,-.56,;8.67,3.94,;9.82,4.98,;7.21,4.42,;8.26,5.44,)| InChI=1S/C28H32F3N5O4/c29-28(30,31)19-4-7-23-22(12-19)27(34-36(23)9-10-37)32-13-26(38)33-20-14-35(15-20)21-5-1-17(2-6-21)18-3-8-24-25(11-18)40-16-39-24/h3-4,7-8,11-12,17,20-21,37H,1-2,5-6,9-10,13-16H2,(H,32,34)(H,33,38) NAWKYIASORHDMZ-UHFFFAOYSA-N 50355252 CHEMBL1834652 C-C chemokine receptor type 2 Homo sapiens 20 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355252&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755801 136361938 CHEMBL1834652 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665297 FC(F)(F)c1ccc2onc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccc4OCOc4c3)c2c1 |r,wU:23.27,20.20,(10.41,3.54,;9.27,2.51,;7.8,2.98,;8.86,4.01,;9.59,1,;11.06,.53,;11.37,-.97,;10.23,-1.99,;10.23,-3.53,;8.77,-4.01,;7.87,-2.76,;6.33,-2.76,;5.56,-1.42,;4.02,-1.42,;3.25,-2.75,;3.26,-.08,;1.72,-.08,;.62,-1.16,;-.47,-.06,;.63,1.02,;-2.01,-.06,;-2.78,-1.39,;-4.32,-1.39,;-5.08,-.04,;-4.32,1.29,;-2.77,1.28,;-6.62,-.04,;-7.38,-1.37,;-8.92,-1.38,;-9.69,-.04,;-11.21,.28,;-11.37,1.81,;-9.96,2.44,;-8.93,1.3,;-7.39,1.3,;8.77,-1.51,;8.46,-.02,)| InChI=1S/C26H27F3N4O4/c27-26(28,29)17-4-8-21-20(10-17)25(32-37-21)30-11-24(34)31-18-12-33(13-18)19-5-1-15(2-6-19)16-3-7-22-23(9-16)36-14-35-22/h3-4,7-10,15,18-19H,1-2,5-6,11-14H2,(H,30,32)(H,31,34) HQGJCOXCZNLUFA-UHFFFAOYSA-N 50355253 CHEMBL1834651 C-C chemokine receptor type 2 Homo sapiens 20 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355253&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755919 136361939 CHEMBL1834651 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665298 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@H](COCC=C)CC2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.17,(10.23,-42.67,;8.98,-41.76,;7.52,-42.23,;6.62,-40.99,;5.08,-40.99,;4.31,-39.65,;2.77,-39.65,;2,-40.98,;2.01,-38.31,;.47,-38.3,;-.63,-39.39,;-1.72,-38.29,;-.62,-37.21,;-3.26,-38.29,;-4.03,-36.95,;-5.57,-36.94,;-6.33,-38.27,;-7.87,-38.27,;-8.65,-36.94,;-7.88,-35.6,;-8.65,-34.27,;-7.88,-32.93,;-5.57,-39.61,;-4.03,-39.62,;7.52,-39.74,;7.21,-38.25,;8.34,-37.23,;9.81,-37.7,;10.12,-39.2,;8.98,-40.22,;8.02,-35.72,;9.16,-34.69,;6.55,-35.25,;7.61,-34.22,)| InChI=1S/C24H32F3N5O2/c1-3-10-34-15-16-4-7-19(8-5-16)32-13-18(14-32)29-22(33)12-28-23-20-11-17(24(25,26)27)6-9-21(20)31(2)30-23/h3,6,9,11,16,18-19H,1,4-5,7-8,10,12-15H2,2H3,(H,28,30)(H,29,33) XSTSZTTUPFLRLY-UHFFFAOYSA-N 50355259 CHEMBL1834645 C-C chemokine receptor type 2 Homo sapiens 66 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355259&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754724 136361945 CHEMBL1834645 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665299 CCOC[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:7.10,4.3,(12.26,-25.29,;13.03,-26.62,;12.26,-27.95,;13.03,-29.29,;14.57,-29.29,;15.34,-27.96,;16.88,-27.97,;17.65,-29.3,;16.87,-30.63,;15.34,-30.63,;19.19,-29.31,;20.28,-30.41,;21.37,-29.32,;20.29,-28.23,;22.91,-29.33,;23.68,-30.66,;22.9,-31.99,;25.22,-30.67,;25.98,-32,;27.52,-32.01,;28.42,-33.25,;29.89,-32.78,;31.13,-33.69,;29.89,-31.24,;31.03,-30.22,;30.71,-28.72,;29.25,-28.24,;28.11,-29.27,;28.43,-30.76,;28.92,-26.74,;30.07,-25.7,;27.46,-26.26,;28.51,-25.24,)| InChI=1S/C23H32F3N5O2/c1-3-33-14-15-4-7-18(8-5-15)31-12-17(13-31)28-21(32)11-27-22-19-10-16(23(24,25)26)6-9-20(19)30(2)29-22/h6,9-10,15,17-18H,3-5,7-8,11-14H2,1-2H3,(H,27,29)(H,28,32) NLACPXOSKRJIGO-UHFFFAOYSA-N 50355260 CHEMBL1834644 C-C chemokine receptor type 2 Homo sapiens 86 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355260&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754723 136361946 CHEMBL1834644 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665300 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@H](CO)CC2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.17,(8.93,-30.5,;7.68,-29.59,;6.22,-30.06,;5.32,-28.82,;3.78,-28.81,;3.01,-27.48,;1.47,-27.47,;.7,-28.8,;.71,-26.14,;-.83,-26.13,;-1.93,-27.22,;-3.02,-26.12,;-1.92,-25.04,;-4.56,-26.11,;-5.32,-24.78,;-6.87,-24.77,;-7.63,-26.1,;-9.17,-26.1,;-9.94,-24.76,;-6.87,-27.44,;-5.33,-27.44,;6.23,-27.57,;5.91,-26.08,;7.04,-25.05,;8.51,-25.53,;8.82,-27.03,;7.68,-28.05,;6.72,-23.55,;7.86,-22.52,;5.25,-23.07,;6.31,-22.05,)| InChI=1S/C21H28F3N5O2/c1-28-18-7-4-14(21(22,23)24)8-17(18)20(27-28)25-9-19(31)26-15-10-29(11-15)16-5-2-13(12-30)3-6-16/h4,7-8,13,15-16,30H,2-3,5-6,9-12H2,1H3,(H,25,27)(H,26,31) LDEUNNVWDAAUOC-UHFFFAOYSA-N 50355261 CHEMBL1834643 C-C chemokine receptor type 2 Homo sapiens 47 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355261&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754722 136361947 CHEMBL1834643 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665301 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:8.11,5.4,(13.3,-4.72,;14.07,-6.05,;13.3,-7.39,;14.07,-8.72,;13.31,-10.06,;15.61,-8.72,;16.38,-10.07,;17.92,-10.07,;18.69,-8.74,;17.92,-7.4,;16.38,-7.39,;20.23,-8.74,;21.32,-9.84,;22.41,-8.76,;21.33,-7.66,;23.95,-8.76,;24.72,-10.1,;23.95,-11.43,;26.26,-10.1,;27.03,-11.44,;28.57,-11.44,;29.47,-12.69,;30.93,-12.21,;32.18,-13.12,;30.93,-10.67,;32.07,-9.65,;31.75,-8.15,;30.29,-7.68,;29.16,-8.7,;29.47,-10.19,;29.97,-6.17,;31.11,-5.14,;28.5,-5.7,;29.56,-4.67,)| InChI=1S/C23H30F3N5O3/c1-3-34-22(33)14-4-7-17(8-5-14)31-12-16(13-31)28-20(32)11-27-21-18-10-15(23(24,25)26)6-9-19(18)30(2)29-21/h6,9-10,14,16-17H,3-5,7-8,11-13H2,1-2H3,(H,27,29)(H,28,32) QTKVWRRRHCBCAH-UHFFFAOYSA-N 50355264 CHEMBL1834640 C-C chemokine receptor type 2 Homo sapiens 40 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355264&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671925 136361950 CHEMBL1834640 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665302 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)n3ccccc3=O)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.44,2.51,;6.97,2.98,;8.03,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.94,-4.01,;7.04,-2.76,;5.5,-2.76,;4.73,-1.42,;3.19,-1.42,;2.42,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.2,1.02,;-2.84,-.06,;-3.61,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.15,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,1.3,;-9.77,1.29,;-10.54,-.04,;-9.77,-1.38,;-8.23,-1.38,;-7.46,-2.71,;7.94,-1.51,;7.63,-.02,)| InChI=1S/C24H27F3N6O2/c25-24(26,27)15-4-9-20-19(11-15)23(31-30-20)28-12-21(34)29-16-13-32(14-16)17-5-7-18(8-6-17)33-10-2-1-3-22(33)35/h1-4,9-11,16-18H,5-8,12-14H2,(H,29,34)(H2,28,30,31) OWPZOIUERRHILB-UHFFFAOYSA-N 50355268 CHEMBL1834636 C-C chemokine receptor type 2 Homo sapiens 170 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355268 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355268&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755083 136361954 CHEMBL1834636 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665303 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(12.85,-40.75,;11.6,-39.84,;10.14,-40.31,;9.24,-39.07,;7.7,-39.07,;6.93,-37.73,;5.39,-37.72,;4.62,-39.06,;4.63,-36.39,;3.09,-36.38,;1.99,-37.47,;.9,-36.37,;2,-35.29,;-.64,-36.36,;-1.41,-37.69,;-2.95,-37.69,;-3.71,-36.35,;-2.95,-35.02,;-1.4,-35.03,;-5.25,-36.35,;-6.03,-37.68,;-7.57,-37.68,;-8.34,-36.34,;-9.83,-36.03,;-10,-34.51,;-8.61,-33.88,;-7.58,-35.02,;-6.03,-35.01,;10.15,-37.82,;9.83,-36.33,;10.96,-35.3,;12.43,-35.78,;12.74,-37.28,;11.6,-38.3,;10.64,-33.8,;11.78,-32.77,;9.17,-33.33,;10.23,-32.3,)| InChI=1S/C27H30F3N5O3/c1-34-22-8-5-18(27(28,29)30)11-21(22)26(33-34)31-12-25(36)32-19-13-35(14-19)20-6-2-16(3-7-20)17-4-9-23-24(10-17)38-15-37-23/h4-5,8-11,16,19-20H,2-3,6-7,12-15H2,1H3,(H,31,33)(H,32,36) QPEQRQQPWVTPFP-UHFFFAOYSA-N 50355269 CHEMBL1834635 C-C chemokine receptor type 2 Homo sapiens 8 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355269&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56664979 136361955 CHEMBL1834635 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665304 COc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(-11.69,1.29,;-10.92,-.05,;-9.38,-.04,;-8.61,1.29,;-7.07,1.29,;-6.3,-.04,;-7.07,-1.37,;-8.6,-1.38,;-4.76,-.04,;-4,-1.39,;-2.46,-1.39,;-1.69,-.06,;-2.45,1.28,;-4,1.29,;-.15,-.06,;.94,-1.16,;2.04,-.08,;.95,1.02,;3.58,-.08,;4.34,-1.42,;3.57,-2.75,;5.88,-1.42,;6.65,-2.76,;8.19,-2.76,;9.09,-4.01,;10.55,-3.53,;10.55,-1.99,;11.69,-.97,;11.38,.53,;9.91,1,;8.78,-.02,;9.1,-1.51,;9.59,2.51,;10.73,3.54,;8.12,2.98,;9.18,4.01,)| InChI=1S/C25H29F3N6O2/c1-36-23-9-4-16(11-29-23)15-2-6-19(7-3-15)34-13-18(14-34)31-22(35)12-30-24-20-10-17(25(26,27)28)5-8-21(20)32-33-24/h4-5,8-11,15,18-19H,2-3,6-7,12-14H2,1H3,(H,31,35)(H2,30,32,33) WANRYTYAXACNHP-UHFFFAOYSA-N 50355270 CHEMBL1834634 C-C chemokine receptor type 2 Homo sapiens 2 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355270 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355270&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754968 136361956 CHEMBL1834634 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665305 NC(=O)Cc1ccc(cc1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:13.17,10.10,(-8.25,-29.41,;-9.01,-28.08,;-10.55,-28.08,;-8.24,-26.74,;-6.7,-26.75,;-5.93,-28.09,;-4.39,-28.09,;-3.62,-26.75,;-4.4,-25.41,;-5.94,-25.41,;-2.08,-26.75,;-1.31,-28.09,;.22,-28.1,;1,-26.77,;.23,-25.43,;-1.32,-25.42,;2.54,-26.77,;3.63,-27.87,;4.72,-26.79,;3.63,-25.69,;6.26,-26.79,;7.03,-28.13,;6.25,-29.46,;8.57,-28.13,;9.33,-29.47,;10.87,-29.47,;11.77,-30.71,;13.24,-30.24,;13.24,-28.7,;14.37,-27.68,;14.06,-26.18,;12.6,-25.71,;11.46,-26.73,;11.78,-28.22,;12.27,-24.2,;13.42,-23.17,;10.81,-23.73,;11.86,-22.7,)| InChI=1S/C27H31F3N6O2/c28-27(29,30)19-7-10-23-22(12-19)26(35-34-23)32-13-25(38)33-20-14-36(15-20)21-8-5-18(6-9-21)17-3-1-16(2-4-17)11-24(31)37/h1-4,7,10,12,18,20-21H,5-6,8-9,11,13-15H2,(H2,31,37)(H,33,38)(H2,32,34,35) LJAWGNFSXAWFQQ-UHFFFAOYSA-N 50355271 CHEMBL1834633 C-C chemokine receptor type 2 Homo sapiens 35 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355271 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355271&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54755079 136361957 CHEMBL1834633 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665306 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccc4OCOc4c3)c2c1 |r,wU:20.20,23.27,(33.39,-15.27,;32.25,-16.3,;30.78,-15.83,;31.83,-14.8,;32.57,-17.8,;34.03,-18.28,;34.35,-19.78,;33.21,-20.8,;33.21,-22.34,;31.74,-22.81,;30.84,-21.57,;29.3,-21.57,;28.54,-20.23,;27,-20.22,;26.22,-21.56,;26.23,-18.89,;24.69,-18.88,;23.6,-19.97,;22.51,-18.87,;23.61,-17.79,;20.97,-18.86,;20.19,-20.19,;18.66,-20.19,;17.89,-18.85,;18.66,-17.52,;20.2,-17.53,;16.35,-18.85,;15.58,-20.18,;14.04,-20.18,;13.27,-18.84,;11.77,-18.53,;11.61,-17.01,;13,-16.38,;14.03,-17.52,;15.57,-17.51,;31.75,-20.32,;31.44,-18.83,)| InChI=1S/C26H28F3N5O3/c27-26(28,29)17-4-7-21-20(10-17)25(33-32-21)30-11-24(35)31-18-12-34(13-18)19-5-1-15(2-6-19)16-3-8-22-23(9-16)37-14-36-22/h3-4,7-10,15,18-19H,1-2,5-6,11-14H2,(H,31,35)(H2,30,32,33) CHXGVUFRAUAFHM-UHFFFAOYSA-N 50355272 CHEMBL1834632 C-C chemokine receptor type 2 Homo sapiens 3 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355272&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754969 136361958 CHEMBL1834632 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665307 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccccc3)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.44,2.51,;6.97,2.98,;8.03,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.94,-4.01,;7.04,-2.76,;5.5,-2.76,;4.73,-1.42,;3.19,-1.42,;2.42,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.2,1.02,;-2.84,-.06,;-3.61,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.15,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,-1.38,;-9.77,-1.38,;-10.54,-.04,;-9.77,1.29,;-8.23,1.3,;7.94,-1.51,;7.63,-.02,)| InChI=1S/C25H28F3N5O/c26-25(27,28)18-8-11-22-21(12-18)24(32-31-22)29-13-23(34)30-19-14-33(15-19)20-9-6-17(7-10-20)16-4-2-1-3-5-16/h1-5,8,11-12,17,19-20H,6-7,9-10,13-15H2,(H,30,34)(H2,29,31,32) MBQDUNUKUGTDDX-UHFFFAOYSA-N 50355273 CHEMBL1834631 C-C chemokine receptor type 2 Homo sapiens 9 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355273&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56671923 136361959 CHEMBL1834631 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665308 FC(F)(F)c1ccc2onc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3nccs3)c2c1 |r,wU:20.20,23.27,(9.33,-4.79,;8.19,-5.82,;6.72,-5.35,;7.78,-4.32,;8.51,-7.33,;9.98,-7.8,;10.29,-9.3,;9.15,-10.32,;9.15,-11.86,;7.69,-12.34,;6.79,-11.09,;5.25,-11.09,;4.48,-9.75,;2.94,-9.75,;2.17,-11.08,;2.18,-8.41,;.64,-8.41,;-.46,-9.49,;-1.55,-8.39,;-.45,-7.31,;-3.09,-8.39,;-3.86,-9.72,;-5.4,-9.72,;-6.16,-8.37,;-5.4,-7.04,;-3.85,-7.05,;-7.7,-8.37,;-8.61,-7.12,;-10.07,-7.6,;-10.07,-9.14,;-8.61,-9.61,;7.7,-9.84,;7.38,-8.35,)| InChI=1S/C22H24F3N5O2S/c23-22(24,25)14-3-6-18-17(9-14)20(29-32-18)27-10-19(31)28-15-11-30(12-15)16-4-1-13(2-5-16)21-26-7-8-33-21/h3,6-9,13,15-16H,1-2,4-5,10-12H2,(H,27,29)(H,28,31) DOAPNMVLEGQTQO-UHFFFAOYSA-N 50355293 CHEMBL1834854 C-C chemokine receptor type 2 Homo sapiens 31 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355293&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56676474 136361979 CHEMBL1834854 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665309 FC(F)(F)c1ccc2onc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3cncs3)c2c1 |r,wU:20.20,23.27,(33.91,5.25,;32.77,4.22,;31.3,4.69,;32.36,5.72,;33.09,2.71,;34.55,2.24,;34.87,.74,;33.73,-.28,;33.73,-1.82,;32.27,-2.29,;31.37,-1.05,;29.83,-1.05,;29.06,.29,;27.52,.29,;26.75,-1.04,;26.75,1.63,;25.21,1.63,;24.12,.55,;23.03,1.65,;24.13,2.73,;21.49,1.65,;20.72,.32,;19.18,.33,;18.41,1.67,;19.18,3,;20.72,2.99,;16.87,1.67,;15.97,2.92,;14.51,2.44,;14.51,.9,;15.97,.43,;32.27,.2,;31.96,1.69,)| InChI=1S/C22H24F3N5O2S/c23-22(24,25)14-3-6-18-17(7-14)21(29-32-18)27-9-20(31)28-15-10-30(11-15)16-4-1-13(2-5-16)19-8-26-12-33-19/h3,6-8,12-13,15-16H,1-2,4-5,9-11H2,(H,27,29)(H,28,31) FQXDXSUCYIDGPA-UHFFFAOYSA-N 50355294 CHEMBL1834853 C-C chemokine receptor type 2 Homo sapiens 31 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355294 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355294&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56683121 136361980 CHEMBL1834853 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665310 COc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1noc2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(-10.72,2.46,;-9.95,1.13,;-8.41,1.13,;-7.64,2.47,;-6.1,2.47,;-5.34,1.13,;-6.1,-.2,;-7.63,-.2,;-3.8,1.13,;-3.03,-.21,;-1.5,-.21,;-.72,1.12,;-1.49,2.45,;-3.04,2.46,;.82,1.11,;1.91,.01,;3,1.1,;1.92,2.19,;4.54,1.09,;5.31,-.24,;4.53,-1.57,;6.85,-.25,;7.61,-1.58,;9.15,-1.59,;10.05,-2.83,;11.52,-2.36,;11.52,-.82,;12.66,.2,;12.34,1.7,;10.88,2.18,;9.74,1.15,;10.06,-.34,;10.55,3.68,;11.7,4.71,;9.09,4.16,;10.14,5.18,)| InChI=1S/C25H28F3N5O3/c1-35-23-9-4-16(11-29-23)15-2-6-19(7-3-15)33-13-18(14-33)31-22(34)12-30-24-20-10-17(25(26,27)28)5-8-21(20)36-32-24/h4-5,8-11,15,18-19H,2-3,6-7,12-14H2,1H3,(H,30,32)(H,31,34) ZZFKFTVPUSBMNB-UHFFFAOYSA-N 50355295 CHEMBL1834852 C-C chemokine receptor type 2 Homo sapiens 23 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355295 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355295&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56659295 136361981 CHEMBL1834852 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665311 Cn1ccc(n1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:6.6,9.13,(-11,-46.89,;-9.75,-45.98,;-9.75,-44.44,;-8.29,-43.96,;-7.38,-45.22,;-8.29,-46.46,;-5.84,-45.21,;-5.08,-46.56,;-3.54,-46.56,;-2.77,-45.23,;-3.54,-43.89,;-5.08,-43.89,;-1.23,-45.24,;-.14,-46.34,;.96,-45.25,;-.13,-44.16,;2.5,-45.25,;3.26,-46.59,;2.49,-47.92,;4.8,-46.6,;5.57,-47.93,;7.11,-47.94,;8.01,-49.18,;9.47,-48.71,;10.72,-49.61,;9.47,-47.17,;10.61,-46.15,;10.3,-44.65,;8.83,-44.17,;7.7,-45.2,;8.01,-46.69,;8.51,-42.67,;9.65,-41.63,;7.04,-42.19,;8.1,-41.17,)| InChI=1S/C24H30F3N7O/c1-32-10-9-20(30-32)15-3-6-18(7-4-15)34-13-17(14-34)29-22(35)12-28-23-19-11-16(24(25,26)27)5-8-21(19)33(2)31-23/h5,8-11,15,17-18H,3-4,6-7,12-14H2,1-2H3,(H,28,31)(H,29,35) BMLUECIKNCZOMW-UHFFFAOYSA-N 50355296 CHEMBL1834851 C-C chemokine receptor type 2 Homo sapiens 200 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355296 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355296&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56669631 136361982 CHEMBL1834851 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665312 Cn1ccnc1[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:6.6,9.13,(14.97,-39.87,;14.49,-38.41,;13.03,-37.93,;13.03,-36.39,;14.49,-35.91,;15.4,-37.17,;16.94,-37.16,;17.7,-38.51,;19.24,-38.51,;20.01,-37.18,;19.25,-35.84,;17.7,-35.84,;21.55,-37.19,;22.64,-38.29,;23.74,-37.2,;22.65,-36.11,;25.28,-37.2,;26.04,-38.54,;25.27,-39.87,;27.58,-38.55,;28.35,-39.88,;29.89,-39.89,;30.79,-41.13,;32.25,-40.66,;33.5,-41.56,;32.25,-39.12,;33.39,-38.1,;33.08,-36.6,;31.61,-36.12,;30.48,-37.15,;30.8,-38.64,;31.29,-34.62,;32.43,-33.58,;29.82,-34.14,;30.88,-33.12,)| InChI=1S/C24H30F3N7O/c1-32-10-9-28-23(32)15-3-6-18(7-4-15)34-13-17(14-34)30-21(35)12-29-22-19-11-16(24(25,26)27)5-8-20(19)33(2)31-22/h5,8-11,15,17-18H,3-4,6-7,12-14H2,1-2H3,(H,29,31)(H,30,35) IHLUBBXLGBYUJB-UHFFFAOYSA-N 50355297 CHEMBL1834850 C-C chemokine receptor type 2 Homo sapiens 1400 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355297 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355297&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56676473 136361983 CHEMBL1834850 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665313 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ncco2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(10.25,-40.58,;9.01,-39.67,;7.54,-40.14,;6.64,-38.9,;5.1,-38.89,;4.33,-37.56,;2.79,-37.55,;2.02,-38.88,;2.03,-36.22,;.49,-36.21,;-.6,-37.3,;-1.69,-36.2,;-.6,-35.12,;-3.23,-36.19,;-4.01,-37.52,;-5.54,-37.52,;-6.31,-36.18,;-5.55,-34.85,;-4,-34.86,;-7.85,-36.18,;-8.75,-34.93,;-10.22,-35.4,;-10.22,-36.94,;-8.75,-37.42,;7.55,-37.65,;7.23,-36.16,;8.36,-35.13,;9.83,-35.61,;10.14,-37.11,;9,-38.13,;8.04,-33.63,;9.18,-32.6,;6.58,-33.15,;7.63,-32.13,)| InChI=1S/C23H27F3N6O2/c1-31-19-7-4-15(23(24,25)26)10-18(19)21(30-31)28-11-20(33)29-16-12-32(13-16)17-5-2-14(3-6-17)22-27-8-9-34-22/h4,7-10,14,16-17H,2-3,5-6,11-13H2,1H3,(H,28,30)(H,29,33) OLVCVHSCGPZHJB-UHFFFAOYSA-N 50355298 CHEMBL1834849 C-C chemokine receptor type 2 Homo sapiens 480 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355298 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355298&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56683120 136361984 CHEMBL1834849 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665314 CC(C)c1ncc(s1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(13.82,-28.32,;15.23,-28.94,;15.39,-30.47,;16.48,-28.04,;16.47,-26.5,;17.94,-26.02,;18.84,-27.27,;17.94,-28.51,;20.38,-27.27,;21.15,-28.62,;22.68,-28.62,;23.46,-27.29,;22.69,-25.95,;21.15,-25.94,;25,-27.29,;26.09,-28.39,;27.18,-27.31,;26.1,-26.21,;28.72,-27.31,;29.49,-28.65,;28.71,-29.98,;31.03,-28.65,;31.79,-29.99,;33.33,-29.99,;34.23,-31.24,;35.7,-30.76,;36.94,-31.67,;35.7,-29.22,;36.84,-28.2,;36.52,-26.7,;35.06,-26.23,;33.92,-27.25,;34.24,-28.74,;34.73,-24.72,;35.88,-23.69,;33.27,-24.25,;34.32,-23.22,)| InChI=1S/C26H33F3N6OS/c1-15(2)25-31-11-22(37-25)16-4-7-19(8-5-16)35-13-18(14-35)32-23(36)12-30-24-20-10-17(26(27,28)29)6-9-21(20)34(3)33-24/h6,9-11,15-16,18-19H,4-5,7-8,12-14H2,1-3H3,(H,30,33)(H,32,36) WLCRNAWGAIMIQQ-UHFFFAOYSA-N 50355299 CHEMBL1834799 C-C chemokine receptor type 2 Homo sapiens 5 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355299 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355299&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56683116 136361985 CHEMBL1834799 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665315 CCc1ncc(s1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:7.7,10.14,(-11.12,-28.31,;-9.71,-28.94,;-8.47,-28.03,;-8.47,-26.49,;-7,-26.01,;-6.1,-27.26,;-7,-28.5,;-4.56,-27.26,;-3.79,-28.61,;-2.26,-28.61,;-1.48,-27.28,;-2.25,-25.94,;-3.8,-25.94,;.06,-27.28,;1.15,-28.38,;2.24,-27.3,;1.15,-26.21,;3.78,-27.3,;4.54,-28.64,;3.77,-29.97,;6.08,-28.64,;6.85,-29.98,;8.39,-29.99,;9.29,-31.23,;10.76,-30.76,;12,-31.66,;10.75,-29.22,;11.89,-28.19,;11.58,-26.69,;10.11,-26.22,;8.98,-27.24,;9.3,-28.74,;9.79,-24.71,;10.93,-23.68,;8.33,-24.24,;9.38,-23.22,)| InChI=1S/C25H31F3N6OS/c1-3-23-29-11-21(36-23)15-4-7-18(8-5-15)34-13-17(14-34)31-22(35)12-30-24-19-10-16(25(26,27)28)6-9-20(19)33(2)32-24/h6,9-11,15,17-18H,3-5,7-8,12-14H2,1-2H3,(H,30,32)(H,31,35) PGRNRBAPTURBFI-UHFFFAOYSA-N 50355300 CHEMBL1834798 C-C chemokine receptor type 2 Homo sapiens 18 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355300 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355300&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56662695 136361986 CHEMBL1834798 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665316 Cc1ncc(s1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:6.6,9.13,(12.2,-18.67,;13.44,-17.76,;13.44,-16.22,;14.91,-15.75,;15.81,-17,;14.91,-18.24,;17.35,-17,;18.12,-18.34,;19.65,-18.34,;20.43,-17.01,;19.66,-15.68,;18.11,-15.67,;21.97,-17.02,;23.06,-18.12,;24.15,-17.03,;23.06,-15.94,;25.69,-17.04,;26.45,-18.37,;25.68,-19.7,;27.99,-18.38,;28.76,-19.71,;30.3,-19.72,;31.2,-20.96,;32.67,-20.49,;33.91,-21.4,;32.66,-18.95,;33.8,-17.93,;33.49,-16.43,;32.02,-15.95,;30.89,-16.98,;31.21,-18.47,;31.7,-14.45,;32.84,-13.42,;30.24,-13.97,;31.29,-12.95,)| InChI=1S/C24H29F3N6OS/c1-14-28-10-21(35-14)15-3-6-18(7-4-15)33-12-17(13-33)30-22(34)11-29-23-19-9-16(24(25,26)27)5-8-20(19)32(2)31-23/h5,8-10,15,17-18H,3-4,6-7,11-13H2,1-2H3,(H,29,31)(H,30,34) QESGQSXZLHDYTQ-UHFFFAOYSA-N 50355301 CHEMBL1834797 C-C chemokine receptor type 2 Homo sapiens 19 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355301 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355301&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56659197 136361987 CHEMBL1834797 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665317 OCCn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2nccs2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(12.47,-23.07,;11.22,-22.17,;11.39,-20.63,;10.14,-19.73,;8.68,-20.2,;7.78,-18.96,;6.24,-18.95,;5.47,-17.62,;3.93,-17.61,;3.16,-18.94,;3.16,-16.27,;1.62,-16.27,;.53,-17.36,;-.56,-16.26,;.54,-15.18,;-2.1,-16.25,;-2.87,-17.58,;-4.41,-17.58,;-5.18,-16.23,;-4.41,-14.91,;-2.87,-14.91,;-6.72,-16.24,;-7.62,-14.98,;-9.08,-15.46,;-9.08,-17,;-7.62,-17.48,;8.68,-17.71,;8.37,-16.22,;9.5,-15.19,;10.96,-15.67,;11.28,-17.17,;10.14,-18.19,;9.18,-13.69,;10.32,-12.65,;7.71,-13.21,;8.77,-12.19,)| InChI=1S/C24H29F3N6O2S/c25-24(26,27)16-3-6-20-19(11-16)22(31-33(20)8-9-34)29-12-21(35)30-17-13-32(14-17)18-4-1-15(2-5-18)23-28-7-10-36-23/h3,6-7,10-11,15,17-18,34H,1-2,4-5,8-9,12-14H2,(H,29,31)(H,30,35) UZVFZTWEBLXYKJ-UHFFFAOYSA-N 50355302 CHEMBL1834796 C-C chemokine receptor type 2 Homo sapiens 29 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355302 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355302&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56659196 136361988 CHEMBL1834796 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665318 NC(=O)n1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2nccs2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(35.73,-11.8,;34.32,-12.42,;34.16,-13.95,;33.08,-11.51,;31.61,-11.99,;30.71,-10.74,;29.17,-10.74,;28.41,-9.4,;26.87,-9.4,;26.09,-10.73,;26.1,-8.06,;24.56,-8.06,;23.47,-9.14,;22.38,-8.04,;23.48,-6.96,;20.84,-8.04,;20.06,-9.37,;18.53,-9.37,;17.76,-8.02,;18.52,-6.69,;20.07,-6.7,;16.22,-8.02,;15.32,-6.77,;13.85,-7.25,;13.85,-8.79,;15.32,-9.26,;31.62,-9.49,;31.3,-8,;32.44,-6.98,;33.9,-7.45,;34.22,-8.95,;33.08,-9.97,;32.11,-5.47,;33.26,-4.44,;30.65,-5,;31.7,-3.97,)| InChI=1S/C23H26F3N7O2S/c24-23(25,26)14-3-6-18-17(9-14)20(31-33(18)22(27)35)29-10-19(34)30-15-11-32(12-15)16-4-1-13(2-5-16)21-28-7-8-36-21/h3,6-9,13,15-16H,1-2,4-5,10-12H2,(H2,27,35)(H,29,31)(H,30,34) OUBSBSYAMLKCPV-UHFFFAOYSA-N 50355303 CHEMBL1834795 C-C chemokine receptor type 2 Homo sapiens 29 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355303 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355303&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56683044 136361989 CHEMBL1834795 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665319 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2nccs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(11.37,-11.31,;10.13,-10.4,;8.66,-10.87,;7.76,-9.63,;6.22,-9.63,;5.45,-8.29,;3.91,-8.29,;3.14,-9.62,;3.15,-6.95,;1.61,-6.94,;.52,-8.03,;-.57,-6.93,;.52,-5.85,;-2.11,-6.93,;-2.89,-8.26,;-4.42,-8.25,;-5.19,-6.91,;-4.43,-5.58,;-2.88,-5.59,;-6.73,-6.91,;-7.63,-5.66,;-9.1,-6.13,;-9.1,-7.67,;-7.63,-8.15,;8.67,-8.38,;8.35,-6.89,;9.48,-5.87,;10.95,-6.34,;11.26,-7.84,;10.12,-8.86,;9.16,-4.36,;10.3,-3.33,;7.7,-3.89,;8.75,-2.86,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)10-18(19)21(30-31)28-11-20(33)29-16-12-32(13-16)17-5-2-14(3-6-17)22-27-8-9-34-22/h4,7-10,14,16-17H,2-3,5-6,11-13H2,1H3,(H,28,30)(H,29,33) KODYZMOGJJLGIT-UHFFFAOYSA-N 50355291 CHEMBL1834794 C-C chemokine receptor type 2 Homo sapiens 13 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355291&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56678508 136361977 CHEMBL1834794 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665320 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cncs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(32.69,-2.28,;31.44,-1.37,;29.98,-1.84,;29.08,-.6,;27.54,-.6,;26.77,.74,;25.23,.74,;24.46,-.59,;24.47,2.08,;22.93,2.09,;21.83,1,;20.74,2.1,;21.84,3.18,;19.21,2.1,;18.43,.77,;16.9,.78,;16.13,2.12,;16.89,3.45,;18.44,3.44,;14.59,2.12,;13.68,3.37,;12.22,2.9,;12.22,1.36,;13.69,.88,;29.99,.65,;29.67,2.14,;30.8,3.16,;32.27,2.69,;32.58,1.19,;31.44,.17,;30.48,4.67,;31.62,5.7,;29.02,5.14,;30.07,6.17,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)8-18(19)22(30-31)28-10-21(33)29-16-11-32(12-16)17-5-2-14(3-6-17)20-9-27-13-34-20/h4,7-9,13-14,16-17H,2-3,5-6,10-12H2,1H3,(H,28,30)(H,29,33) XBPRBIMQCWCMJS-UHFFFAOYSA-N 50355277 CHEMBL1834793 C-C chemokine receptor type 2 Homo sapiens 28 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355277&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56678507 136361963 CHEMBL1834793 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665321 FC(F)(F)c1ccc2onc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3nccs3)c2c1 |r,wU:20.20,23.27,(9.33,-4.79,;8.19,-5.82,;6.72,-5.35,;7.78,-4.32,;8.51,-7.33,;9.98,-7.8,;10.29,-9.3,;9.15,-10.32,;9.15,-11.86,;7.69,-12.34,;6.79,-11.09,;5.25,-11.09,;4.48,-9.75,;2.94,-9.75,;2.17,-11.08,;2.18,-8.41,;.64,-8.41,;-.46,-9.49,;-1.55,-8.39,;-.45,-7.31,;-3.09,-8.39,;-3.86,-9.72,;-5.4,-9.72,;-6.16,-8.37,;-5.4,-7.04,;-3.85,-7.05,;-7.7,-8.37,;-8.61,-7.12,;-10.07,-7.6,;-10.07,-9.14,;-8.61,-9.61,;7.7,-9.84,;7.38,-8.35,)| InChI=1S/C22H24F3N5O2S/c23-22(24,25)14-3-6-18-17(9-14)20(29-32-18)27-10-19(31)28-15-11-30(12-15)16-4-1-13(2-5-16)21-26-7-8-33-21/h3,6-9,13,15-16H,1-2,4-5,10-12H2,(H,27,29)(H,28,31) DOAPNMVLEGQTQO-UHFFFAOYSA-N 50355293 CHEMBL1834854 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 11 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355293&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56676474 136361979 CHEMBL1834854 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665322 FC(F)(F)c1ccc2onc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3cncs3)c2c1 |r,wU:20.20,23.27,(33.91,5.25,;32.77,4.22,;31.3,4.69,;32.36,5.72,;33.09,2.71,;34.55,2.24,;34.87,.74,;33.73,-.28,;33.73,-1.82,;32.27,-2.29,;31.37,-1.05,;29.83,-1.05,;29.06,.29,;27.52,.29,;26.75,-1.04,;26.75,1.63,;25.21,1.63,;24.12,.55,;23.03,1.65,;24.13,2.73,;21.49,1.65,;20.72,.32,;19.18,.33,;18.41,1.67,;19.18,3,;20.72,2.99,;16.87,1.67,;15.97,2.92,;14.51,2.44,;14.51,.9,;15.97,.43,;32.27,.2,;31.96,1.69,)| InChI=1S/C22H24F3N5O2S/c23-22(24,25)14-3-6-18-17(7-14)21(29-32-18)27-9-20(31)28-15-10-30(11-15)16-4-1-13(2-5-16)19-8-26-12-33-19/h3,6-8,12-13,15-16H,1-2,4-5,9-11H2,(H,27,29)(H,28,31) FQXDXSUCYIDGPA-UHFFFAOYSA-N 50355294 CHEMBL1834853 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 16 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355294 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355294&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56683121 136361980 CHEMBL1834853 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665323 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@@H](CC2)C#C)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(32.38,-50.73,;31.13,-49.82,;29.67,-50.29,;28.77,-49.05,;27.23,-49.04,;26.46,-47.71,;24.92,-47.7,;24.15,-49.03,;24.16,-46.37,;22.62,-46.36,;21.52,-47.45,;20.43,-46.35,;21.53,-45.27,;18.89,-46.34,;18.13,-45.01,;16.58,-45,;15.82,-46.33,;16.58,-47.67,;18.12,-47.67,;14.28,-46.33,;12.74,-46.33,;29.68,-47.8,;29.36,-46.31,;30.49,-45.28,;31.96,-45.76,;32.27,-47.26,;31.13,-48.28,;30.17,-43.78,;31.31,-42.75,;28.7,-43.3,;29.76,-42.28,)| InChI=1S/C22H26F3N5O/c1-3-14-4-7-17(8-5-14)30-12-16(13-30)27-20(31)11-26-21-18-10-15(22(23,24)25)6-9-19(18)29(2)28-21/h1,6,9-10,14,16-17H,4-5,7-8,11-13H2,2H3,(H,26,28)(H,27,31) PSWNFJQWICYKCD-UHFFFAOYSA-N 50355304 CHEMBL1833983 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >50 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355304 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355304&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56672021 136361990 CHEMBL1833983 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665324 Cn1ccc(n1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:6.6,9.13,(-11,-46.89,;-9.75,-45.98,;-9.75,-44.44,;-8.29,-43.96,;-7.38,-45.22,;-8.29,-46.46,;-5.84,-45.21,;-5.08,-46.56,;-3.54,-46.56,;-2.77,-45.23,;-3.54,-43.89,;-5.08,-43.89,;-1.23,-45.24,;-.14,-46.34,;.96,-45.25,;-.13,-44.16,;2.5,-45.25,;3.26,-46.59,;2.49,-47.92,;4.8,-46.6,;5.57,-47.93,;7.11,-47.94,;8.01,-49.18,;9.47,-48.71,;10.72,-49.61,;9.47,-47.17,;10.61,-46.15,;10.3,-44.65,;8.83,-44.17,;7.7,-45.2,;8.01,-46.69,;8.51,-42.67,;9.65,-41.63,;7.04,-42.19,;8.1,-41.17,)| InChI=1S/C24H30F3N7O/c1-32-10-9-20(30-32)15-3-6-18(7-4-15)34-13-17(14-34)29-22(35)12-28-23-19-11-16(24(25,26)27)5-8-21(19)33(2)31-23/h5,8-11,15,17-18H,3-4,6-7,12-14H2,1-2H3,(H,28,31)(H,29,35) BMLUECIKNCZOMW-UHFFFAOYSA-N 50355296 CHEMBL1834851 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >50 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355296 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355296&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56669631 136361982 CHEMBL1834851 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665325 CC(C)c1ncc(s1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(13.82,-28.32,;15.23,-28.94,;15.39,-30.47,;16.48,-28.04,;16.47,-26.5,;17.94,-26.02,;18.84,-27.27,;17.94,-28.51,;20.38,-27.27,;21.15,-28.62,;22.68,-28.62,;23.46,-27.29,;22.69,-25.95,;21.15,-25.94,;25,-27.29,;26.09,-28.39,;27.18,-27.31,;26.1,-26.21,;28.72,-27.31,;29.49,-28.65,;28.71,-29.98,;31.03,-28.65,;31.79,-29.99,;33.33,-29.99,;34.23,-31.24,;35.7,-30.76,;36.94,-31.67,;35.7,-29.22,;36.84,-28.2,;36.52,-26.7,;35.06,-26.23,;33.92,-27.25,;34.24,-28.74,;34.73,-24.72,;35.88,-23.69,;33.27,-24.25,;34.32,-23.22,)| InChI=1S/C26H33F3N6OS/c1-15(2)25-31-11-22(37-25)16-4-7-19(8-5-16)35-13-18(14-35)32-23(36)12-30-24-20-10-17(26(27,28)29)6-9-21(20)34(3)33-24/h6,9-11,15-16,18-19H,4-5,7-8,12-14H2,1-3H3,(H,30,33)(H,32,36) WLCRNAWGAIMIQQ-UHFFFAOYSA-N 50355299 CHEMBL1834799 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 17000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355299 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355299&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56683116 136361985 CHEMBL1834799 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665326 CCc1ncc(s1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:7.7,10.14,(-11.12,-28.31,;-9.71,-28.94,;-8.47,-28.03,;-8.47,-26.49,;-7,-26.01,;-6.1,-27.26,;-7,-28.5,;-4.56,-27.26,;-3.79,-28.61,;-2.26,-28.61,;-1.48,-27.28,;-2.25,-25.94,;-3.8,-25.94,;.06,-27.28,;1.15,-28.38,;2.24,-27.3,;1.15,-26.21,;3.78,-27.3,;4.54,-28.64,;3.77,-29.97,;6.08,-28.64,;6.85,-29.98,;8.39,-29.99,;9.29,-31.23,;10.76,-30.76,;12,-31.66,;10.75,-29.22,;11.89,-28.19,;11.58,-26.69,;10.11,-26.22,;8.98,-27.24,;9.3,-28.74,;9.79,-24.71,;10.93,-23.68,;8.33,-24.24,;9.38,-23.22,)| InChI=1S/C25H31F3N6OS/c1-3-23-29-11-21(36-23)15-4-7-18(8-5-15)34-13-17(14-34)31-22(35)12-30-24-19-10-16(25(26,27)28)6-9-20(19)33(2)32-24/h6,9-11,15,17-18H,3-5,7-8,12-14H2,1-2H3,(H,30,32)(H,31,35) PGRNRBAPTURBFI-UHFFFAOYSA-N 50355300 CHEMBL1834798 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 23000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355300 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355300&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56662695 136361986 CHEMBL1834798 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665327 Cc1ncc(s1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:6.6,9.13,(12.2,-18.67,;13.44,-17.76,;13.44,-16.22,;14.91,-15.75,;15.81,-17,;14.91,-18.24,;17.35,-17,;18.12,-18.34,;19.65,-18.34,;20.43,-17.01,;19.66,-15.68,;18.11,-15.67,;21.97,-17.02,;23.06,-18.12,;24.15,-17.03,;23.06,-15.94,;25.69,-17.04,;26.45,-18.37,;25.68,-19.7,;27.99,-18.38,;28.76,-19.71,;30.3,-19.72,;31.2,-20.96,;32.67,-20.49,;33.91,-21.4,;32.66,-18.95,;33.8,-17.93,;33.49,-16.43,;32.02,-15.95,;30.89,-16.98,;31.21,-18.47,;31.7,-14.45,;32.84,-13.42,;30.24,-13.97,;31.29,-12.95,)| InChI=1S/C24H29F3N6OS/c1-14-28-10-21(35-14)15-3-6-18(7-4-15)33-12-17(13-33)30-22(34)11-29-23-19-9-16(24(25,26)27)5-8-20(19)32(2)31-23/h5,8-10,15,17-18H,3-4,6-7,11-13H2,1-2H3,(H,29,31)(H,30,34) QESGQSXZLHDYTQ-UHFFFAOYSA-N 50355301 CHEMBL1834797 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 25000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355301 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355301&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56659197 136361987 CHEMBL1834797 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665328 OCCn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2nccs2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(12.47,-23.07,;11.22,-22.17,;11.39,-20.63,;10.14,-19.73,;8.68,-20.2,;7.78,-18.96,;6.24,-18.95,;5.47,-17.62,;3.93,-17.61,;3.16,-18.94,;3.16,-16.27,;1.62,-16.27,;.53,-17.36,;-.56,-16.26,;.54,-15.18,;-2.1,-16.25,;-2.87,-17.58,;-4.41,-17.58,;-5.18,-16.23,;-4.41,-14.91,;-2.87,-14.91,;-6.72,-16.24,;-7.62,-14.98,;-9.08,-15.46,;-9.08,-17,;-7.62,-17.48,;8.68,-17.71,;8.37,-16.22,;9.5,-15.19,;10.96,-15.67,;11.28,-17.17,;10.14,-18.19,;9.18,-13.69,;10.32,-12.65,;7.71,-13.21,;8.77,-12.19,)| InChI=1S/C24H29F3N6O2S/c25-24(26,27)16-3-6-20-19(11-16)22(31-33(20)8-9-34)29-12-21(35)30-17-13-32(14-17)18-4-1-15(2-5-18)23-28-7-10-36-23/h3,6-7,10-11,15,17-18,34H,1-2,4-5,8-9,12-14H2,(H,29,31)(H,30,35) UZVFZTWEBLXYKJ-UHFFFAOYSA-N 50355302 CHEMBL1834796 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >50000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355302 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355302&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56659196 136361988 CHEMBL1834796 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665329 NC(=O)n1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2nccs2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(35.73,-11.8,;34.32,-12.42,;34.16,-13.95,;33.08,-11.51,;31.61,-11.99,;30.71,-10.74,;29.17,-10.74,;28.41,-9.4,;26.87,-9.4,;26.09,-10.73,;26.1,-8.06,;24.56,-8.06,;23.47,-9.14,;22.38,-8.04,;23.48,-6.96,;20.84,-8.04,;20.06,-9.37,;18.53,-9.37,;17.76,-8.02,;18.52,-6.69,;20.07,-6.7,;16.22,-8.02,;15.32,-6.77,;13.85,-7.25,;13.85,-8.79,;15.32,-9.26,;31.62,-9.49,;31.3,-8,;32.44,-6.98,;33.9,-7.45,;34.22,-8.95,;33.08,-9.97,;32.11,-5.47,;33.26,-4.44,;30.65,-5,;31.7,-3.97,)| InChI=1S/C23H26F3N7O2S/c24-23(25,26)14-3-6-18-17(9-14)20(31-33(18)22(27)35)29-10-19(34)30-15-11-32(12-15)16-4-1-13(2-5-16)21-28-7-8-36-21/h3,6-9,13,15-16H,1-2,4-5,10-12H2,(H2,27,35)(H,29,31)(H,30,34) OUBSBSYAMLKCPV-UHFFFAOYSA-N 50355303 CHEMBL1834795 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 31000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355303 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355303&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56683044 136361989 CHEMBL1834795 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665330 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2nccs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(11.37,-11.31,;10.13,-10.4,;8.66,-10.87,;7.76,-9.63,;6.22,-9.63,;5.45,-8.29,;3.91,-8.29,;3.14,-9.62,;3.15,-6.95,;1.61,-6.94,;.52,-8.03,;-.57,-6.93,;.52,-5.85,;-2.11,-6.93,;-2.89,-8.26,;-4.42,-8.25,;-5.19,-6.91,;-4.43,-5.58,;-2.88,-5.59,;-6.73,-6.91,;-7.63,-5.66,;-9.1,-6.13,;-9.1,-7.67,;-7.63,-8.15,;8.67,-8.38,;8.35,-6.89,;9.48,-5.87,;10.95,-6.34,;11.26,-7.84,;10.12,-8.86,;9.16,-4.36,;10.3,-3.33,;7.7,-3.89,;8.75,-2.86,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)10-18(19)21(30-31)28-11-20(33)29-16-12-32(13-16)17-5-2-14(3-6-17)22-27-8-9-34-22/h4,7-10,14,16-17H,2-3,5-6,11-13H2,1H3,(H,28,30)(H,29,33) KODYZMOGJJLGIT-UHFFFAOYSA-N 50355291 CHEMBL1834794 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 27000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355291&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56678508 136361977 CHEMBL1834794 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665331 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cncs2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(32.69,-2.28,;31.44,-1.37,;29.98,-1.84,;29.08,-.6,;27.54,-.6,;26.77,.74,;25.23,.74,;24.46,-.59,;24.47,2.08,;22.93,2.09,;21.83,1,;20.74,2.1,;21.84,3.18,;19.21,2.1,;18.43,.77,;16.9,.78,;16.13,2.12,;16.89,3.45,;18.44,3.44,;14.59,2.12,;13.68,3.37,;12.22,2.9,;12.22,1.36,;13.69,.88,;29.99,.65,;29.67,2.14,;30.8,3.16,;32.27,2.69,;32.58,1.19,;31.44,.17,;30.48,4.67,;31.62,5.7,;29.02,5.14,;30.07,6.17,)| InChI=1S/C23H27F3N6OS/c1-31-19-7-4-15(23(24,25)26)8-18(19)22(30-31)28-10-21(33)29-16-11-32(12-16)17-5-2-14(3-6-17)20-9-27-13-34-20/h4,7-9,13-14,16-17H,2-3,5-6,10-12H2,1H3,(H,28,30)(H,29,33) XBPRBIMQCWCMJS-UHFFFAOYSA-N 50355277 CHEMBL1834793 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 44000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355277&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56678507 136361963 CHEMBL1834793 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665332 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3cncs3)c2c1 |r,wU:20.20,23.27,(9.53,6.18,;8.39,5.15,;6.93,5.63,;7.98,6.65,;8.71,3.65,;10.18,3.17,;10.49,1.67,;9.35,.65,;9.36,-.89,;7.89,-1.36,;6.99,-.12,;5.45,-.11,;4.68,1.22,;3.14,1.23,;2.37,-.1,;2.38,2.56,;.84,2.57,;-.25,1.48,;-1.34,2.58,;-.25,3.66,;-2.88,2.59,;-3.66,1.26,;-5.19,1.26,;-5.96,2.6,;-5.2,3.93,;-3.65,3.92,;-7.5,2.6,;-8.4,3.85,;-9.87,3.38,;-9.87,1.84,;-8.4,1.36,;7.9,1.13,;7.58,2.62,)| InChI=1S/C22H25F3N6OS/c23-22(24,25)14-3-6-18-17(7-14)21(30-29-18)27-9-20(32)28-15-10-31(11-15)16-4-1-13(2-5-16)19-8-26-12-33-19/h3,6-8,12-13,15-16H,1-2,4-5,9-11H2,(H,28,32)(H2,27,29,30) VIVZXPJCCFWJDH-UHFFFAOYSA-N 50355278 CHEMBL1834792 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >50000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355278 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355278&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56671795 136361964 CHEMBL1834792 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665333 Cc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:7.7,10.14,(-11.36,.17,;-9.82,.17,;-9.05,1.51,;-7.51,1.51,;-6.74,.18,;-7.51,-1.16,;-9.04,-1.16,;-5.2,.18,;-4.44,-1.17,;-2.9,-1.17,;-2.13,.16,;-2.89,1.5,;-4.44,1.5,;-.59,.16,;.5,-.94,;1.6,.14,;.51,1.23,;3.14,.14,;3.9,-1.2,;3.13,-2.53,;5.44,-1.2,;6.21,-2.54,;7.75,-2.55,;8.65,-3.79,;10.11,-3.32,;11.36,-4.22,;10.11,-1.78,;11.25,-.75,;10.94,.75,;9.47,1.22,;8.34,.2,;8.66,-1.3,;9.15,2.73,;10.29,3.76,;7.68,3.2,;8.74,4.22,)| InChI=1S/C26H31F3N6O/c1-16-3-4-18(12-30-16)17-5-8-21(9-6-17)35-14-20(15-35)32-24(36)13-31-25-22-11-19(26(27,28)29)7-10-23(22)34(2)33-25/h3-4,7,10-12,17,20-21H,5-6,8-9,13-15H2,1-2H3,(H,31,33)(H,32,36) BJIIFQCSJMKUPV-UHFFFAOYSA-N 50355279 CHEMBL1834791 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 18000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355279 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355279&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56661451 136361965 CHEMBL1834791 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665334 COc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(-11.74,1.5,;-10.97,.17,;-9.43,.17,;-8.66,1.51,;-7.13,1.51,;-6.36,.18,;-7.12,-1.16,;-8.66,-1.16,;-4.82,.18,;-4.05,-1.17,;-2.52,-1.17,;-1.74,.16,;-2.51,1.5,;-4.05,1.5,;-.2,.16,;.89,-.94,;1.98,.14,;.9,1.23,;3.52,.14,;4.29,-1.2,;3.51,-2.53,;5.83,-1.2,;6.59,-2.54,;8.13,-2.55,;9.03,-3.79,;10.5,-3.32,;11.74,-4.22,;10.5,-1.78,;11.64,-.75,;11.32,.75,;9.86,1.22,;8.73,.2,;9.04,-1.3,;9.54,2.73,;10.68,3.76,;8.07,3.2,;9.12,4.22,)| InChI=1S/C26H31F3N6O2/c1-34-22-9-6-18(26(27,28)29)11-21(22)25(33-34)31-13-23(36)32-19-14-35(15-19)20-7-3-16(4-8-20)17-5-10-24(37-2)30-12-17/h5-6,9-12,16,19-20H,3-4,7-8,13-15H2,1-2H3,(H,31,33)(H,32,36) SYJSQOHBESPDKE-UHFFFAOYSA-N 50355280 CHEMBL1834790 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 12000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355280&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56671794 136361966 CHEMBL1834790 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665335 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2cccnc2)c2cc(ccc12)C(F)(F)F |r,wU:16.20,13.13,(10.59,-4.22,;9.34,-3.32,;7.88,-3.79,;6.98,-2.55,;5.44,-2.54,;4.67,-1.2,;3.13,-1.2,;2.36,-2.53,;2.37,.14,;.83,.14,;-.27,-.94,;-1.36,.16,;-.26,1.23,;-2.9,.16,;-3.67,-1.17,;-5.21,-1.17,;-5.97,.18,;-5.21,1.5,;-3.66,1.5,;-7.51,.18,;-8.28,1.51,;-9.82,1.51,;-10.59,.17,;-9.81,-1.16,;-8.28,-1.16,;7.89,-1.3,;7.57,.2,;8.7,1.22,;10.17,.75,;10.48,-.75,;9.34,-1.78,;8.38,2.73,;9.52,3.76,;6.91,3.2,;7.97,4.22,)| InChI=1S/C25H29F3N6O/c1-33-22-9-6-18(25(26,27)28)11-21(22)24(32-33)30-13-23(35)31-19-14-34(15-19)20-7-4-16(5-8-20)17-3-2-10-29-12-17/h2-3,6,9-12,16,19-20H,4-5,7-8,13-15H2,1H3,(H,30,32)(H,31,35) DPMNRWVBWPCZHV-UHFFFAOYSA-N 50355281 CHEMBL1834789 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 24000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355281 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355281&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56671793 136361967 CHEMBL1834789 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665336 Cc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:7.7,10.14,(-11.31,-.05,;-9.77,-.04,;-9,1.29,;-7.46,1.29,;-6.69,-.04,;-7.45,-1.37,;-8.99,-1.38,;-5.15,-.04,;-4.38,-1.39,;-2.85,-1.39,;-2.07,-.06,;-2.84,1.28,;-4.39,1.29,;-.53,-.06,;.56,-1.16,;1.65,-.08,;.56,1.02,;3.19,-.08,;3.96,-1.42,;3.18,-2.75,;5.5,-1.42,;6.26,-2.76,;7.8,-2.76,;8.7,-4.01,;10.17,-3.53,;10.17,-1.99,;11.31,-.97,;10.99,.53,;9.53,1,;8.39,-.02,;8.71,-1.51,;9.2,2.51,;10.35,3.54,;7.74,2.98,;8.79,4.01,)| InChI=1S/C25H29F3N6O/c1-15-2-3-17(11-29-15)16-4-7-20(8-5-16)34-13-19(14-34)31-23(35)12-30-24-21-10-18(25(26,27)28)6-9-22(21)32-33-24/h2-3,6,9-11,16,19-20H,4-5,7-8,12-14H2,1H3,(H,31,35)(H2,30,32,33) STKWJCBTZQGCNO-UHFFFAOYSA-N 50355282 CHEMBL1834788 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 27000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355282&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56675205 136361968 CHEMBL1834788 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665338 CN(C)c1cccc(c1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:9.9,12.16,(-11.35,-2.51,;-9.81,-2.5,;-9.04,-3.83,;-9.05,-1.16,;-9.82,.17,;-9.06,1.51,;-7.52,1.51,;-6.75,.18,;-7.51,-1.16,;-5.21,.18,;-4.44,-1.17,;-2.91,-1.17,;-2.13,.16,;-2.9,1.5,;-4.44,1.5,;-.59,.16,;.5,-.94,;1.59,.14,;.51,1.23,;3.13,.14,;3.9,-1.2,;3.12,-2.53,;5.44,-1.2,;6.2,-2.54,;7.74,-2.55,;8.64,-3.79,;10.11,-3.32,;11.35,-4.22,;10.11,-1.78,;11.25,-.75,;10.93,.75,;9.47,1.22,;8.33,.2,;8.65,-1.3,;9.14,2.73,;10.29,3.76,;7.68,3.2,;8.73,4.22,)| InChI=1S/C28H35F3N6O/c1-35(2)23-6-4-5-19(13-23)18-7-10-22(11-8-18)37-16-21(17-37)33-26(38)15-32-27-24-14-20(28(29,30)31)9-12-25(24)36(3)34-27/h4-6,9,12-14,18,21-22H,7-8,10-11,15-17H2,1-3H3,(H,32,34)(H,33,38) NNTVFWNDCFPONC-UHFFFAOYSA-N 50355284 CHEMBL1834786 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 12000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355284 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355284&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56657930 136361970 CHEMBL1834786 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665339 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccccc2)c2cc(ccc12)C(F)(F)F |r,wU:16.20,13.13,(10.59,-4.22,;9.34,-3.32,;7.88,-3.79,;6.98,-2.55,;5.44,-2.54,;4.67,-1.2,;3.13,-1.2,;2.36,-2.53,;2.37,.14,;.83,.14,;-.27,-.94,;-1.36,.16,;-.26,1.23,;-2.9,.16,;-3.67,-1.17,;-5.21,-1.17,;-5.97,.18,;-5.21,1.5,;-3.66,1.5,;-7.51,.18,;-8.28,1.51,;-9.82,1.51,;-10.59,.17,;-9.81,-1.16,;-8.28,-1.16,;7.89,-1.3,;7.57,.2,;8.7,1.22,;10.17,.75,;10.48,-.75,;9.34,-1.78,;8.38,2.73,;9.52,3.76,;6.91,3.2,;7.97,4.22,)| InChI=1S/C26H30F3N5O/c1-33-23-12-9-19(26(27,28)29)13-22(23)25(32-33)30-14-24(35)31-20-15-34(16-20)21-10-7-18(8-11-21)17-5-3-2-4-6-17/h2-6,9,12-13,18,20-21H,7-8,10-11,14-16H2,1H3,(H,30,32)(H,31,35) GWGRACKHWJVFCC-UHFFFAOYSA-N 50355285 CHEMBL1834785 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 10000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355285 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355285&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56657929 136361971 CHEMBL1834785 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665340 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C2CCCC2)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.63,5.18,;-9.85,3.85,;-10.62,2.51,;-9.85,1.18,;-10.62,-.15,;-8.31,1.18,;-7.55,-.16,;-6.01,-.17,;-5.24,1.16,;-6,2.5,;-7.55,2.51,;-3.7,1.16,;-2.61,.06,;-1.51,1.15,;-2.6,2.24,;.03,1.14,;.79,-.2,;.02,-1.53,;2.33,-.2,;3.1,-1.54,;4.64,-1.54,;5.54,-2.78,;7,-2.31,;8.25,-3.22,;8.25,-4.75,;9.72,-5.23,;10.63,-3.98,;9.72,-2.74,;7,-.77,;8.14,.25,;7.83,1.75,;6.36,2.22,;5.23,1.2,;5.55,-.29,;6.04,3.73,;7.18,4.76,;4.57,4.2,;5.63,5.23,)| InChI=1S/C27H36F3N5O3/c1-2-38-26(37)17-7-10-20(11-8-17)34-15-19(16-34)32-24(36)14-31-25-22-13-18(27(28,29)30)9-12-23(22)35(33-25)21-5-3-4-6-21/h9,12-13,17,19-21H,2-8,10-11,14-16H2,1H3,(H,31,33)(H,32,36) FYZNJPJSHPKWIX-UHFFFAOYSA-N 50355286 CHEMBL1834784 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 4100 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355286 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355286&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56668313 136361972 CHEMBL1834784 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665341 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CN=C1NC(Cc2ccccc2)c2ccc(cc12)C(F)(F)F |r,w:19.20,wU:5.4,8.11,(-11.55,4.32,;-10.78,2.98,;-11.54,1.65,;-10.77,.32,;-11.54,-1.02,;-9.23,.32,;-8.47,-1.03,;-6.93,-1.03,;-6.16,.3,;-6.92,1.64,;-8.47,1.64,;-4.62,.3,;-3.53,-.8,;-2.43,.28,;-3.52,1.38,;-.89,.28,;-.13,-1.06,;-.9,-2.39,;1.41,-1.06,;2.18,-2.4,;3.72,-2.4,;4.62,-3.65,;6.08,-3.17,;7.33,-4.08,;8.74,-3.46,;9.98,-4.37,;11.38,-3.74,;11.55,-2.21,;10.29,-1.3,;8.89,-1.93,;6.08,-1.63,;7.22,-.61,;6.91,.89,;5.44,1.36,;4.31,.34,;4.63,-1.15,;5.12,2.87,;6.26,3.9,;3.65,3.34,;4.71,4.37,)| InChI=1S/C30H35F3N4O3/c1-2-40-29(39)20-8-11-23(12-9-20)37-17-22(18-37)35-27(38)16-34-28-25-15-21(30(31,32)33)10-13-24(25)26(36-28)14-19-6-4-3-5-7-19/h3-7,10,13,15,20,22-23,26H,2,8-9,11-12,14,16-18H2,1H3,(H,34,36)(H,35,38) MYRGKAVLHHTTPL-UHFFFAOYSA-N 50355287 CHEMBL1834783 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1400 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355287&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56657928 136361973 CHEMBL1834783 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665342 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(c2ccc(cc12)C(F)(F)F)S(C)(=O)=O |r,wU:5.4,8.11,(-10.14,4.84,;-9.37,3.5,;-10.14,2.17,;-9.37,.84,;-10.14,-.5,;-7.83,.84,;-7.06,-.51,;-5.53,-.51,;-4.75,.82,;-5.52,2.16,;-7.06,2.16,;-3.21,.82,;-2.12,-.28,;-1.03,.8,;-2.11,1.89,;.51,.8,;1.28,-.54,;.5,-1.87,;2.82,-.54,;3.58,-1.88,;5.12,-1.88,;6.02,-3.13,;7.49,-2.66,;7.49,-1.11,;8.63,-.09,;8.31,1.41,;6.85,1.88,;5.71,.86,;6.03,-.64,;6.52,3.39,;7.67,4.42,;5.06,3.86,;6.11,4.88,;8.73,-3.56,;10.14,-2.94,;7.95,-4.88,;9.49,-4.88,)| InChI=1S/C23H30F3N5O5S/c1-3-36-22(33)14-4-7-17(8-5-14)30-12-16(13-30)28-20(32)11-27-21-18-10-15(23(24,25)26)6-9-19(18)31(29-21)37(2,34)35/h6,9-10,14,16-17H,3-5,7-8,11-13H2,1-2H3,(H,27,29)(H,28,32) OKJTXDQDWLLOMB-UHFFFAOYSA-N 50355288 CHEMBL1834782 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 25000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355288 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355288&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56678506 136361974 CHEMBL1834782 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665343 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C(N)=O)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.14,4.94,;-9.37,3.61,;-10.14,2.27,;-9.37,.94,;-10.14,-.39,;-7.83,.94,;-7.06,-.4,;-5.53,-.4,;-4.75,.93,;-5.52,2.26,;-7.06,2.27,;-3.21,.92,;-2.12,-.18,;-1.03,.91,;-2.11,2,;.51,.9,;1.28,-.43,;.5,-1.77,;2.82,-.44,;3.58,-1.78,;5.12,-1.78,;6.02,-3.02,;7.49,-2.55,;8.73,-3.46,;10.14,-2.83,;8.57,-4.99,;7.49,-1.01,;8.63,.01,;8.31,1.51,;6.85,1.99,;5.71,.96,;6.03,-.53,;6.52,3.49,;7.67,4.52,;5.06,3.96,;6.11,4.99,)| InChI=1S/C23H29F3N6O4/c1-2-36-21(34)13-3-6-16(7-4-13)31-11-15(12-31)29-19(33)10-28-20-17-9-14(23(24,25)26)5-8-18(17)32(30-20)22(27)35/h5,8-9,13,15-16H,2-4,6-7,10-12H2,1H3,(H2,27,35)(H,28,30)(H,29,33) BSPCGOZVENCINN-UHFFFAOYSA-N 50355289 CHEMBL1834781 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 20000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355289&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54756045 136361975 CHEMBL1834781 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665344 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(CC(F)(F)F)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.8,4.32,;-10.03,2.98,;-10.8,1.65,;-10.03,.32,;-10.8,-1.02,;-8.49,.32,;-7.72,-1.03,;-6.19,-1.03,;-5.41,.3,;-6.18,1.64,;-7.73,1.64,;-3.87,.3,;-2.78,-.8,;-1.69,.28,;-2.78,1.37,;-.15,.28,;.62,-1.06,;-.16,-2.39,;2.16,-1.06,;2.92,-2.4,;4.46,-2.4,;5.36,-3.65,;6.83,-3.18,;8.07,-4.08,;9.48,-3.46,;9.64,-1.93,;10.72,-4.36,;10.8,-2.67,;6.83,-1.63,;7.96,-.61,;7.65,.89,;6.19,1.36,;5.05,.34,;5.37,-1.16,;5.86,2.87,;7.01,3.9,;4.4,3.34,;5.45,4.36,)| InChI=1S/C24H29F6N5O3/c1-2-38-22(37)14-3-6-17(7-4-14)34-11-16(12-34)32-20(36)10-31-21-18-9-15(24(28,29)30)5-8-19(18)35(33-21)13-23(25,26)27/h5,8-9,14,16-17H,2-4,6-7,10-13H2,1H3,(H,31,33)(H,32,36) JDJZCKOOSFAVKN-UHFFFAOYSA-N 50355290 CHEMBL1834780 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2500 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355290&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54755562 136361976 CHEMBL1834780 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665345 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(CC=C)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.76,4.32,;-9.99,2.98,;-10.76,1.65,;-9.99,.32,;-10.76,-1.02,;-8.45,.32,;-7.68,-1.03,;-6.15,-1.03,;-5.37,.3,;-6.14,1.64,;-7.69,1.64,;-3.83,.3,;-2.74,-.8,;-1.65,.28,;-2.74,1.37,;-.11,.28,;.65,-1.06,;-.12,-2.39,;2.19,-1.06,;2.96,-2.4,;4.5,-2.4,;5.4,-3.65,;6.87,-3.18,;8.11,-4.08,;9.52,-3.46,;10.76,-4.36,;6.86,-1.63,;8,-.61,;7.69,.89,;6.22,1.36,;5.09,.34,;5.41,-1.16,;5.9,2.87,;7.04,3.9,;4.44,3.34,;5.49,4.36,)| InChI=1S/C25H32F3N5O3/c1-3-11-33-21-10-7-17(25(26,27)28)12-20(21)23(31-33)29-13-22(34)30-18-14-32(15-18)19-8-5-16(6-9-19)24(35)36-4-2/h3,7,10,12,16,18-19H,1,4-6,8-9,11,13-15H2,2H3,(H,29,31)(H,30,34) BDWRIURLGQMQKO-UHFFFAOYSA-N 50355247 CHEMBL1834779 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 3700 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355247&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54756156 136361933 CHEMBL1834779 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665346 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(CC)c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-10.14,4.18,;-9.37,2.84,;-10.14,1.51,;-9.37,.18,;-10.14,-1.16,;-7.83,.18,;-7.06,-1.17,;-5.53,-1.17,;-4.75,.16,;-5.52,1.5,;-7.06,1.5,;-3.21,.16,;-2.12,-.94,;-1.03,.14,;-2.11,1.23,;.51,.14,;1.28,-1.2,;.5,-2.53,;2.82,-1.2,;3.58,-2.54,;5.12,-2.55,;6.02,-3.79,;7.49,-3.32,;8.73,-4.22,;10.14,-3.6,;7.49,-1.78,;8.63,-.75,;8.31,.75,;6.85,1.22,;5.71,.2,;6.03,-1.3,;6.52,2.73,;7.67,3.76,;5.06,3.2,;6.11,4.22,)| InChI=1S/C24H32F3N5O3/c1-3-32-20-10-7-16(24(25,26)27)11-19(20)22(30-32)28-12-21(33)29-17-13-31(14-17)18-8-5-15(6-9-18)23(34)35-4-2/h7,10-11,15,17-18H,3-6,8-9,12-14H2,1-2H3,(H,28,30)(H,29,33) HLMHWYIWIILJEU-UHFFFAOYSA-N 50355248 CHEMBL1834721 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 7600 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355248&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54755560 136361934 CHEMBL1834721 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665347 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1noc2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-9.38,3.96,;-8.61,2.63,;-9.38,1.29,;-8.61,-.04,;-9.38,-1.38,;-7.07,-.04,;-6.3,-1.39,;-4.77,-1.39,;-3.99,-.06,;-4.76,1.28,;-6.31,1.29,;-2.45,-.06,;-1.36,-1.16,;-.27,-.08,;-1.36,1.02,;1.27,-.08,;2.03,-1.42,;1.26,-2.75,;3.57,-1.42,;4.34,-2.76,;5.88,-2.76,;6.78,-4.01,;8.25,-3.53,;8.24,-1.99,;9.38,-.97,;9.07,.53,;7.6,1,;6.47,-.02,;6.79,-1.51,;7.28,2.51,;8.42,3.54,;5.82,2.98,;6.87,4.01,)| InChI=1S/C22H27F3N4O4/c1-2-32-21(31)13-3-6-16(7-4-13)29-11-15(12-29)27-19(30)10-26-20-17-9-14(22(23,24)25)5-8-18(17)33-28-20/h5,8-9,13,15-16H,2-4,6-7,10-12H2,1H3,(H,26,28)(H,27,30) XODCWPJDJRYTNL-UHFFFAOYSA-N 50355292 CHEMBL1834720 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 5600 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355292&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54756038 136361978 CHEMBL1834720 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665348 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-9.38,3.96,;-8.61,2.63,;-9.38,1.29,;-8.61,-.04,;-9.38,-1.38,;-7.07,-.04,;-6.3,-1.39,;-4.77,-1.39,;-3.99,-.06,;-4.76,1.28,;-6.31,1.29,;-2.45,-.06,;-1.36,-1.16,;-.27,-.08,;-1.36,1.02,;1.27,-.08,;2.03,-1.42,;1.26,-2.75,;3.57,-1.42,;4.34,-2.76,;5.88,-2.76,;6.78,-4.01,;8.25,-3.53,;8.24,-1.99,;9.38,-.97,;9.07,.53,;7.6,1,;6.47,-.02,;6.79,-1.51,;7.28,2.51,;8.42,3.54,;5.82,2.98,;6.87,4.01,)| InChI=1S/C22H28F3N5O3/c1-2-33-21(32)13-3-6-16(7-4-13)30-11-15(12-30)27-19(31)10-26-20-17-9-14(22(23,24)25)5-8-18(17)28-29-20/h5,8-9,13,15-16H,2-4,6-7,10-12H2,1H3,(H,27,31)(H2,26,28,29) BFNOLBZMRSIRMC-UHFFFAOYSA-N 50355249 CHEMBL1834719 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 9100 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355249&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54755081 136361935 CHEMBL1834719 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665349 NC(=O)n1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(10.56,-4.99,;10.72,-3.46,;12.13,-2.83,;9.48,-2.55,;8.01,-3.02,;7.11,-1.78,;5.57,-1.78,;4.8,-.44,;3.26,-.43,;2.49,-1.77,;2.5,.9,;.96,.91,;-.13,-.18,;-1.22,.92,;-.13,2,;-2.76,.93,;-3.54,-.4,;-5.07,-.4,;-5.84,.94,;-5.08,2.27,;-3.53,2.26,;-7.38,.94,;-8.14,-.39,;-9.67,-.39,;-10.45,.94,;-11.96,1.26,;-12.13,2.79,;-10.72,3.43,;-9.68,2.28,;-8.14,2.28,;8.02,-.53,;7.7,.96,;8.83,1.99,;10.3,1.51,;10.61,.01,;9.47,-1.01,;8.51,3.49,;9.65,4.52,;7.05,3.96,;8.1,4.99,)| InChI=1S/C27H29F3N6O4/c28-27(29,30)17-4-7-21-20(10-17)25(34-36(21)26(31)38)32-11-24(37)33-18-12-35(13-18)19-5-1-15(2-6-19)16-3-8-22-23(9-16)40-14-39-22/h3-4,7-10,15,18-19H,1-2,5-6,11-14H2,(H2,31,38)(H,32,34)(H,33,37) DFOPMFXQYWVKQK-UHFFFAOYSA-N 50355250 CHEMBL1834718 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 12000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355250&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56668309 136361936 CHEMBL1834718 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665350 CC(C)(C)NC(=O)n1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:22.26,19.19,(11.1,-6.21,;11.26,-4.68,;12.67,-4.05,;12.35,-5.76,;10.02,-3.77,;10.18,-2.24,;11.59,-1.61,;8.93,-1.33,;7.47,-1.8,;6.57,-.56,;5.03,-.56,;4.26,.78,;2.72,.78,;1.95,-.55,;1.96,2.12,;.42,2.13,;-.67,1.04,;-1.76,2.14,;-.67,3.22,;-3.3,2.14,;-4.08,.81,;-5.61,.82,;-6.38,2.16,;-5.62,3.49,;-4.07,3.48,;-7.92,2.16,;-8.68,.83,;-10.21,.82,;-10.99,2.16,;-12.5,2.48,;-12.67,4.01,;-11.26,4.65,;-10.23,3.5,;-8.68,3.5,;7.48,.69,;7.16,2.18,;8.29,3.2,;9.76,2.73,;10.07,1.23,;8.93,.21,;7.97,4.71,;9.11,5.74,;6.51,5.18,;7.56,6.21,)| InChI=1S/C31H37F3N6O4/c1-30(2,3)37-29(42)40-24-10-7-20(31(32,33)34)13-23(24)28(38-40)35-14-27(41)36-21-15-39(16-21)22-8-4-18(5-9-22)19-6-11-25-26(12-19)44-17-43-25/h6-7,10-13,18,21-22H,4-5,8-9,14-17H2,1-3H3,(H,35,38)(H,36,41)(H,37,42) HYZGGNZNVAYPFO-UHFFFAOYSA-N 50355251 CHEMBL1834717 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 4700 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355251&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56661444 136361937 CHEMBL1834717 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665351 OCCn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(11.97,-5.44,;10.72,-4.54,;10.88,-3,;9.64,-2.1,;8.17,-2.57,;7.27,-1.33,;5.73,-1.32,;4.97,.01,;3.43,.02,;2.65,-1.31,;2.66,1.36,;1.12,1.36,;.03,.27,;-1.06,1.37,;.04,2.45,;-2.6,1.38,;-3.38,.05,;-4.91,.05,;-5.68,1.4,;-4.91,2.72,;-3.37,2.72,;-7.22,1.39,;-7.97,.07,;-9.51,.06,;-10.29,1.4,;-11.8,1.71,;-11.97,3.25,;-10.56,3.88,;-9.52,2.74,;-7.98,2.73,;8.18,-.08,;7.86,1.41,;9,2.44,;10.46,1.96,;10.78,.46,;9.64,-.56,;8.67,3.94,;9.82,4.98,;7.21,4.42,;8.26,5.44,)| InChI=1S/C28H32F3N5O4/c29-28(30,31)19-4-7-23-22(12-19)27(34-36(23)9-10-37)32-13-26(38)33-20-14-35(15-20)21-5-1-17(2-6-21)18-3-8-24-25(11-18)40-16-39-24/h3-4,7-8,11-12,17,20-21,37H,1-2,5-6,9-10,13-16H2,(H,32,34)(H,33,38) NAWKYIASORHDMZ-UHFFFAOYSA-N 50355252 CHEMBL1834652 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 7600 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355252&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54755801 136361938 CHEMBL1834652 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665352 FC(F)(F)c1ccc2onc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccc4OCOc4c3)c2c1 |r,wU:23.27,20.20,(10.41,3.54,;9.27,2.51,;7.8,2.98,;8.86,4.01,;9.59,1,;11.06,.53,;11.37,-.97,;10.23,-1.99,;10.23,-3.53,;8.77,-4.01,;7.87,-2.76,;6.33,-2.76,;5.56,-1.42,;4.02,-1.42,;3.25,-2.75,;3.26,-.08,;1.72,-.08,;.62,-1.16,;-.47,-.06,;.63,1.02,;-2.01,-.06,;-2.78,-1.39,;-4.32,-1.39,;-5.08,-.04,;-4.32,1.29,;-2.77,1.28,;-6.62,-.04,;-7.38,-1.37,;-8.92,-1.38,;-9.69,-.04,;-11.21,.28,;-11.37,1.81,;-9.96,2.44,;-8.93,1.3,;-7.39,1.3,;8.77,-1.51,;8.46,-.02,)| InChI=1S/C26H27F3N4O4/c27-26(28,29)17-4-8-21-20(10-17)25(32-37-21)30-11-24(34)31-18-12-33(13-18)19-5-1-15(2-6-19)16-3-7-22-23(9-16)36-14-35-22/h3-4,7-10,15,18-19H,1-2,5-6,11-14H2,(H,30,32)(H,31,34) HQGJCOXCZNLUFA-UHFFFAOYSA-N 50355253 CHEMBL1834651 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1900 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355253&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54755919 136361939 CHEMBL1834651 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665353 CS(=O)(=O)N[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-7.87,2.63,;-8.63,1.29,;-10.13,1.7,;-9.73,.21,;-7.86,-.04,;-6.32,-.04,;-5.56,1.29,;-4.01,1.28,;-3.25,-.06,;-4.02,-1.39,;-5.56,-1.39,;-1.71,-.06,;-.62,-1.16,;.48,-.08,;-.61,1.02,;2.02,-.08,;2.78,-1.42,;2.01,-2.75,;4.32,-1.42,;5.09,-2.76,;6.63,-2.76,;7.53,-4.01,;8.99,-3.53,;8.99,-1.99,;10.13,-.97,;9.82,.53,;8.35,1,;7.22,-.02,;7.54,-1.51,;8.03,2.51,;9.17,3.54,;6.56,2.98,;7.62,4.01,)| InChI=1S/C20H27F3N6O3S/c1-33(31,32)28-13-3-5-15(6-4-13)29-10-14(11-29)25-18(30)9-24-19-16-8-12(20(21,22)23)2-7-17(16)26-27-19/h2,7-8,13-15,28H,3-6,9-11H2,1H3,(H,25,30)(H2,24,26,27) ULYVIQRDWMYXRX-UHFFFAOYSA-N 50355254 CHEMBL1834650 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 23000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355254&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56678640 136361940 CHEMBL1834650 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665354 N[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:1.0,4.7,(-9,-.04,;-7.46,-.04,;-6.69,1.29,;-5.15,1.28,;-4.38,-.06,;-5.16,-1.39,;-6.69,-1.39,;-2.84,-.06,;-1.75,-1.16,;-.66,-.08,;-1.74,1.02,;.88,-.08,;1.65,-1.42,;.87,-2.75,;3.19,-1.42,;3.95,-2.76,;5.49,-2.76,;6.39,-4.01,;7.86,-3.53,;7.86,-1.99,;9,-.97,;8.68,.53,;7.22,1,;6.08,-.02,;6.4,-1.51,;6.9,2.51,;8.04,3.54,;5.43,2.98,;6.48,4.01,)| InChI=1S/C19H25F3N6O/c20-19(21,22)11-1-6-16-15(7-11)18(27-26-16)24-8-17(29)25-13-9-28(10-13)14-4-2-12(23)3-5-14/h1,6-7,12-14H,2-5,8-10,23H2,(H,25,29)(H2,24,26,27) KHGASTLPNIZCGV-UHFFFAOYSA-N 50355255 CHEMBL1834649 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >50000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355255&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56668413 136361941 CHEMBL1834649 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665355 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@@H]3CC[C@@H](CC3)OCC=C)c2c1 |r,wU:23.27,20.20,(8.42,3.54,;7.28,2.51,;5.82,2.98,;6.87,4.01,;7.6,1,;9.07,.53,;9.38,-.97,;8.24,-1.99,;8.25,-3.53,;6.78,-4.01,;5.88,-2.76,;4.34,-2.76,;3.57,-1.42,;2.03,-1.42,;1.26,-2.75,;1.27,-.08,;-.27,-.08,;-1.36,-1.16,;-2.45,-.06,;-1.36,1.02,;-3.99,-.06,;-4.76,1.28,;-6.31,1.29,;-7.07,-.04,;-6.3,-1.39,;-4.77,-1.39,;-8.61,-.04,;-9.38,1.29,;-8.61,2.63,;-9.38,3.96,;6.79,-1.51,;6.47,-.02,)| InChI=1S/C22H28F3N5O2/c1-2-9-32-17-6-4-16(5-7-17)30-12-15(13-30)27-20(31)11-26-21-18-10-14(22(23,24)25)3-8-19(18)28-29-21/h2-3,8,10,15-17H,1,4-7,9,11-13H2,(H,27,31)(H2,26,28,29) USSMAYHMTCOLDZ-UHFFFAOYSA-N 50355256 CHEMBL1834648 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 7400 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355256&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56675302 136361942 CHEMBL1834648 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665356 O[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:1.0,4.7,(-9,-.04,;-7.46,-.04,;-6.69,1.29,;-5.15,1.28,;-4.38,-.06,;-5.16,-1.39,;-6.69,-1.39,;-2.84,-.06,;-1.75,-1.16,;-.66,-.08,;-1.74,1.02,;.88,-.08,;1.65,-1.42,;.87,-2.75,;3.19,-1.42,;3.95,-2.76,;5.49,-2.76,;6.39,-4.01,;7.86,-3.53,;7.86,-1.99,;9,-.97,;8.68,.53,;7.22,1,;6.08,-.02,;6.4,-1.51,;6.9,2.51,;8.04,3.54,;5.43,2.98,;6.48,4.01,)| InChI=1S/C19H24F3N5O2/c20-19(21,22)11-1-6-16-15(7-11)18(26-25-16)23-8-17(29)24-12-9-27(10-12)13-2-4-14(28)5-3-13/h1,6-7,12-14,28H,2-5,8-10H2,(H,24,29)(H2,23,25,26) JHOIOEADFLDOHZ-UHFFFAOYSA-N 50355258 CHEMBL1834646 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 30000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355258&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56675300 136361944 CHEMBL1834646 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665357 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@H](COCC=C)CC2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.17,(10.23,-42.67,;8.98,-41.76,;7.52,-42.23,;6.62,-40.99,;5.08,-40.99,;4.31,-39.65,;2.77,-39.65,;2,-40.98,;2.01,-38.31,;.47,-38.3,;-.63,-39.39,;-1.72,-38.29,;-.62,-37.21,;-3.26,-38.29,;-4.03,-36.95,;-5.57,-36.94,;-6.33,-38.27,;-7.87,-38.27,;-8.65,-36.94,;-7.88,-35.6,;-8.65,-34.27,;-7.88,-32.93,;-5.57,-39.61,;-4.03,-39.62,;7.52,-39.74,;7.21,-38.25,;8.34,-37.23,;9.81,-37.7,;10.12,-39.2,;8.98,-40.22,;8.02,-35.72,;9.16,-34.69,;6.55,-35.25,;7.61,-34.22,)| InChI=1S/C24H32F3N5O2/c1-3-10-34-15-16-4-7-19(8-5-16)32-13-18(14-32)29-22(33)12-28-23-20-11-17(24(25,26)27)6-9-21(20)31(2)30-23/h3,6,9,11,16,18-19H,1,4-5,7-8,10,12-15H2,2H3,(H,28,30)(H,29,33) XSTSZTTUPFLRLY-UHFFFAOYSA-N 50355259 CHEMBL1834645 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 5000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355259&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54754724 136361945 CHEMBL1834645 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665358 CCOC[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:7.10,4.3,(12.26,-25.29,;13.03,-26.62,;12.26,-27.95,;13.03,-29.29,;14.57,-29.29,;15.34,-27.96,;16.88,-27.97,;17.65,-29.3,;16.87,-30.63,;15.34,-30.63,;19.19,-29.31,;20.28,-30.41,;21.37,-29.32,;20.29,-28.23,;22.91,-29.33,;23.68,-30.66,;22.9,-31.99,;25.22,-30.67,;25.98,-32,;27.52,-32.01,;28.42,-33.25,;29.89,-32.78,;31.13,-33.69,;29.89,-31.24,;31.03,-30.22,;30.71,-28.72,;29.25,-28.24,;28.11,-29.27,;28.43,-30.76,;28.92,-26.74,;30.07,-25.7,;27.46,-26.26,;28.51,-25.24,)| InChI=1S/C23H32F3N5O2/c1-3-33-14-15-4-7-18(8-5-15)31-12-17(13-31)28-21(32)11-27-22-19-10-16(23(24,25)26)6-9-20(19)30(2)29-22/h6,9-10,15,17-18H,3-5,7-8,11-14H2,1-2H3,(H,27,29)(H,28,32) NLACPXOSKRJIGO-UHFFFAOYSA-N 50355260 CHEMBL1834644 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 5600 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355260&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54754723 136361946 CHEMBL1834644 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665359 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@H](CO)CC2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.17,(8.93,-30.5,;7.68,-29.59,;6.22,-30.06,;5.32,-28.82,;3.78,-28.81,;3.01,-27.48,;1.47,-27.47,;.7,-28.8,;.71,-26.14,;-.83,-26.13,;-1.93,-27.22,;-3.02,-26.12,;-1.92,-25.04,;-4.56,-26.11,;-5.32,-24.78,;-6.87,-24.77,;-7.63,-26.1,;-9.17,-26.1,;-9.94,-24.76,;-6.87,-27.44,;-5.33,-27.44,;6.23,-27.57,;5.91,-26.08,;7.04,-25.05,;8.51,-25.53,;8.82,-27.03,;7.68,-28.05,;6.72,-23.55,;7.86,-22.52,;5.25,-23.07,;6.31,-22.05,)| InChI=1S/C21H28F3N5O2/c1-28-18-7-4-14(21(22,23)24)8-17(18)20(27-28)25-9-19(31)26-15-10-29(11-15)16-5-2-13(12-30)3-6-16/h4,7-8,13,15-16,30H,2-3,5-6,9-12H2,1H3,(H,25,27)(H,26,31) LDEUNNVWDAAUOC-UHFFFAOYSA-N 50355261 CHEMBL1834643 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 32000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355261&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54754722 136361947 CHEMBL1834643 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665360 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)C(N)=O)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(31.19,-22.92,;29.94,-22.01,;28.48,-22.49,;27.58,-21.24,;26.04,-21.24,;25.27,-19.9,;23.73,-19.9,;22.96,-21.23,;22.97,-18.56,;21.43,-18.56,;20.33,-19.64,;19.24,-18.54,;20.34,-17.46,;17.7,-18.54,;16.93,-19.87,;15.39,-19.87,;14.63,-18.52,;15.39,-17.19,;16.94,-17.2,;13.09,-18.52,;12.32,-17.19,;12.32,-19.86,;28.49,-19.99,;28.17,-18.5,;29.3,-17.48,;30.77,-17.95,;31.08,-19.45,;29.94,-20.47,;28.98,-15.97,;30.12,-14.94,;27.51,-15.5,;28.57,-14.47,)| InChI=1S/C21H27F3N6O2/c1-29-17-7-4-13(21(22,23)24)8-16(17)20(28-29)26-9-18(31)27-14-10-30(11-14)15-5-2-12(3-6-15)19(25)32/h4,7-8,12,14-15H,2-3,5-6,9-11H2,1H3,(H2,25,32)(H,26,28)(H,27,31) AFBZMWCSHPIYMB-UHFFFAOYSA-N 50355262 CHEMBL1834642 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 32000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355262&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54754845 136361948 CHEMBL1834642 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665361 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)C(O)=O)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(9.81,-20.88,;8.56,-19.98,;7.1,-20.45,;6.2,-19.21,;4.66,-19.2,;3.89,-17.86,;2.35,-17.86,;1.58,-19.19,;1.59,-16.52,;.05,-16.52,;-1.05,-17.6,;-2.14,-16.5,;-1.04,-15.43,;-3.68,-16.5,;-4.45,-17.83,;-5.99,-17.83,;-6.75,-16.48,;-5.99,-15.16,;-4.45,-15.16,;-8.29,-16.48,;-9.07,-15.15,;-9.06,-17.82,;7.1,-17.96,;6.79,-16.46,;7.92,-15.44,;9.39,-15.91,;9.7,-17.41,;8.56,-18.44,;7.6,-13.93,;8.74,-12.9,;6.13,-13.46,;7.19,-12.44,)| InChI=1S/C21H26F3N5O3/c1-28-17-7-4-13(21(22,23)24)8-16(17)19(27-28)25-9-18(30)26-14-10-29(11-14)15-5-2-12(3-6-15)20(31)32/h4,7-8,12,14-15H,2-3,5-6,9-11H2,1H3,(H,25,27)(H,26,30)(H,31,32) XZAJJVGHCXUBKX-UHFFFAOYSA-N 50355263 CHEMBL1834641 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 25000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355263&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56661559 136361949 CHEMBL1834641 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665362 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:8.11,5.4,(13.3,-4.72,;14.07,-6.05,;13.3,-7.39,;14.07,-8.72,;13.31,-10.06,;15.61,-8.72,;16.38,-10.07,;17.92,-10.07,;18.69,-8.74,;17.92,-7.4,;16.38,-7.39,;20.23,-8.74,;21.32,-9.84,;22.41,-8.76,;21.33,-7.66,;23.95,-8.76,;24.72,-10.1,;23.95,-11.43,;26.26,-10.1,;27.03,-11.44,;28.57,-11.44,;29.47,-12.69,;30.93,-12.21,;32.18,-13.12,;30.93,-10.67,;32.07,-9.65,;31.75,-8.15,;30.29,-7.68,;29.16,-8.7,;29.47,-10.19,;29.97,-6.17,;31.11,-5.14,;28.5,-5.7,;29.56,-4.67,)| InChI=1S/C23H30F3N5O3/c1-3-34-22(33)14-4-7-17(8-5-14)31-12-16(13-31)28-20(32)11-27-21-18-10-15(23(24,25)26)6-9-19(18)30(2)29-21/h6,9-10,14,16-17H,3-5,7-8,11-13H2,1-2H3,(H,27,29)(H,28,32) QTKVWRRRHCBCAH-UHFFFAOYSA-N 50355264 CHEMBL1834640 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 8000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355264&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56671925 136361950 CHEMBL1834640 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665363 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@@H](CC2)C2CCCCC2)c2cc(ccc12)C(F)(F)F |r,wU:16.20,13.13,(10.9,-11.84,;9.66,-10.93,;8.19,-11.4,;7.29,-10.16,;5.75,-10.16,;4.99,-8.82,;3.45,-8.81,;2.67,-10.15,;2.68,-7.48,;1.14,-7.47,;.05,-8.56,;-1.04,-7.46,;.06,-6.38,;-2.58,-7.45,;-3.35,-6.12,;-4.89,-6.11,;-5.66,-7.44,;-4.89,-8.78,;-3.36,-8.78,;-7.2,-7.44,;-7.97,-6.11,;-9.5,-6.1,;-10.28,-7.43,;-9.51,-8.77,;-7.96,-8.78,;8.2,-8.91,;7.88,-7.42,;9.02,-6.39,;10.48,-6.87,;10.8,-8.37,;9.66,-9.39,;8.69,-4.89,;9.84,-3.86,;7.23,-4.42,;8.28,-3.39,)| InChI=1S/C26H36F3N5O/c1-33-23-12-9-19(26(27,28)29)13-22(23)25(32-33)30-14-24(35)31-20-15-34(16-20)21-10-7-18(8-11-21)17-5-3-2-4-6-17/h9,12-13,17-18,20-21H,2-8,10-11,14-16H2,1H3,(H,30,32)(H,31,35) BPTIGDWWEZBMFT-UHFFFAOYSA-N 50355265 CHEMBL1834639 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 3100 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355265&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56671924 136361951 CHEMBL1834639 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665364 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@@H](CC2)C#N)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(30.89,-2.35,;29.64,-1.44,;28.17,-1.91,;27.27,-.67,;25.73,-.67,;24.97,.67,;23.43,.67,;22.65,-.66,;22.66,2.01,;21.12,2.02,;20.03,.93,;18.94,2.03,;20.04,3.11,;17.4,2.03,;16.63,3.37,;15.09,3.38,;14.32,2.05,;15.09,.71,;16.62,.7,;12.78,2.05,;11.25,2.05,;28.18,.58,;27.87,2.07,;29,3.09,;30.46,2.62,;30.78,1.12,;29.64,.1,;28.68,4.6,;29.82,5.63,;27.21,5.07,;28.26,6.1,)| InChI=1S/C21H25F3N6O/c1-29-18-7-4-14(21(22,23)24)8-17(18)20(28-29)26-10-19(31)27-15-11-30(12-15)16-5-2-13(9-25)3-6-16/h4,7-8,13,15-16H,2-3,5-6,10-12H2,1H3,(H,26,28)(H,27,31) YMWLGNDIOUYMFZ-UHFFFAOYSA-N 50355266 CHEMBL1834638 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 24000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355266&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54754844 136361952 CHEMBL1834638 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665365 CC(C)[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:6.9,3.2,(-9.77,4.13,;-9,2.8,;-9.77,1.46,;-7.46,2.8,;-6.7,4.12,;-5.15,4.12,;-4.38,2.78,;-5.16,1.45,;-6.69,1.45,;-2.85,2.78,;-1.76,1.68,;-.66,2.76,;-1.75,3.85,;.88,2.76,;1.64,1.42,;.87,.09,;3.18,1.42,;3.95,.08,;5.49,.08,;6.39,-1.17,;7.85,-.7,;7.85,.85,;8.99,1.87,;8.68,3.37,;7.21,3.84,;6.08,2.82,;6.4,1.32,;6.89,5.35,;8.03,6.38,;5.43,5.82,;6.48,6.84,)| InChI=1S/C22H30F3N5O/c1-13(2)14-3-6-17(7-4-14)30-11-16(12-30)27-20(31)10-26-21-18-9-15(22(23,24)25)5-8-19(18)28-29-21/h5,8-9,13-14,16-17H,3-4,6-7,10-12H2,1-2H3,(H,27,31)(H2,26,28,29) ALAVGBJMBKWLAD-UHFFFAOYSA-N 50355267 CHEMBL1834637 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 6200 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355267 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355267&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54755193 136361953 CHEMBL1834637 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665366 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)n3ccccc3=O)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.44,2.51,;6.97,2.98,;8.03,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.94,-4.01,;7.04,-2.76,;5.5,-2.76,;4.73,-1.42,;3.19,-1.42,;2.42,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.2,1.02,;-2.84,-.06,;-3.61,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.15,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,1.3,;-9.77,1.29,;-10.54,-.04,;-9.77,-1.38,;-8.23,-1.38,;-7.46,-2.71,;7.94,-1.51,;7.63,-.02,)| InChI=1S/C24H27F3N6O2/c25-24(26,27)15-4-9-20-19(11-15)23(31-30-20)28-12-21(34)29-16-13-32(14-16)17-5-7-18(8-6-17)33-10-2-1-3-22(33)35/h1-4,9-11,16-18H,5-8,12-14H2,(H,29,34)(H2,28,30,31) OWPZOIUERRHILB-UHFFFAOYSA-N 50355268 CHEMBL1834636 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 34000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355268 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355268&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54755083 136361954 CHEMBL1834636 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665367 Cn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2ccc3OCOc3c2)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(12.85,-40.75,;11.6,-39.84,;10.14,-40.31,;9.24,-39.07,;7.7,-39.07,;6.93,-37.73,;5.39,-37.72,;4.62,-39.06,;4.63,-36.39,;3.09,-36.38,;1.99,-37.47,;.9,-36.37,;2,-35.29,;-.64,-36.36,;-1.41,-37.69,;-2.95,-37.69,;-3.71,-36.35,;-2.95,-35.02,;-1.4,-35.03,;-5.25,-36.35,;-6.03,-37.68,;-7.57,-37.68,;-8.34,-36.34,;-9.83,-36.03,;-10,-34.51,;-8.61,-33.88,;-7.58,-35.02,;-6.03,-35.01,;10.15,-37.82,;9.83,-36.33,;10.96,-35.3,;12.43,-35.78,;12.74,-37.28,;11.6,-38.3,;10.64,-33.8,;11.78,-32.77,;9.17,-33.33,;10.23,-32.3,)| InChI=1S/C27H30F3N5O3/c1-34-22-8-5-18(27(28,29)30)11-21(22)26(33-34)31-12-25(36)32-19-13-35(14-19)20-6-2-16(3-7-20)17-4-9-23-24(10-17)38-15-37-23/h4-5,8-11,16,19-20H,2-3,6-7,12-15H2,1H3,(H,31,33)(H,32,36) QPEQRQQPWVTPFP-UHFFFAOYSA-N 50355269 CHEMBL1834635 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 840 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355269&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56664979 136361955 CHEMBL1834635 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665368 COc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(-11.69,1.29,;-10.92,-.05,;-9.38,-.04,;-8.61,1.29,;-7.07,1.29,;-6.3,-.04,;-7.07,-1.37,;-8.6,-1.38,;-4.76,-.04,;-4,-1.39,;-2.46,-1.39,;-1.69,-.06,;-2.45,1.28,;-4,1.29,;-.15,-.06,;.94,-1.16,;2.04,-.08,;.95,1.02,;3.58,-.08,;4.34,-1.42,;3.57,-2.75,;5.88,-1.42,;6.65,-2.76,;8.19,-2.76,;9.09,-4.01,;10.55,-3.53,;10.55,-1.99,;11.69,-.97,;11.38,.53,;9.91,1,;8.78,-.02,;9.1,-1.51,;9.59,2.51,;10.73,3.54,;8.12,2.98,;9.18,4.01,)| InChI=1S/C25H29F3N6O2/c1-36-23-9-4-16(11-29-23)15-2-6-19(7-3-15)34-13-18(14-34)31-22(35)12-30-24-20-10-17(25(26,27)28)5-8-21(20)32-33-24/h4-5,8-11,15,18-19H,2-3,6-7,12-14H2,1H3,(H,31,35)(H2,30,32,33) WANRYTYAXACNHP-UHFFFAOYSA-N 50355270 CHEMBL1834634 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2500 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355270 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355270&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54754968 136361956 CHEMBL1834634 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665369 NC(=O)Cc1ccc(cc1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:13.17,10.10,(-8.25,-29.41,;-9.01,-28.08,;-10.55,-28.08,;-8.24,-26.74,;-6.7,-26.75,;-5.93,-28.09,;-4.39,-28.09,;-3.62,-26.75,;-4.4,-25.41,;-5.94,-25.41,;-2.08,-26.75,;-1.31,-28.09,;.22,-28.1,;1,-26.77,;.23,-25.43,;-1.32,-25.42,;2.54,-26.77,;3.63,-27.87,;4.72,-26.79,;3.63,-25.69,;6.26,-26.79,;7.03,-28.13,;6.25,-29.46,;8.57,-28.13,;9.33,-29.47,;10.87,-29.47,;11.77,-30.71,;13.24,-30.24,;13.24,-28.7,;14.37,-27.68,;14.06,-26.18,;12.6,-25.71,;11.46,-26.73,;11.78,-28.22,;12.27,-24.2,;13.42,-23.17,;10.81,-23.73,;11.86,-22.7,)| InChI=1S/C27H31F3N6O2/c28-27(29,30)19-7-10-23-22(12-19)26(35-34-23)32-13-25(38)33-20-14-36(15-20)21-8-5-18(6-9-21)17-3-1-16(2-4-17)11-24(31)37/h1-4,7,10,12,18,20-21H,5-6,8-9,11,13-15H2,(H2,31,37)(H,33,38)(H2,32,34,35) LJAWGNFSXAWFQQ-UHFFFAOYSA-N 50355271 CHEMBL1834633 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 9500 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355271 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355271&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54755079 136361957 CHEMBL1834633 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665370 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccc4OCOc4c3)c2c1 |r,wU:20.20,23.27,(33.39,-15.27,;32.25,-16.3,;30.78,-15.83,;31.83,-14.8,;32.57,-17.8,;34.03,-18.28,;34.35,-19.78,;33.21,-20.8,;33.21,-22.34,;31.74,-22.81,;30.84,-21.57,;29.3,-21.57,;28.54,-20.23,;27,-20.22,;26.22,-21.56,;26.23,-18.89,;24.69,-18.88,;23.6,-19.97,;22.51,-18.87,;23.61,-17.79,;20.97,-18.86,;20.19,-20.19,;18.66,-20.19,;17.89,-18.85,;18.66,-17.52,;20.2,-17.53,;16.35,-18.85,;15.58,-20.18,;14.04,-20.18,;13.27,-18.84,;11.77,-18.53,;11.61,-17.01,;13,-16.38,;14.03,-17.52,;15.57,-17.51,;31.75,-20.32,;31.44,-18.83,)| InChI=1S/C26H28F3N5O3/c27-26(28,29)17-4-7-21-20(10-17)25(33-32-21)30-11-24(35)31-18-12-34(13-18)19-5-1-15(2-6-19)16-3-8-22-23(9-16)37-14-36-22/h3-4,7-10,15,18-19H,1-2,5-6,11-14H2,(H,31,35)(H2,30,32,33) CHXGVUFRAUAFHM-UHFFFAOYSA-N 50355272 CHEMBL1834632 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1100 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355272&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54754969 136361958 CHEMBL1834632 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665371 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3ccccc3)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.44,2.51,;6.97,2.98,;8.03,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.94,-4.01,;7.04,-2.76,;5.5,-2.76,;4.73,-1.42,;3.19,-1.42,;2.42,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.2,1.02,;-2.84,-.06,;-3.61,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.15,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,-1.38,;-9.77,-1.38,;-10.54,-.04,;-9.77,1.29,;-8.23,1.3,;7.94,-1.51,;7.63,-.02,)| InChI=1S/C25H28F3N5O/c26-25(27,28)18-8-11-22-21(12-18)24(32-31-22)29-13-23(34)30-19-14-33(15-19)20-9-6-17(7-10-20)16-4-2-1-3-5-16/h1-5,8,11-12,17,19-20H,6-7,9-10,13-15H2,(H,30,34)(H2,29,31,32) MBQDUNUKUGTDDX-UHFFFAOYSA-N 50355273 CHEMBL1834631 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1200 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355273&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56671923 136361959 CHEMBL1834631 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665372 FC(F)(F)c1ccc2onc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3nccs3)c2c1 |r,wU:20.20,23.27,(9.33,-4.79,;8.19,-5.82,;6.72,-5.35,;7.78,-4.32,;8.51,-7.33,;9.98,-7.8,;10.29,-9.3,;9.15,-10.32,;9.15,-11.86,;7.69,-12.34,;6.79,-11.09,;5.25,-11.09,;4.48,-9.75,;2.94,-9.75,;2.17,-11.08,;2.18,-8.41,;.64,-8.41,;-.46,-9.49,;-1.55,-8.39,;-.45,-7.31,;-3.09,-8.39,;-3.86,-9.72,;-5.4,-9.72,;-6.16,-8.37,;-5.4,-7.04,;-3.85,-7.05,;-7.7,-8.37,;-8.61,-7.12,;-10.07,-7.6,;-10.07,-9.14,;-8.61,-9.61,;7.7,-9.84,;7.38,-8.35,)| InChI=1S/C22H24F3N5O2S/c23-22(24,25)14-3-6-18-17(9-14)20(29-32-18)27-10-19(31)28-15-11-30(12-15)16-4-1-13(2-5-16)21-26-7-8-33-21/h3,6-9,13,15-16H,1-2,4-5,10-12H2,(H,27,29)(H,28,31) DOAPNMVLEGQTQO-UHFFFAOYSA-N 50355293 CHEMBL1834854 C-C chemokine receptor type 2 Homo sapiens 27 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355293&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56676474 136361979 CHEMBL1834854 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665373 COc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1noc2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(-10.72,2.46,;-9.95,1.13,;-8.41,1.13,;-7.64,2.47,;-6.1,2.47,;-5.34,1.13,;-6.1,-.2,;-7.63,-.2,;-3.8,1.13,;-3.03,-.21,;-1.5,-.21,;-.72,1.12,;-1.49,2.45,;-3.04,2.46,;.82,1.11,;1.91,.01,;3,1.1,;1.92,2.19,;4.54,1.09,;5.31,-.24,;4.53,-1.57,;6.85,-.25,;7.61,-1.58,;9.15,-1.59,;10.05,-2.83,;11.52,-2.36,;11.52,-.82,;12.66,.2,;12.34,1.7,;10.88,2.18,;9.74,1.15,;10.06,-.34,;10.55,3.68,;11.7,4.71,;9.09,4.16,;10.14,5.18,)| InChI=1S/C25H28F3N5O3/c1-35-23-9-4-16(11-29-23)15-2-6-19(7-3-15)33-13-18(14-33)31-22(34)12-30-24-20-10-17(25(26,27)28)5-8-21(20)36-32-24/h4-5,8-11,15,18-19H,2-3,6-7,12-14H2,1H3,(H,30,32)(H,31,34) ZZFKFTVPUSBMNB-UHFFFAOYSA-N 50355295 CHEMBL1834852 C-C chemokine receptor type 2 Homo sapiens 20 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355295 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355295&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56659295 136361981 CHEMBL1834852 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665374 Cn1ccc(n1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:6.6,9.13,(-11,-46.89,;-9.75,-45.98,;-9.75,-44.44,;-8.29,-43.96,;-7.38,-45.22,;-8.29,-46.46,;-5.84,-45.21,;-5.08,-46.56,;-3.54,-46.56,;-2.77,-45.23,;-3.54,-43.89,;-5.08,-43.89,;-1.23,-45.24,;-.14,-46.34,;.96,-45.25,;-.13,-44.16,;2.5,-45.25,;3.26,-46.59,;2.49,-47.92,;4.8,-46.6,;5.57,-47.93,;7.11,-47.94,;8.01,-49.18,;9.47,-48.71,;10.72,-49.61,;9.47,-47.17,;10.61,-46.15,;10.3,-44.65,;8.83,-44.17,;7.7,-45.2,;8.01,-46.69,;8.51,-42.67,;9.65,-41.63,;7.04,-42.19,;8.1,-41.17,)| InChI=1S/C24H30F3N7O/c1-32-10-9-20(30-32)15-3-6-18(7-4-15)34-13-17(14-34)29-22(35)12-28-23-19-11-16(24(25,26)27)5-8-21(19)33(2)31-23/h5,8-11,15,17-18H,3-4,6-7,12-14H2,1-2H3,(H,28,31)(H,29,35) BMLUECIKNCZOMW-UHFFFAOYSA-N 50355296 CHEMBL1834851 C-C chemokine receptor type 2 Homo sapiens 140 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355296 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355296&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56669631 136361982 CHEMBL1834851 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665375 CC(C)c1ncc(s1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(13.82,-28.32,;15.23,-28.94,;15.39,-30.47,;16.48,-28.04,;16.47,-26.5,;17.94,-26.02,;18.84,-27.27,;17.94,-28.51,;20.38,-27.27,;21.15,-28.62,;22.68,-28.62,;23.46,-27.29,;22.69,-25.95,;21.15,-25.94,;25,-27.29,;26.09,-28.39,;27.18,-27.31,;26.1,-26.21,;28.72,-27.31,;29.49,-28.65,;28.71,-29.98,;31.03,-28.65,;31.79,-29.99,;33.33,-29.99,;34.23,-31.24,;35.7,-30.76,;36.94,-31.67,;35.7,-29.22,;36.84,-28.2,;36.52,-26.7,;35.06,-26.23,;33.92,-27.25,;34.24,-28.74,;34.73,-24.72,;35.88,-23.69,;33.27,-24.25,;34.32,-23.22,)| InChI=1S/C26H33F3N6OS/c1-15(2)25-31-11-22(37-25)16-4-7-19(8-5-16)35-13-18(14-35)32-23(36)12-30-24-20-10-17(26(27,28)29)6-9-21(20)34(3)33-24/h6,9-11,15-16,18-19H,4-5,7-8,12-14H2,1-3H3,(H,30,33)(H,32,36) WLCRNAWGAIMIQQ-UHFFFAOYSA-N 50355299 CHEMBL1834799 C-C chemokine receptor type 2 Homo sapiens 12 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355299 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355299&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56683116 136361985 CHEMBL1834799 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665376 CCc1ncc(s1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:7.7,10.14,(-11.12,-28.31,;-9.71,-28.94,;-8.47,-28.03,;-8.47,-26.49,;-7,-26.01,;-6.1,-27.26,;-7,-28.5,;-4.56,-27.26,;-3.79,-28.61,;-2.26,-28.61,;-1.48,-27.28,;-2.25,-25.94,;-3.8,-25.94,;.06,-27.28,;1.15,-28.38,;2.24,-27.3,;1.15,-26.21,;3.78,-27.3,;4.54,-28.64,;3.77,-29.97,;6.08,-28.64,;6.85,-29.98,;8.39,-29.99,;9.29,-31.23,;10.76,-30.76,;12,-31.66,;10.75,-29.22,;11.89,-28.19,;11.58,-26.69,;10.11,-26.22,;8.98,-27.24,;9.3,-28.74,;9.79,-24.71,;10.93,-23.68,;8.33,-24.24,;9.38,-23.22,)| InChI=1S/C25H31F3N6OS/c1-3-23-29-11-21(36-23)15-4-7-18(8-5-15)34-13-17(14-34)31-22(35)12-30-24-19-10-16(25(26,27)28)6-9-20(19)33(2)32-24/h6,9-11,15,17-18H,3-5,7-8,12-14H2,1-2H3,(H,30,32)(H,31,35) PGRNRBAPTURBFI-UHFFFAOYSA-N 50355300 CHEMBL1834798 C-C chemokine receptor type 2 Homo sapiens 7 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355300 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355300&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56662695 136361986 CHEMBL1834798 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665377 Cc1ncc(s1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1nn(C)c2ccc(cc12)C(F)(F)F |r,wU:6.6,9.13,(12.2,-18.67,;13.44,-17.76,;13.44,-16.22,;14.91,-15.75,;15.81,-17,;14.91,-18.24,;17.35,-17,;18.12,-18.34,;19.65,-18.34,;20.43,-17.01,;19.66,-15.68,;18.11,-15.67,;21.97,-17.02,;23.06,-18.12,;24.15,-17.03,;23.06,-15.94,;25.69,-17.04,;26.45,-18.37,;25.68,-19.7,;27.99,-18.38,;28.76,-19.71,;30.3,-19.72,;31.2,-20.96,;32.67,-20.49,;33.91,-21.4,;32.66,-18.95,;33.8,-17.93,;33.49,-16.43,;32.02,-15.95,;30.89,-16.98,;31.21,-18.47,;31.7,-14.45,;32.84,-13.42,;30.24,-13.97,;31.29,-12.95,)| InChI=1S/C24H29F3N6OS/c1-14-28-10-21(35-14)15-3-6-18(7-4-15)33-12-17(13-33)30-22(34)11-29-23-19-9-16(24(25,26)27)5-8-20(19)32(2)31-23/h5,8-10,15,17-18H,3-4,6-7,11-13H2,1-2H3,(H,29,31)(H,30,34) QESGQSXZLHDYTQ-UHFFFAOYSA-N 50355301 CHEMBL1834797 C-C chemokine receptor type 2 Homo sapiens 33 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355301 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355301&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56659197 136361987 CHEMBL1834797 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665378 OCCn1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2nccs2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(12.47,-23.07,;11.22,-22.17,;11.39,-20.63,;10.14,-19.73,;8.68,-20.2,;7.78,-18.96,;6.24,-18.95,;5.47,-17.62,;3.93,-17.61,;3.16,-18.94,;3.16,-16.27,;1.62,-16.27,;.53,-17.36,;-.56,-16.26,;.54,-15.18,;-2.1,-16.25,;-2.87,-17.58,;-4.41,-17.58,;-5.18,-16.23,;-4.41,-14.91,;-2.87,-14.91,;-6.72,-16.24,;-7.62,-14.98,;-9.08,-15.46,;-9.08,-17,;-7.62,-17.48,;8.68,-17.71,;8.37,-16.22,;9.5,-15.19,;10.96,-15.67,;11.28,-17.17,;10.14,-18.19,;9.18,-13.69,;10.32,-12.65,;7.71,-13.21,;8.77,-12.19,)| InChI=1S/C24H29F3N6O2S/c25-24(26,27)16-3-6-20-19(11-16)22(31-33(20)8-9-34)29-12-21(35)30-17-13-32(14-17)18-4-1-15(2-5-18)23-28-7-10-36-23/h3,6-7,10-11,15,17-18,34H,1-2,4-5,8-9,12-14H2,(H,29,31)(H,30,35) UZVFZTWEBLXYKJ-UHFFFAOYSA-N 50355302 CHEMBL1834796 C-C chemokine receptor type 2 Homo sapiens 22 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355302 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355302&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56659196 136361988 CHEMBL1834796 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665379 NC(=O)n1nc(NCC(=O)NC2CN(C2)[C@H]2CC[C@H](CC2)c2nccs2)c2cc(ccc12)C(F)(F)F |r,wU:18.22,15.15,(35.73,-11.8,;34.32,-12.42,;34.16,-13.95,;33.08,-11.51,;31.61,-11.99,;30.71,-10.74,;29.17,-10.74,;28.41,-9.4,;26.87,-9.4,;26.09,-10.73,;26.1,-8.06,;24.56,-8.06,;23.47,-9.14,;22.38,-8.04,;23.48,-6.96,;20.84,-8.04,;20.06,-9.37,;18.53,-9.37,;17.76,-8.02,;18.52,-6.69,;20.07,-6.7,;16.22,-8.02,;15.32,-6.77,;13.85,-7.25,;13.85,-8.79,;15.32,-9.26,;31.62,-9.49,;31.3,-8,;32.44,-6.98,;33.9,-7.45,;34.22,-8.95,;33.08,-9.97,;32.11,-5.47,;33.26,-4.44,;30.65,-5,;31.7,-3.97,)| InChI=1S/C23H26F3N7O2S/c24-23(25,26)14-3-6-18-17(9-14)20(31-33(18)22(27)35)29-10-19(34)30-15-11-32(12-15)16-4-1-13(2-5-16)21-28-7-8-36-21/h3,6-9,13,15-16H,1-2,4-5,10-12H2,(H2,27,35)(H,29,31)(H,30,34) OUBSBSYAMLKCPV-UHFFFAOYSA-N 50355303 CHEMBL1834795 C-C chemokine receptor type 2 Homo sapiens 7 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355303 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355303&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56683044 136361989 CHEMBL1834795 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665380 Cn1nc(NCC(=O)NC2CN(C2)[C@@H]2CC[C@@H](CC2)C#C)c2cc(ccc12)C(F)(F)F |r,wU:13.13,16.20,(32.38,-50.73,;31.13,-49.82,;29.67,-50.29,;28.77,-49.05,;27.23,-49.04,;26.46,-47.71,;24.92,-47.7,;24.15,-49.03,;24.16,-46.37,;22.62,-46.36,;21.52,-47.45,;20.43,-46.35,;21.53,-45.27,;18.89,-46.34,;18.13,-45.01,;16.58,-45,;15.82,-46.33,;16.58,-47.67,;18.12,-47.67,;14.28,-46.33,;12.74,-46.33,;29.68,-47.8,;29.36,-46.31,;30.49,-45.28,;31.96,-45.76,;32.27,-47.26,;31.13,-48.28,;30.17,-43.78,;31.31,-42.75,;28.7,-43.3,;29.76,-42.28,)| InChI=1S/C22H26F3N5O/c1-3-14-4-7-17(8-5-14)30-12-16(13-30)27-20(31)11-26-21-18-10-15(22(23,24)25)6-9-19(18)29(2)28-21/h1,6,9-10,14,16-17H,4-5,7-8,11-13H2,2H3,(H,26,28)(H,27,31) PSWNFJQWICYKCD-UHFFFAOYSA-N 50355304 CHEMBL1833983 C-C chemokine receptor type 2 Homo sapiens 10000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355304 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355304&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56672021 136361990 CHEMBL1833983 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665381 COc1ccc(cn1)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1noc2ccc(cc12)C(F)(F)F |r,wU:8.8,11.15,(-10.72,2.46,;-9.95,1.13,;-8.41,1.13,;-7.64,2.47,;-6.1,2.47,;-5.34,1.13,;-6.1,-.2,;-7.63,-.2,;-3.8,1.13,;-3.03,-.21,;-1.5,-.21,;-.72,1.12,;-1.49,2.45,;-3.04,2.46,;.82,1.11,;1.91,.01,;3,1.1,;1.92,2.19,;4.54,1.09,;5.31,-.24,;4.53,-1.57,;6.85,-.25,;7.61,-1.58,;9.15,-1.59,;10.05,-2.83,;11.52,-2.36,;11.52,-.82,;12.66,.2,;12.34,1.7,;10.88,2.18,;9.74,1.15,;10.06,-.34,;10.55,3.68,;11.7,4.71,;9.09,4.16,;10.14,5.18,)| InChI=1S/C25H28F3N5O3/c1-35-23-9-4-16(11-29-23)15-2-6-19(7-3-15)33-13-18(14-33)31-22(34)12-30-24-20-10-17(25(26,27)28)5-8-21(20)36-32-24/h4-5,8-11,15,18-19H,2-3,6-7,12-14H2,1H3,(H,30,32)(H,31,34) ZZFKFTVPUSBMNB-UHFFFAOYSA-N 50355295 CHEMBL1834852 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 8.7 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355295 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355295&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56659295 136361981 CHEMBL1834852 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665382 FC(F)(F)c1ccc2[nH]nc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3cccnc3)c2c1 |r,wU:23.27,20.20,(9.58,3.54,;8.43,2.51,;6.97,2.98,;8.02,4.01,;8.76,1,;10.22,.53,;10.54,-.97,;9.4,-1.99,;9.4,-3.53,;7.93,-4.01,;7.03,-2.76,;5.49,-2.76,;4.73,-1.42,;3.19,-1.42,;2.41,-2.75,;2.42,-.08,;.88,-.08,;-.21,-1.16,;-1.3,-.06,;-.21,1.02,;-2.84,-.06,;-3.62,-1.39,;-5.15,-1.39,;-5.92,-.04,;-5.16,1.29,;-3.61,1.28,;-7.46,-.04,;-8.23,1.29,;-9.77,1.29,;-10.54,-.04,;-9.76,-1.38,;-8.22,-1.37,;7.94,-1.51,;7.62,-.02,)| InChI=1S/C24H27F3N6O/c25-24(26,27)17-5-8-21-20(10-17)23(32-31-21)29-12-22(34)30-18-13-33(14-18)19-6-3-15(4-7-19)16-2-1-9-28-11-16/h1-2,5,8-11,15,18-19H,3-4,6-7,12-14H2,(H,30,34)(H2,29,31,32) YXXGTVBNVRVOKC-UHFFFAOYSA-N 50355283 CHEMBL1834787 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 36000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355283 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355283&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56671792 136361969 CHEMBL1834787 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665383 CCO[C@H]1CC[C@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:3.2,6.9,(-8.61,2.63,;-9.38,1.29,;-8.61,-.04,;-7.07,-.04,;-6.31,1.29,;-4.76,1.28,;-3.99,-.06,;-4.77,-1.39,;-6.3,-1.39,;-2.45,-.06,;-1.36,-1.16,;-.27,-.08,;-1.36,1.02,;1.27,-.08,;2.03,-1.42,;1.26,-2.75,;3.57,-1.42,;4.34,-2.76,;5.88,-2.76,;6.78,-4.01,;8.24,-3.53,;8.24,-1.99,;9.38,-.97,;9.07,.53,;7.6,1,;6.47,-.02,;6.79,-1.51,;7.28,2.51,;8.42,3.54,;5.82,2.98,;6.87,4.01,)| InChI=1S/C21H28F3N5O2/c1-2-31-16-6-4-15(5-7-16)29-11-14(12-29)26-19(30)10-25-20-17-9-13(21(22,23)24)3-8-18(17)27-28-20/h3,8-9,14-16H,2,4-7,10-12H2,1H3,(H,26,30)(H2,25,27,28) CVZMFXLZFUQQCZ-UHFFFAOYSA-N 50355257 CHEMBL1834647 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 4500 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355257&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56675301 136361943 CHEMBL1834647 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50665384 FC(F)(F)c1ccc2onc(NCC(=O)NC3CN(C3)[C@H]3CC[C@H](CC3)c3cncs3)c2c1 |r,wU:20.20,23.27,(33.91,5.25,;32.77,4.22,;31.3,4.69,;32.36,5.72,;33.09,2.71,;34.55,2.24,;34.87,.74,;33.73,-.28,;33.73,-1.82,;32.27,-2.29,;31.37,-1.05,;29.83,-1.05,;29.06,.29,;27.52,.29,;26.75,-1.04,;26.75,1.63,;25.21,1.63,;24.12,.55,;23.03,1.65,;24.13,2.73,;21.49,1.65,;20.72,.32,;19.18,.33,;18.41,1.67,;19.18,3,;20.72,2.99,;16.87,1.67,;15.97,2.92,;14.51,2.44,;14.51,.9,;15.97,.43,;32.27,.2,;31.96,1.69,)| InChI=1S/C22H24F3N5O2S/c23-22(24,25)14-3-6-18-17(7-14)21(29-32-18)27-9-20(31)28-15-10-30(11-15)16-4-1-13(2-5-16)19-8-26-12-33-19/h3,6-8,12-13,15-16H,1-2,4-5,9-11H2,(H,27,29)(H,28,31) FQXDXSUCYIDGPA-UHFFFAOYSA-N 50355294 CHEMBL1834853 C-C chemokine receptor type 2 Homo sapiens 37 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355294 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355294&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56683121 136361980 CHEMBL1834853 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50665385 CCOC(=O)[C@@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1noc2ccc(cc12)C(F)(F)F |r,wU:5.4,8.11,(-9.38,3.96,;-8.61,2.63,;-9.38,1.29,;-8.61,-.04,;-9.38,-1.38,;-7.07,-.04,;-6.3,-1.39,;-4.77,-1.39,;-3.99,-.06,;-4.76,1.28,;-6.31,1.29,;-2.45,-.06,;-1.36,-1.16,;-.27,-.08,;-1.36,1.02,;1.27,-.08,;2.03,-1.42,;1.26,-2.75,;3.57,-1.42,;4.34,-2.76,;5.88,-2.76,;6.78,-4.01,;8.25,-3.53,;8.24,-1.99,;9.38,-.97,;9.07,.53,;7.6,1,;6.47,-.02,;6.79,-1.51,;7.28,2.51,;8.42,3.54,;5.82,2.98,;6.87,4.01,)| InChI=1S/C22H27F3N4O4/c1-2-32-21(31)13-3-6-16(7-4-13)29-11-15(12-29)27-19(30)10-26-20-17-9-14(22(23,24)25)5-8-18(17)33-28-20/h5,8-9,13,15-16H,2-4,6-7,10-12H2,1H3,(H,26,28)(H,27,30) XODCWPJDJRYTNL-UHFFFAOYSA-N 50355292 CHEMBL1834720 C-C chemokine receptor type 2 Homo sapiens 29 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50355292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50355292&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54756038 136361978 CHEMBL1834720 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 51023812 COc1ccc(cn1)[C@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:12.16,wD:8.9,(-11.69,1.29,;-10.92,-.05,;-9.38,-.04,;-8.61,1.29,;-7.07,1.29,;-6.3,-.04,;-7.07,-1.37,;-8.6,-1.38,;-4.76,-.04,;-5.53,-1.37,;-4,-1.39,;-2.46,-1.39,;-1.69,-.06,;-2.45,1.28,;-4,1.29,;-.15,-.06,;.94,-1.16,;2.04,-.08,;.95,1.02,;3.58,-.08,;4.34,-1.42,;3.57,-2.75,;5.88,-1.42,;6.65,-2.76,;8.19,-2.76,;9.09,-4.01,;10.55,-3.53,;10.55,-1.99,;11.69,-.97,;11.38,.53,;9.91,1,;8.78,-.02,;9.1,-1.51,;9.59,2.51,;10.73,3.54,;8.12,2.98,;9.18,4.01,)| InChI=1S/C25H29F3N6O3/c1-37-22-5-3-16(11-29-22)24(36)8-6-18(7-9-24)34-13-17(14-34)31-21(35)12-30-23-19-10-15(25(26,27)28)2-4-20(19)32-33-23/h2-5,10-11,17-18,36H,6-9,12-14H2,1H3,(H,31,35)(H2,30,32,33) PCADRQQNOPBVHT-UHFFFAOYSA-N 50419280 CHEMBL2092884 C-C chemokine receptor type 2 Homo sapiens 10 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50419280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50419280&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754967 163368304 CHEMBL2092884 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 51023813 COc1ccc(cn1)[C@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:12.16,wD:8.9,(-11.69,1.29,;-10.92,-.05,;-9.38,-.04,;-8.61,1.29,;-7.07,1.29,;-6.3,-.04,;-7.07,-1.37,;-8.6,-1.38,;-4.76,-.04,;-5.53,-1.37,;-4,-1.39,;-2.46,-1.39,;-1.69,-.06,;-2.45,1.28,;-4,1.29,;-.15,-.06,;.94,-1.16,;2.04,-.08,;.95,1.02,;3.58,-.08,;4.34,-1.42,;3.57,-2.75,;5.88,-1.42,;6.65,-2.76,;8.19,-2.76,;9.09,-4.01,;10.55,-3.53,;10.55,-1.99,;11.69,-.97,;11.38,.53,;9.91,1,;8.78,-.02,;9.1,-1.51,;9.59,2.51,;10.73,3.54,;8.12,2.98,;9.18,4.01,)| InChI=1S/C25H29F3N6O3/c1-37-22-5-3-16(11-29-22)24(36)8-6-18(7-9-24)34-13-17(14-34)31-21(35)12-30-23-19-10-15(25(26,27)28)2-4-20(19)32-33-23/h2-5,10-11,17-18,36H,6-9,12-14H2,1H3,(H,31,35)(H2,30,32,33) PCADRQQNOPBVHT-UHFFFAOYSA-N 50419280 CHEMBL2092884 C-C chemokine receptor type 2 Homo sapiens 16 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50419280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50419280&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 54754967 163368304 CHEMBL2092884 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 51023814 COc1ccc(cn1)[C@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNc1n[nH]c2ccc(cc12)C(F)(F)F |r,wU:12.16,wD:8.9,(-11.69,1.29,;-10.92,-.05,;-9.38,-.04,;-8.61,1.29,;-7.07,1.29,;-6.3,-.04,;-7.07,-1.37,;-8.6,-1.38,;-4.76,-.04,;-5.53,-1.37,;-4,-1.39,;-2.46,-1.39,;-1.69,-.06,;-2.45,1.28,;-4,1.29,;-.15,-.06,;.94,-1.16,;2.04,-.08,;.95,1.02,;3.58,-.08,;4.34,-1.42,;3.57,-2.75,;5.88,-1.42,;6.65,-2.76,;8.19,-2.76,;9.09,-4.01,;10.55,-3.53,;10.55,-1.99,;11.69,-.97,;11.38,.53,;9.91,1,;8.78,-.02,;9.1,-1.51,;9.59,2.51,;10.73,3.54,;8.12,2.98,;9.18,4.01,)| InChI=1S/C25H29F3N6O3/c1-37-22-5-3-16(11-29-22)24(36)8-6-18(7-9-24)34-13-17(14-34)31-21(35)12-30-23-19-10-15(25(26,27)28)2-4-20(19)32-33-23/h2-5,10-11,17-18,36H,6-9,12-14H2,1H3,(H,31,35)(H2,30,32,33) PCADRQQNOPBVHT-UHFFFAOYSA-N 50419280 CHEMBL2092884 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 32000 ChEMBL 10.1016/j.bmcl.2011.08.074 10.7270/Q23N23SD 21917454 Zhang, X; Hufnagel, H; Hou, C; Opas, E; McKenney, S; Crysler, C; O'Neill, J; Johnson, D; Sui, Z 9/20/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50419280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50419280&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 54754967 163368304 CHEMBL2092884 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0